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Abstract
Human fungal pathogens, which cause approximately two million life-threatening
infections annually, represent a leading cause of morbidity and mortality for
immunocompromised individuals. Numerous fungal pathogens with increased virulence,
known as hypervirulence, have been identified, and the study of these organisms merits
further investigation as this would lead to a greater understanding of host-pathogen
interaction and regulation of virulence in fungi. We have identified two strains of
hypervirulent Candida albicans, which is the most frequent cause of systemic fungal
infections worldwide. These hypervirulent strains have mutations within the two major
phospholipid biosynthetic routes in C. albicans, known as the cytidine-diphosphate
diacylglycerol (CDP-DAG) and Kennedy pathways. Deletion of the Pem1 and Pem2
methyltransferases results in a buildup of the phospholipid phosphatidylethanolamine
(PE) within the CDP-DAG pathway, and this correlates with hypervirulence. Similarly,
overexpression of the Kennedy pathway, via constitutive expression of EPT1, results in
hypervirulence that correlates with increased PE synthesis. Deletion of EPT1 correlates
with reduced PE and reduced virulence. Prior research indicates that decreasing CDPDAG derived PE, by deletion of the Psd1 and Psd2 enzymes causes a decrease in
virulence. Thus, modulation of PE synthesis acts as a rheostat for virulence in C. albicans.
In this dissertation, we have determined that loss of PE synthesis by the CDP-DAG route
results in avirulence due to an inability to obtain sufficient ethanolamine from the host. To
determine how increased PE causes hypervirulence, transcriptomic analysis was
performed for both high PE and low PE strains. Interestingly, while there were no
transcriptional differences identified for the EPT1 overexpressor, there were increases in
vi

cell wall chitin and also hyphal growth, which suggests that an increase in PE modulates
virulence via a post-transcriptional mechanism. While the mechanism has not been fully
elucidated, hyphae are a major virulence factor for C. albicans that contribute to tissue
damage, and it has been demonstrated that chitin modulates immune responses. Taken
together, these phenotypes could explain why the EPT1 overexpressor is hypervirulent.
To our knowledge, the EPT1 overexpressor and PEM1 PEM2 null mutants are the first
descriptions of fungal hypervirulence resulting from mutations in phospholipid
biosynthetic pathways.
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: Hypervirulent Fungal Pathogens
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Introduction
Fungal infections are a major cause of co-morbidity and mortality in immunocompromised
patients (Perlroth et al., 2007). A recent study performed by the Centers for Disease
Control and Prevention estimated that there were approximately 75,000 hospitalizations
and almost 9 million outpatient visits for fungal infections in the United States in 2017,
which came at an estimated cost of $7.2 billion (Benedict et al., 2018). Of the fungi that
cause disseminated infection, some of the most prevalent infections in 2017 were caused
by Candida, Aspergillus, Histoplasma, Cryptococcus, and Pneumocystis spp. (Benedict
et al., 2018). Worldwide, there are over 2 million reported cases of life-threatening
infection and ~1.7 billion cases of superficial mycoses each year as a result of these five
fungi (Brown et al., 2012). The world-wide health crisis resulting from fungal infections is
worsened by an increasing prevalence of antifungal resistance, and multi-drug resistant
fungal infections (Revie et al., 2018). In addition, the increased frequency at which
systemic fungal infections are observed can be partially attributed to medical advances
that increase the longevity of immunosuppressed individuals (Perlroth et al., 2007).
Compounding these issues, novel fungal pathogens have emerged (e.g. Candida auris),
and there is a common yet understudied phenomenon of hypervirulence in human fungal
pathogens (Brown et al., 2016; de Cassia Orlandi Sardi et al., 2018). As a combined result
of these factors, there will likely be a rise in the incidence of life-threatening fungal
infections and fungal associated mortality for immunocompromised individuals unless
there is continued development of novel antifungals, which will require continued
advances in our understanding of fungal virulence and host-pathogen interactions.
One method we can use to develop a better understanding of fungal virulence and
2

regulation of virulence, is to investigate the phenomenon of “enhanced virulence,” which
has been widely observed in fungi and is commonly referred to “hypervirulence.” While
hypervirulence can encompass a variety of phenotypes, such as lower infectious dose or
increased damage against tissue culture cells, the term typically refers to occasions in
which an organism obtains a higher fungal burden within the host and can kill the host
more rapidly than its wild-type counterpart. Hypervirulent fungi have been isolated from
the environment, from patients in a clinical setting, and have also been created in the
laboratory (D'Souza et al., 2001; Wheeler et al., 2003; Kamran et al., 2004; Ma and May,
2010; Yu et al., 2018; Tams et al., 2019). The study of these pathogens has led to the
identification of specific genes that have a negative impact on virulence, which have been
described as “anti-virulence” or “virulence moderating genes,” as disruption of these
genes leads to a hypervirulent phenotype (Foreman-Wykert and Miller, 2003; Kamran et
al., 2004).
Since mutations that arise in virulence-moderating genes increase the virulence of
fungal pathogens, it is important to identify and characterize mutants with this phenotype
as the appearance of clinically important hypervirulent fungal pathogens (HVFPs) could
increase mortality in susceptible patients, allow for more frequent incidences of infection
in immunocompetent individuals, and potentially result in more severe superficial and
mucosal mycoses. Furthermore, several studies have identified drug resistant HVFPs
(Angiolella et al., 2008). Although antifungal resistance usually results in a fitness cost,
there are several examples, notably in C. glabrata, in which drug resistance correlates
with the development of hypervirulence (Vale-Silva and Sanglard, 2015). If drug
resistance is a selective pressure for hypervirulence, this could create dual-threat fungal
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pathogens as they would not only become more difficult to treat due to reduced antifungal efficacy, but because they also have an enhanced virulence phenotype (Angiolella
et al., 2008; Ferrari et al., 2009; Vale-Silva and Sanglard, 2015). Given the already
problematic rise in anti-fungal drug resistance, it is important to more thoroughly
investigate any relationship between drug resistance and hypervirulence.
Besides potential threats posed by HVFPs, the study of these organisms may help
answer questions regarding the regulation of virulence factors in fungi and may allow for
the identification of novel virulence factors or anti-fungal drug targets. The traditional
approach to search for novel drug targets has been to identify mutations which confer a
fitness disadvantage or avirulence. Therefore, there has been less focus on those
mutations for which an advantage is conferred. However, given the frequency at which
hypervirulence has been observed, and because regulatory virulence moderating genes
(e.g. transcription factors) are often identified, the identification and evaluation of HVFPs
can serve as a tool to develop a more thorough understanding of how fungal virulence is
regulated and thus is important for the development of novel antifungal agents.
Fungal Virulence Factors and Common Virulence-Moderating Genes
Saprophytic fungi such as Aspergillus spp. typically cause disease only in
immunocompromised individuals, however there are some saprophytic pathogens such
as Histoplasma and Cryptococcus spp. that can cause disease in otherwise healthy
individuals (Wheat, 2006; Kwon-Chung et al., 2014; van de Veerdonk et al., 2017). Other
fungi such as Candida glabrata and Candida albicans are commensal organisms that can
be found in the vaginal, oral, and gut microbiomes, and therefore must maintain the ability
to survive host defenses and not damage the host during normal growth (Nobile and
4

Johnson, 2015). This is a delicate balancing act that can be disrupted if the immune
system does not effectively stop fungal overgrowth or cannot respond to fungal mediated
damage as a result of immunosuppression (Badiee and Hashemizadeh, 2014). As is the
case for other infectious organisms, the ability of these fungal pathogens to cause disease
is reliant upon virulence factors that allow for growth in the host, manipulation of host
defenses, and damage to the host. The major virulence factors in fungi vary depending
on species, but can include growth at 37ºC, temperature dependent dimorphism,
formation of capsule, invasive growth, evasion from immunosurveillance or escape from
immune cells, and the production of lipases, proteases, adhesins, invasins, and toxic
peptides (Ghannoum, 2000; Naglik et al., 2003; Yang, 2003; O'Meara and Alspaugh,
2012; Mayer et al., 2013; Badiee and Hashemizadeh, 2014) (Figure 1.1, A-D).
Mutations in virulence moderating genes are frequently identified in HVFPs which
cause them to more easily cross the boundary from commensalism to pathogenesis.
Such mutations may cause increased expression of virulence factors or an increased
readiness to enter a pathogenic state. The most common mutations that are associated
with hypervirulence occur within transcription factors, and given that transcription factors
regulate numerous genes, it is often difficult to determine which gene(s) the transcription
factor impacts that are causative of hypervirulence (Kamran et al., 2004; Ferrari et al.,
2009; O'Meara et al., 2010; Kakade et al., 2019). In many cases, hypervirulence caused
by mutation in a transcription factor results in several phenotypes that, either
independently or together, may drive hypervirulence.
Hypervirulence can be induced not only by alterations in virulence factors
presented by the fungus, but also by changes that impact cell wall architecture (Bahnan
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Figure 1.1. Common fungal virulence factors.
(A) Some fungi can form filaments that aid in dissemination across epithelial and
endothelial barriers. For example, C. albicans can produce hyphae that actively
penetrate these barriers or induce their own endocytosis. (B) Filamentation can aid
in escape from the phagolysosome of immune cells and thus aid in immune evasion.
(C) Dimorphism, the switch from yeast to pseudohyphae or to hyphae, and in some
cases from filamentous to yeast form cells, is an important virulence factor. (D) C.
neoformans can form a polysaccharide capsule that aids in immune evasion.
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et al., 2012; Duvenage et al., 2019). It is conceivable that alterations in the cell wall which
lead to hypervirulence may occur due to exposure of antigenic cell wall components and
subsequent inflammation with immunopathology, or alternatively as a result of decreased
fungal antigen recognition by the immune system and immune evasion. In this chapter,
several commonly observed phenotypes associated with hypervirulence will be discussed
including (i) increased invasion or filamentation, (ii) changes to cell wall composition and
subsequent modification of host immune response, and (iii) drug resistance.
Hypervirulence Driven by Increased Invasion or Filamentation
Filamentation is used by some fungi, such as Candida and Aspergillus spp., to form
biofilms or to physically rupture cells in host tissues (Figure 1.1, A) (Mayer et al., 2013;
van de Veerdonk et al., 2017). In addition to directly damaging cells, C. albicans hyphae
can induce their own phagocytosis by endothelial cells to aid in migration across
endothelial cell barriers, and hyphae can aid in immune evasion as they mediate escape
from the phagolysosome of granulocytes (Figure 1.1, A-B). (Wachtler et al., 2012; Mayer
et al., 2013). The formation of hyphae is arguably one of the most important virulence
factors for C. albicans, as locking it in the yeast form results in avirulence in the mouse
systemic model of infection, and also because there are numerous virulence factors for
which expression is dependent upon formation of hyphae (Figure 1.1, C). (Lo et al., 1997;
Wilson et al., 2016). Avirulence of yeast-locked cells is most likely due to a combined loss
of the ability to actively penetrate cells and to induce endocytosis, as well as downregulation of hyphal associated virulence factors (Wilson et al., 2016). Interestingly,
locking C. albicans in the filamentous form also results in avirulence, presumably due to
an inability to disseminate effectively (Braun and Johnson, 1997; Murad et al., 2001).
7

Therefore, it is important to be able to switch between the yeast and hyphal forms for the
organism to be virulent. Several studies have shown that hypervirulence of C. albicans is
correlated with an increased filamentation phenotype (Angiolella et al., 2008; Carlisle et
al., 2009; Bahnan et al., 2012; Duvenage et al., 2019). This suggests that pushing C.
albicans towards increased filamentation causes increased virulence, however C.
albicans must still be able to form yeast cells or virulence is lost, as is the case for C.
albicans locked completely in the filamentous state (Braun and Johnson, 1997; Murad et
al., 2001).
To determine how the degree of filamentation impacts virulence for C. albicans,
one study employed the use of a doxycycline repressible system to overexpress UME6,
which is a transcriptional activator of hyphal formation and other hyphal associated genes
(Carlisle et al., 2009). The result of UME6 overexpression in vitro was increased hyphal
production and increased agar invasion, and this correlated to hypervirulence in the
mouse model of disseminated candidiasis (Carlisle et al., 2009). Importantly, in this
mouse model, mice were infected with yeast form cells, and expression of UME6 was
induced within the mouse by the absence of doxycycline in the drinking water. This
allowed for yeast form cells to disseminate throughout the mouse, and then for strong
formation of hyphae to occur (Carlisle et al., 2009). One caveat to this approach is that a
transcription factor was overexpressed, and other hyphal associated genes were induced.
Hypervirulence in this mutant is therefore likely due to a pleiotropic effect of increased
hyphal formation as well as increased expression of other virulence factors. For example,
it was observed that transcription of candidalysin, a small pore forming toxic peptide, was
also increased in the UME6 overexpression strain in vitro (Carlisle et al., 2009).
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A deletion of the C. albicans PIR32 gene, which encodes a cell wall protein that is
homologous to S. cerevisiae Pir proteins that are important for cell wall integrity, also
results in increased hyphal formation at 37°C in potato dextrose broth (Bahnan et al.,
2012). Despite increased hyphal formation, this mutant exhibits a decreased capability to
from biofilms, a decreased capacity for adhesion to plastic, and a slightly delayed ability
to adhere to epithelial cells (Bahnan et al., 2012). Regardless, the mutant has a stark
increase in virulence in the mouse model of systemic infection as compared to the wildtype strain (Bahnan et al., 2012). One possible explanation is that this strain has a drastic
increase in the amount of chitin in the cell, which is known to be a stress response to
compensate for the loss of cell wall proteins (Bahnan et al., 2012). The authors
hypothesize that the increase in filamentation causes increased damage to organs, and
that the increased chitin, which is a structural component of the cell wall important for
rigidity, may increase resistance to host immune attacks (Bahnan et al., 2012).
Hypervirulence In Non-Hyphal Pathogens
C. glabrata and C. neoformans may invade tissue without filamentation, while others are
required to transition from mycelium into a yeast state to be able to cause disease, such
as H. capsulatum (Medoff et al., 1987; Chang et al., 2004; Brunke and Hube, 2013). It is
thought that in the case of C. glabrata, invasion occurs via induced endocytosis rather
than active penetration, however, there have been several observed cases in which C.
glabrata is able to form pseudohyphae, which could contribute to active penetration
(Csank and Haynes, 2000; Brunke et al., 2014).
In fact, a 2014 study demonstrated that the formation of pseudohyphae correlates
with a hypervirulent phenotype in C. glabrata (Brunke et al., 2014). A microevolution
9

experiment was performed in which C. glabrata was co-incubated with macrophages for
a period of six months, and this resulted in the formation of an “EVO” strain that displayed
pseudohyphal growth, wrinkled colonies, and a hypervirulent phenotype (Brunke et al.,
2014). Hypervirulence of this strain is evidenced by increased macrophage damage at an
early timepoint, better escape from macrophages, and an increased ability to kill chicken
embryos. In mice, this mutant also exhibited increased brain fungal burden that correlates
with an increased immune response, and more rapid weight loss of infected mice as
compared to those infected with wild-type (Brunke et al., 2014). However, as with many
other hypervirulent phenotypes, filamentation was not the only observation that could
result in hypervirulence, as the EVO strain also displayed an increase in cell wall
thickness and a separation defect, which has been observed in other hypervirulent
mutants (Wheeler et al., 2003; Kamran et al., 2004; Brunke et al., 2014).
There are multiple reasons that shifting the fungal cell population towards
increased filamentation may increase virulence. These may include (i) an increased ability
to penetrate and damage cells due to mechanical stress (Mayer et al., 2013; Brunke et
al., 2014), (ii) an increased ability to escape immune cell phagolysosomes or to be
phagocytosed due to large particle size (Wachtler et al., 2012), (iii) expression of other
virulence factors are can be tied to hyphal formation (Wilson et al., 2016), and (iv)
increased ability to translocate across epithelial and endothelial cell barriers as a
response to increased induced phagocytosis may aid in dissemination (Wachtler et al.,
2012).
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Cell Wall Composition and Hypervirulence
The fungal cell wall is the primary interface by which fungi interact with their environment,
and a site where numerous virulence factors are presented for interaction with the host
(Munro, 2010). The composition of fungal cell walls varies widely between species, but
common components may include polymers of glucose like α(1,3)-glucan, β(1,3)-glucan,
β(1,6)-glucan, and mixed β(1,3)/β(1,4)-glucan. Additional polysaccharide components
may include mannan, chitin, and chitosan. Mannan consists of heavily glycosylated cell
wall proteins that are typically attached to the cell wall via a remnant of a
glycosylphosphoinositol (GPI) anchor or covalent linkage to cell wall glucans (Free,
2013). Chitin is a polymer of β(1,4)-N-acetyl glucosamine to which cell wall mannans,
glucans, and ultimately cell wall proteins are linked (Munro, 2010). Chitin may be
deacetylated into chitosan, which is a more soluble form of the polymer (Free, 2013).
Some species also contain the non-polysaccharide molecule melanin in their cell walls,
which is formed from the cross linking of phenolic compounds and serves to protect fungi
from UV irradiation as well as oxidative damage (Free, 2013). One species that produces
melanin, C. neoformans, also produces a polysaccharide capsule that decreases fungal
immune recognition, modulates phagocytosis, protects from damage caused by host
reactive oxygen species, and is considered to be an important virulence factor (Figure
1.1, D.) (McClelland et al., 2006; O'Meara and Alspaugh, 2012). This capsule is mostly
comprised of a galactose backbone decorated with mannose, xylose, and glucuronic acid
side chains, which has collectively been referred to as glucuronoxylomannogalactan
(GXMGal), and while it is evident that capsule is a critical virulence factor for C.
neoformans, there are conflicting reports in which both hyper-capsulated or hypo11

capsulated mutants strains are avirulent (McClelland et al., 2006; Doering, 2009;
Casadevall et al., 2018).
For all fungal pathogens however, maintaining the integrity and composition of the
cell wall is important, as mutations that result in cell wall damage or in the exposure of
pathogen associated molecular patterns (PAMPs) can result in increased immune
recognition, clearance, and virulence attenuation (Brown and Gordon, 2005; Plato et al.,
2015). For example, some C. albicans strains with increased β(1,3)-glucan exposure are
avirulent in the mouse model of disseminated candidiasis, and β(1,3)-glucan exposure is
correlated to increased tumor necrosis factor alpha (TNF-α) release from macrophages
in vitro (Chen et al., 2010; Davis et al., 2014). While the ability of β(1,3)-glucan to induce
an immune response has been extensively studied, the role of chitin responsible
maintaining cell rigidity is less clear.
Purified fungal chitin may act as a pro-inflammatory or anti-inflammatory molecule
depending on particle size (Da Silva et al., 2009). Induction of chitin synthesis occurs in
a cell cycle dependent manner, is regulated mostly in a post-transcriptional manner, and
expression of chitin synthases is increased upon the dimorphic switch to hyphal
morphology in C. albicans (Munro et al., 1998; Orlean, 2012). Cell wall stress, such as
that induced by the drug caspofungin or by the deletion of important cell wall proteins,
may also induce the production of chitin (Wheeler and Fink, 2006). The consequences of
altered chitin levels on host-pathogen interactions remain somewhat unclear, however
there are several instances in which hypervirulent S. cerevisiae, C. albicans, and C.
glabrata strains with increased chitin content have been identified, and this area of study
therefore merits further research.
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In 2004, Kamran et al. identified a virulence moderating gene in C. glabrata by
screening a transposon library for mutants with an increased ability to persist in vivo
(Kamran et al., 2004). One mutant was represented by a gene that has homology to the
transcription factor ACE2 in S. cerevisiae that is a positive transcriptional activator of the
chitinase CTS1 (Dohrmann et al., 1992). The C. glabrata ace2Δ mutant exhibited a
clumping phenotype that correlated to a loss of CTS1 mRNA, and this strain was
hypervirulent in a neutropenic mouse model of disseminated candidiasis (Kamran et al.,
2004). To test if hypervirulence was due to vascular occlusion, chitinase treatment was
performed to stop clumping, and ace2Δ cells were still hypervirulent as compared to wildtype. Furthermore, the infectious dose of ace2Δ is 200-fold lower than wild-type.
Inactivation of ACE2 also lead to increases in TNF-α and Interleukin 6 (IL-6), both of which
are pro-inflammatory cytokines (Kamran et al., 2004).
In a follow up study, a proteomic analysis was performed which determined that
there were decreases in several proteins involved in cell wall biogenesis and remodeling
in ace2Δ, and that hypervirulence was therefore likely a result of changes in hostpathogen interactions, especially given the increase in host immune response (Kamran
et al., 2004; Stead et al., 2005). It was further confirmed that ACE2 regulates CTS1 in C.
glabrata in a proteomic analysis of the secretome of the ace2Δ mutant (Stead et al.,
2010). There was also an observed decrease in a putative endoglucanase, ETF2, and
there were increases in intracellular proteins on the cell surface (Stead et al., 2010). The
authors postulate that the increased leakiness of these intracellular proteins, as well as
changes in recognition of antigenic cell wall components may result in the hypervirulence
of this strain (Stead et al., 2010). It was not determined if the loss of CTS1 leads to a
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build-up of chitin, and this would be interesting as there are reports that suggest that chitin
plays a major role in hypervirulence. As a complement to this, it would also be interesting
to determine if C. glabrata or S. cerevisiae CTS1 mutants have a hypervirulent phenotype,
or if the further changes in the transcriptional profile conferred by loss of C. glabrata ACE2
are required for this hypervirulent phenotype.
Kelly et al. investigated ACE2 in C. albicans (Kelly et al., 2004). In S. cerevisiae
and C. glabrata there is a paralog to ACE2 known as SWI5 that is not present in C.
albicans, thus ACE2 may perform the function of both transcription factors in C. albicans
(Kelly et al., 2004). In addition, for C. albicans there are three chitinase genes (CHT1,
CHT2, and CHT3), whereas C. glabrata and S. cerevisiae have a single chitinase (CTS1)
(Kelly et al., 2004). In the C. albicans ace2Δ/Δ mutant, there was an increase in the
formation of pseudohyphae, an increase in agar invasion, and hyphae were longer (Kelly
et al., 2004). However, this mutant was avirulent in the mouse model of disseminated
candidiasis likely due to an inability of the cells to disseminate (Kelly et al., 2004).
As previously discussed, C. albicans must be able to transition between both yeast
and hyphal forms for virulence. Also, for C. albicans there may be a different gene set
that is regulated by ACE2 since there are two paralogs in S. cerevisiae and C. glabrata.
qRT-PCR showed that a loss of ACE2 caused a decrease in CHT3 but not CHT2 (CHT3
is a functional homolog to cgCTS1) (Dunkler et al., 2005). Therefore, it would be
interesting to determine if C. albicans null mutants of the CHT1-3 genes would result in
avirulence or hypervirulence. In addition, it would be interesting to determine if repression
of C. albicans ACE2 via a doxycycline repressible system would be sufficient to induce
hypervirulence by driving strong hyphal formation after dissemination, as was performed
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for overexpression of UME6.
A final study was undertaken with ACE2 mutants from C. albicans, C. glabrata,
and S. cerevisiae to compare the effects of knocking out ACE2 on virulence for each
strain in the same controlled environment and the same mouse model. In this model there
was a minimal increase in mean survival time for the C. albicans ace2Δ mutant and the
C. glabrata ace2Δ strain was confirmed as hypervirulent, even using a ten-fold lower
inoculum than wild-type. (MacCallum et al., 2006). Hypervirulence correlated to a higher
fungal burden in kidney brain and lung (MacCallum et al., 2006). For a virulent strain of
S. cerevisiae there was a decrease in survival of mice infected with the ace2Δ knockout,
however there was no difference in fungal burden (MacCallum et al., 2006). Importantly,
infection in immunocompetent mice did not result in hypervirulence, which further
indicates that the hypervirulence is not due to clumping and vascular occlusion
(MacCallum et al., 2006).
Changes to chitin may also influence the hypervirulent phenotype for the
previously discussed EVO strain of C. glabrata, as it was found that in addition to the
formation of pseudohyphae, there was a point mutation in the CHS2 gene, and that the
cells have a separation defect (Brunke et al., 2014). The authors note that a separate
clinical isolate that also exhibited pseudohyphal formation, but had no mutation in CHS2,
also had increased macrophage damage. The authors concluded that since the genetic
basis for the pseudohyphal phenotype is not due to a CHS2 mutation, then the formation
of pseudohyphae is driving hypervirulence. This is possible, however since a chitin
synthesis defect can drive pseudohyphal growth, it is possible that hypervirulence is
related more directly chitin levels. Mutants that show hypervirulence and altered chitin
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levels include C. glabrata ada2Δ, S. cerevisiae ssd1Δ, and the previously discussed C.
glabrata ace2Δ mutant, and C. albicans pir32Δ (Wheeler et al., 2003; Kamran et al., 2004;
Bahnan et al., 2012; Yu et al., 2018).
In C. albicans, ADA2 is a component of the Spt-Ada-Gcn5 acetyltransferase
(SAGA) complex, which is important for drug tolerance (Yu et al., 2018). In multiple fungi,
a loss of this gene confers growth defects and sensitivity to cell wall stressors (Yu et al.,
2018). Loss of ADA2 in C. glabrata also increases sensitivity to antibiotics and cell wall
stressors, however, the strain was hypervirulent in a mouse model of disseminated
infection and infected animals had higher fungal burden in the kidneys, spleen, and brain
(Yu et al., 2018). In addition, the strain had increased filamentation, which was also
observed for the C. glabrata ace2Δ mutant, and there was an increase in TNF-α response
in infected mice (Kamran et al., 2004; Yu et al., 2018). Transcriptional profiling determined
that 26 adhesin genes were upregulated, which suggests that hypervirulence could be
related to greater adhesion to the host and is again attributed to multiple factors (Yu et
al., 2018).
Although S. cerevisiae is typically not considered pathogenic, there have been
occurrences of infection in immunocompromised individuals, and DBA/2 mice are
susceptible to infection with some S. cerevisiae isolates (Wheeler et al., 2003). In a 2002
study, a strain with a mutation in SSD1, which is important for high temperature growth,
was demonstrated to be hypervirulent a systemic mouse model (Wheeler et al., 2003).
Interestingly, the ssd1Δ strain exhibits an increase in both cell wall β(1,3)-glucan and
chitin content and has a clumping phenotype similar to the ace2Δ mutants (Wheeler et
al., 2003; Kamran et al., 2004). The cell wall changes correlate to increased TNF-α, IL-6
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and IL1-β in vitro, and therefore immune modulation may play a role in the increased
virulence (Wheeler et al., 2003). Importantly, Balb/c mice, which are not susceptible to S.
cerevisiae infection, do not succumb when infected with this mutant, indicating that the
death of the DBA/2 mice was not due to vascular occlusion secondary to the SSD1
clumping phenotype, but rather changes in the cell wall of this mutant (Wheeler et al.,
2003).
Drug Resistant HVFPs
There is evidence that drug resistance in fungi may also drive hypervirulence, which is
especially concerning given the current and problematic rise in drug resistance (ValeSilva and Sanglard, 2015). While the correlation between HVFPs and drug resistance is
somewhat unclear, it is possible that the mechanisms for development of drug resistance
have pleiotropic effects which also allow for greater damage to the host or resistance to
the immune response. For example, biofilms are a major virulence factor in fungi that
allow them to colonize medical implants and intravenous catheters and are also important
for the invasion of host tissues and drug resistance (Nett et al., 2008; Fanning and
Mitchell, 2012). A study performed with clinical isolates of Candida albicans demonstrated
that when serially passaged in the presence of either fluconazole or miconazole, not only
did drug resistance emerge, but also hypervirulence (Angiolella et al., 2008). This
phenotype was associated with increased hyphal formation and branching, increased
agar invasion, increased biofilm formation, and an increased capacity to adhere to
polystyrene (Angiolella et al., 2008). These drug resistant isolates had a stark increase in
virulence, which was demonstrated in a disseminated mouse model of infection in which
57% and 70% mortality was observed for fluconazole and miconazole resistant strains,
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respectively, whereas there was only 10% mortality observed in mice infected with the
wild-type C. albicans (Angiolella et al., 2008). Impacts observed for these strains that may
explain the drug resistance include mutations in MDR1 and FKS1 (Angiolella et al., 2008).
Given that biofilms confer a fitness advantage for organisms under the pressure of
antifungal treatment, and that increased filamentation is correlated with hypervirulence, it
is a logical conclusion that the use of antibiotics may, in some cases, drive hypervirulence.
Another example in which drug resistance correlated with hypervirulence was
observed in 2009 with C. glabrata. It was demonstrated that increased resistance to
fluconazole via a gain of function (GOF) mutation in the PDR1 transcription factor, which
regulates the drug efflux pumps CDR1, CDR2, and SNQ2, resulted in hypervirulence
even in the absence of fluconazole (Ferrari et al., 2009). The azole resistant isolate had
increased kidney fungal burden and caused increased mortality rate in a disseminated
model of either immunosuppressed or immunocompetent mice (Ferrari et al., 2009). This
was independent of the strain background, as introduction of the hyperactive allele was
performed in both drug sensitive and resistant pdr1Δ backgrounds, with the same result
(Ferrari et al., 2009). Further, four different PDR1 gain of function alleles (L280F, T588A,
E1083Q, and P822L) with single amino acid substitutions, which conferred differential
transcriptional increases of CDR1, CDR2, or SNQ2, resulted in hypervirulence and
increased kidney burden, indicating that overactivation of PDR1 by several different
mutations can confer hypervirulence (Ferrari et al., 2009). The authors hypothesized that
hypervirulence was due differential expression of genes involved in stress response,
resistance to DNA damage, and cell wall structure. This was later confirmed with a
microarray analysis (Vermitsky et al., 2006).
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In the same study, three azole resistant clinical isolates with mutations which did
not map to PDR1 were identified, and it was observed that these mutants had a petite
phenotype and mitochondrial dysfunction (Ferrari et al., 2009). However, a fourth
hypervirulent azole resistant C. glabrata isolate (BP41) with mitochondrial defects has
been isolated, and this strain did have increased expression of PDR1 (Ferrari et al., 2011).
Therefore, it is difficult to determine if mitochondrial defects alone may contribute to
hypervirulence, or if PDR1 plays an important role (Ferrari et al., 2011). Regardless, this
study demonstrated that a clinical isolate which had acquired fluconazole resistance
(BP41) was hypervirulent in the rat vaginal model as well as a mouse model of
disseminated candidiasis as compared to its azole susceptible parental strain. In the
disseminated model mice infected with this strain had higher fungal burden in both the
spleen and kidneys (Ferrari et al., 2011). In addition to increased expression of PDR1,
BP41 demonstrated an increase in expression of numerous cell wall remodeling genes,
as well as GPI anchored aspartyl proteases, which are known virulence factors (Ferrari
et al., 2011). Another mutant strain with mitochondrial defects (DSY4339) was created in
vitro by ethidium bromide mutagenesis in this study, however the virulence phenotype
differed in that it had decreased virulence and it did not display increased expression of
PDR1 (Ferrari et al., 2011). The authors did not determine the susceptibility to fluconazole
for DSY4339, so it is not clear if there is a correlation of drug resistance to virulence. For
C. albicans, inhibition of classical respiration processes by treatment with both sodium
nitroprusside and salicylhydroxamic acid not only induces increased hyphal formation,
but also induces cell wall remodeling, increased expression of virulence factors, and
hypervirulence (Duvenage et al., 2019). Therefore, between the two organisms the
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relationship between mitochondrial dysfunction and hypervirulence remains unclear,
although for C. glabrata, PDR1 overexpression does seem to drive hypervirulence.
Since drug resistance can in some cases result in hypervirulence, then the
problems caused by antifungal resistance may be two-fold. The over/misuse of drugs can
select for drug resistant organisms that are harder to treat and may aid in the evolution of
more aggressive HVFPs, further exacerbating this issue. While the correlation between
hypervirulence and drug resistance has been observed numerous times in bacteria,
especially in the organism Klebsiella pneumonia, there have been less reports of this
phenomenon in fungi, and this is therefore an area of research that merits greater
investigation (Lee et al., 2017).
Mechanisms by Which Chitin May Contribute to Virulence
Although chitin typically only makes up 3-4% of the fungal cell wall, this component is
important for rigidity of the cell and virulence (Gow et al., 2017). It has been clearly
demonstrated that chitin impacts the immune response in several studies. For example,
when added to peritoneal macrophages, purified fungal particles of intermediate chitin
(IC) size (40-70 μm) can induce an inflammatory TNF-α response, whereas small chitin
(SC) particles of less than 40 μm induce the strong production of anti-inflammatory
interleukin 10 (IL-10), and also the production of TNF-α albeit to a lesser extent than that
of IC (Da Silva et al., 2009). It was demonstrated that induction of a TNF-α response for
IC was dependent on toll like receptor 2 (TLR2) and to some extent the C-type signaling
lectin, Dectin-1 (Da Silva et al., 2009). For smaller chitin particles, IL-10 induction from
macrophages was completely dependent on Dectin-1, but TLR2 was dispensable (Da
Silva et al., 2009). Other studies have demonstrated that chitin can induce host arginases,
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which reduce arginine, a substrate used for the synthesis of reactive nitrogen species
(RNS). This causes macrophages to decrease RNS production that would otherwise
damage the fungus (Wagener et al., 2017).
As chitin can have an impact on immune response, there are several mechanisms
by which changes to cell wall chitin may induce hypervirulence that act oppositely of one
another with regard to immune response (Figure 1.2, A-C). Normally, chitin is at the basal
layer of the cell wall, and other cell wall components are bound to it, including
immunogenic components such as β(1,3)-glucan (Figure 1.2, A). Increases in chitin could
damage/alter the cell wall and internal components could leak out of the cell, or this may
cause exposure of immune epitopes within the cell wall, such as β(1,3)-glucan, that
increase immune response and therefore produce an increase in immunopathology
(Figure 1.2, B). This is supported in several cases of hypervirulence by the observation
of increased TNF-α release. Alternatively, overproduction of chitin could result in
interaction of chitin with immune cells (Figure 1.2, C). Since chitin could act in an
immunosuppressive capacity, this could allow the fungus to avoid the host immune
response and therefore continue to grow and damage the host. Besides these
hypotheses, increased chitin production or a decrease in chitinase activity may decrease
the ability of cells to separate properly, which could result in a clumping phenotype.
Clumping of cells may prevent granulocytes from phagocytosing larger groups of cells,
and for those cells that have been phagocytosed, clumping may aid in physical pressure
that results in escape from the phagolysosome. Most studies investigating the effects of
chitin on the immune response have been performed with purified chitin, either from
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Figure 1.2. Alterations in chitin may modulate host immune response.
The C. albicans cell wall is used as a model. The wall contains a chitin base linked to β(1,3)-glucan. To β(1,3)-glucan,
β(1,6)-glucans are linked. Heavily mannosylated GPI anchored proteins decorate the outer wall. (A) Exposed β(1,3)glucan is an immunogenic epitope, and exposure can occur via host induced damage. Dectin-1 is a C-type signaling
lectin that can detect β(1,3)-glucan thus inducing a pro-inflammatory response. (B) Overproduction of chitin could cause
increased exposure of β(1,3)-glucan, or other immunogenic cell wall components, resulting in increased
immunopathology and hypervirulence. (C) Alternatively, increased chitin could be recognized by Dectin-1 and PAMPs
such as toll like receptor 2 (TLR2), which could result in immune suppression.
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fungal or invertebrate sources, and these chitin particles are typically exceptionally large
compared to the size of a fungal cell. Thus, more work should be done with live mutants
and strains to determine if varying levels of chitin in the context of live cells impact immune
responses.
Novel Virulence Moderating Genes
To our knowledge, no mutations have been identified in fungal phospholipid biosynthetic
pathways that result in hypervirulence, until recently. In this dissertation we describe
evidence for the first mutations in two separate phospholipid biosynthetic routes for C.
albicans that, surprisingly, result in hypervirulence. Phospholipid biosynthetic pathways
are a requirement for the growth of fungal pathogens, as phospholipids are the major
structural components of all cell membranes, and numerous studies have demonstrated
that they are not only essential for growth but are also required for virulence (Chen et al.,
2008; Chen et al., 2010; Davis et al., 2018). The mutations conferring hypervirulence in
C. albicans that we have identified lie within two major phospholipid biosynthetic routes
known as the cytidine-diphosphate diacylglycerol (CDP-DAG) pathway, and the Kennedy
pathway (Figure 1.3). Within the CDP-DAG pathway, CDP-DAG is converted to either
phosphatidylinositol (PI) or alternatively to phosphatidylserine (PS) (Figure 1.3, red
arrows) (Paulus and Kennedy, 1960; Atkinson et al., 1980; Letts et al., 1983). PS can be
decarboxylated to form phosphatidylethanolamine (PE) which can then be methylated to
form phosphatidylcholine (PC) (Figure 1.3, red arrows) (Kodaki and Yamashita, 1987;
Clancey et al., 1993; Trotter and Voelker, 1995). PC and PE, which are the major
phospholipids in yeast, can also be formed via the Kennedy pathway (Figure 1.3, green
arrows) (Gibellini and Smith, 2010; Cassilly et al., 2017; Tams et al., 2019). Exogenous
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Figure 1.3. Yeast phospholipid biosynthesis.
There are two major routes for phospholipid synthesis in yeast: the cytidine
diphosphate diacylglycerol (CDP-DAG) pathway (red arrows), and the Kennedy
pathway (green arrows). In the CDP-DAG pathway, CDP-DAG is converted to either
phosphatidylinositol (PI) or phosphatidylserine (PS). PS can be decarboxylated to form
phosphatidylethanolamine (PE) which can be further methylated to form
phosphatidylcholine (PC). Alternatively, exogenous ethanolamine (green hexagons)
or choline (blue hexagons) can be imported into the cell and converted into PE and
PC, respectively, via the Kennedy pathway.
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ethanolamine and choline can be imported into the cell, and once internalized can be
converted into PE and PC, respectively, through a three-step enzymatic process (Gibellini
and Smith, 2010). Interestingly, overexpression of Ept1, which catalyzes the final step of
the Kennedy pathway to form PE and PC, results in hypervirulence (Figure 1.3) (Tams et
al., 2019). In addition, disruption of Pem1 and Pem2, which catalyze the methylation of
PE to PC in the CDP-DAG pathway, results in hypervirulence that correlates with a
buildup of PE (Tams et al., 2019). While the mechanism of hypervirulence is not yet fully
understood for these mutants, several phenotypes we have observed are common to
other hypervirulent mutants discussed in this chapter, including increased cell wall chitin
levels and increased hyphal length.
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Abstract
Candida albicans is an opportunistic human fungal pathogen that causes life-threatening
systemic infections, as well as oral mucosal infections. Phospholipids are crucial for
pathogenesis

in

C.

albicans,

phosphatidylethanolamine

(PE)

as

disruption

biosynthesis

of

phosphatidylserine

within

the

cytidine

(PS)

and

diphosphate

diacylglycerol (CDP-DAG) pathway causes avirulence in a mouse model of systemic
infection. The synthesis of PE by this pathway plays a crucial role in virulence, but it was
unknown if downstream conversion of PE to phosphatidylcholine (PC) is required for
pathogenicity. Therefore, the enzymes responsible for methylating PE to PC, Pem1 and
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Pem2, were disrupted. The resulting pem1∆/∆ pem2∆/∆ mutant was not less virulent in
mice, but rather hypervirulent. Since the pem1∆/∆ pem2∆/∆ mutant accumulated PE, this
led to the hypothesis that increased PE synthesis increases virulence. To test this, the
alternative Kennedy pathway for PE/PC synthesis was exploited. This pathway makes
PE and PC from exogenous ethanolamine and choline, respectively, using three
enzymatic steps. In contrast to Saccharomyces cerevisiae, C. albicans was found to use
one

enzyme,

Ept1,

for

the

final

enzymatic

step

(ethanolamine/cholinephosphotransferase) that generates both PE and PC. EPT1 was
overexpressed, which resulted in increases in both PE and PC synthesis. Moreover, the
EPT1 overexpressor strain is hypervirulent in mice and causes them to succumb to
systemic infection more rapidly than wild-type. In contrast, disruption of EPT1 causes loss
of PE and PC synthesis by the Kennedy pathway, and decreased kidney fungal burden
during the mouse systemic infection model, indicating a mild loss of virulence. In addition,
the ept1∆/∆ mutant exhibits decreased cytotoxicity against oral epithelial cells in vitro,
whereas the EPT1 overexpression strain exhibits increased cytotoxicity. Taken
altogether, our data indicate that mutations that result in increased PE synthesis cause
greater virulence and mutations that decrease PE synthesis attenuate virulence.
Introduction
Candida albicans is a fungus that typically resides as a commensal in the gastrointestinal
tract of up to 70% of healthy individuals, as well as within the oral mucosa (Bouza and
Munoz, 2008). However, C. albicans can cause vaginal infections as well as opportunistic
oral and systemic infections, which are more commonly seen in immunocompromised or
immunosuppressed individuals (Kabir et al., 2012). Systemic blood stream infections
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(BSIs) are of particular concern as they have mortality rates of approximately 30-50%
(Williams and Lewis, 2011), and Candida spp. are the fourth most common causes of
BSIs in the United States (Kabir et al., 2012). Treatment of systemic infections has
encountered some limitations as a result of poor oral availability and high drug toxicity of
some drugs (Letscher-Bru and Herbrecht, 2003; Mukherjee et al., 2005). In addition,
resistance to standard antifungal treatments such as fluconazole, by Candida spp., is an
emerging issue (Sanguinetti et al., 2015). It is therefore imperative that novel drug targets
are discovered.
Phospholipid biosynthetic pathways are an attractive area to search for drug
targets, as phospholipids are the major structural lipids that form cellular membranes (de
Kroon et al., 2013). Cells must therefore synthesize them from precursors acquired from
their environment to support growth during infection. In addition to having a structural role
within the cell, intermediate phospholipid metabolites can act as second messengers, and
may therefore serve important regulatory functions (Exton, 1994; de Kroon et al., 2013).
As such, they are required for the growth and pathogenesis of C. albicans.
The most abundant phospholipids in C. albicans are phosphatidylglycerol (PG),
cardiolipin

(CL)

phosphatidylserine

(PS),

phosphatidylethanolamine

(PE),

phosphatidylcholine (PC), and phosphatidylinositol (PI) (Singh et al., 2010; Cassilly et al.,
2017). The major biosynthetic pathway for the phospholipids PS, PE, and PC in C.
albicans is known as the cytidine-diphosphate diacylglycerol (CDP-DAG) pathway (Figure
2.1) (Henry et al., 2012). Within this pathway, the common phospholipid precursor CDPDAG is condensed with serine to form PS by the PS synthase Cho1 (Bae-Lee and
Carman, 1984; Henry et al., 2012). PS is then decarboxylated by one of two PS
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Figure 2.1. Synthesis of yeast phospholipids.
Model for yeast phosphatidylserine (PS), phosphatidylethanolamine (PE), and
phosphatidylcholine (PC) biosynthesis. Proteins involved in CDP-DAG pathway
mediated phospholipid biosynthesis are shown in purple, and those involved in
Kennedy pathway mediated phospholipid biosynthesis are shown in blue.
Abbreviations:
CDP-DAG,
cytidine
diphosphate
diacylglycerol;
MME,
monomethylphosphatidylethanolamine; DME, dimethylphosphatidylethanolamine;
Etn, ethanolamine; Cho, choline; P-Etn, phosphoethanolamine; P-Cho,
phosphocholine;
CDP-Etn,
cytidinediphosphoethanolamine;
CDP-Cho,
cytidinediphosphocholine.
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decarboxylases, Psd1 or Psd2, to form PE (Henry et al., 2012). Based on work from S.
cerevisiae, PE is then sequentially methylated by the PE methyltransferases Pem1 and
Pem2 to form PC (Henry et al., 2012). Previously, our lab has demonstrated that the
cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are avirulent in the mouse model of systemic
infection (Chen et al., 2010). Interestingly, these mutants are avirulent despite having the
ability to utilize an alternative phospholipid biosynthetic pathway known as the Kennedy
pathway. This pathway uses exogenous ethanolamine or choline to synthesize PE or PC,
respectively (Figure 2.1) (Gibellini and Smith, 2010). We have recently reported that the
Kennedy pathway alone cannot support virulence because the cho1∆/∆ and psd1∆/∆
psd2∆/∆ mutants cannot import sufficient ethanolamine from the host to support PE
synthesis (Davis et al., 2018). Growth of either mutant is restored in vitro in medium
containing >100 µM ethanolamine, which is higher than the estimated concentration of
~30 µM within the host (Houweling et al., 1992; Davis et al., 2018). In addition, virulence
is restored if PE synthesis is supported by heterologous expression of the Arabidopsis
thaliana serine decarboxylase (AtSDC) (Davis et al., 2018). This enzyme allows for
decarboxylation of cytoplasmic serine to yield ethanolamine, which can be used to
synthesize PE via the Kennedy pathway. Thus AtSDC bypasses deficiencies due to
importing low levels of exogenous ethanolamine (Davis et al., 2018). Therefore, wild-type
fungus requires the CDP-DAG pathway to generate enough PE to cause disease since it
cannot import enough ethanolamine to compensate for PE loss using the Kennedy
pathway. Loss of PE synthesis should also impact downstream PC synthesis, and the
impact of PC on virulence has been largely unstudied in this organism. In this study, we
sought to determine if the loss of PC biosynthesis from the CDP-DAG pathway would
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attenuate virulence, or if the Kennedy pathway could compensate for this loss. In addition,
we directly determined if Kennedy pathway mediated production of PE and/or PC is also
important for virulence in C. albicans when the CDP-DAG pathway is still functional.
Materials and Methods
Strains and growth media
Candida albicans strains used in this study were derived from the SC5314 background
(Gillum et al., 1984) (Table 2.1). Standard medium used for culturing C. albicans was
YPD (1% yeast extract, 2% dextrose, and 2% peptone) and cultures were maintained
aerobically at 30°C in a shaking incubator at 225 RPM (Styles, 2002). DH5-α Escherichia
coli (NEB, C2987I) were used for plasmid construction (Table 2.2), and were cultured in
LB broth (1% tryptone, 1% NaCl, 0.5% yeast extract) in a rotating incubator at 37°C
(Guthrie C., 2002).

Plasmid construction
Primers described in this section are shown in appendix B. The PEM1 knockout vector
was created using the SAT1 flipper plasmid pSFS2A (CatR) (Reuss et al., 2004). A 589
bp region of the PEM1 (CHO2/CR_02540W_A/orf19.169) 5’ non-coding region (NCR)
was amplified using the primers JCO197 and JCO198 which introduced KpnI and ApaI
sites, respectively. This fragment was cloned into the KpnI and ApaI sites of pSFS2A. In
addition, a 589 bp 3’ NCR of PEM1 was amplified using JCO199 and JCO200 and was
subsequently cloned into the SacII and SacI sites of pSFS2A to create the pYLC390
PEM1 knockout vector. In addition to the PEM1 knockout vector, a PMET3 repressible
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Table 2.1. C. albicans strains used in chapter two.
Strain

Parent Strain

Genotype

Source

SC5314

Clinical isolate

Prototrophic Wild Type

Gillum et al., 1984

YLC394

SC5314

PEM1/pem1Δ-SAT1

This Study

YLC401

YLC394

PEM1/pem1Δ-FRT

This Study

YLC417

YLC401

pem1Δ/pem1::PMET3-PEM1-SAT1

This Study

YLC393

SC5314

PEM2/pem2Δ-SAT1

This Study

YLC400

YLC393

PEM2/pem2Δ-FRT

This Study

YLC405

YLC400

pem2Δ/Δ-SAT1

This Study

YLC406

YLC405

pem2Δ/Δ-FRT

This Study

BTY38

YLC406

PEM1/pem1Δ pem2Δ/Δ-SAT1

This Study

BTY66

BTY38

PEM1/pem1Δ pem2Δ/Δ-FRT

This Study

BTY72

BTY66

pem1Δ/Δ pem2Δ/Δ-SAT1

This Study

BTY77

BTY72

pem1Δ/Δ pem2Δ/Δ-FRT

This Study

BTY138

BTY77

pem1∆/∆ pem2∆/pem2∆::PEM2-SAT1

This Study

BTY147

BTY138

pem1∆/∆ pem2∆/pem2∆::PEM2 FRT

This Study

BTY167

BTY147

pem1∆/∆::PEM1 pem2∆/pem2∆::PEM2-SAT1

This Study

BTY169

BTY167

pem1∆/∆::PEM1 pem2∆/pem2∆::PEM2-FRT

This Study

BTY88

SC5314

PENO1::PENO1-EPT1

This Study

BTY97

SC5314

EPT1/ept1∆-SAT1

This Study

BTY101

BTY97

EPT1/ept1∆-FRT

This Study

BTY104

BTY101

ept1∆/∆-SAT1

This Study

BTY108

BTY104

ept1∆/∆-FRT

This Study

BTY130

BTY108

ept1∆/∆ PENO1::PENO1-EPT1-SAT1

This Study

BTY192

BTY108

ept1∆/∆::EPT1-SAT1

This Study

BTY200

BTY192

ept1∆/∆::EPT1-FRT

This Study

BTY81

BTY77

pem1Δ/Δ pem2Δ/Δ PENO1::PENO1-BTA1-SAT1

This Study
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Table 2.2. E. coli strains used in chapter two.
Plasmid

Description

pSFS2A

SAT1 flipper cassette; (CATR)

pYLC390
pYLC388
pYLC314
pYLC315
pYLC410
pYLC414
pBT33
pBT47
pBT49

PEM1 knockout construct; 5' NCR (KpnI-ApaI) + 3' NCR (SacII-I) of
PEM1
PEM2 knockout construct; 5' NCR (KpnI-ApaI) + 3' NCR (SacII-I) of
PEM2
Methionine repressible expression cassette; SAT1-PMET3 (EcoRIEcoRI);

(AMPR)

Parent Vector
Reuss et al.,
2004
pSFS2A
pSFS2A
pBluescript
SK+

Methionine repressible expression cassette; SAT1-PMET3 (EcoRI-

pBluescript

EcoRI); (AMPR)

SK+

PEM1 repressible expression vector; 5' NCR of PEM1 (KpnI-ApaI) +
SAT1-PMET3 (EcoRI-EcoRI)
PEM1 repressible expression vector; 5' NCR of PEM1 (KpnI-ApaI) +
SAT1-PMET3 (EcoRI-EcoRI) + PEM1 ORF (SacII-SacI)
PEM2 reintegration construct; 5' NCR and PEM2 ORF (KpnI-ApaI) + 3'
NCR (SacII-SacI) of PEM2
PEM1 reintegration construct; 5' NCR + PEM1 ORF (ApaI-XhoI)
PEM1 reintegration construct; 5' NCR and PEM1 ORF (ApaI-XhoI) + 3'
NCR (NotI-SacI) of PEM1

pYLC315
pYLC410
pYLC388
pSFS2A
pBT47

pBT1

Overexpression Vector; PENO1 (BamHI-NotI)

pYLC314

pBT11

EPT1 overexpression cassette; PENO1-EPT1 (NotI-SacI)

pBT1

pBT16
pBT51
pBT53
pBT5

EPT1 knockout construct; 5' NCR and EPT1 ORF (KpnI, XhoI) + 3'
NCR (NotI, SacI) of EPT1 (CATR)
EPT1 reintegration construct; 5' NCR + EPT1 ORF (KpnI-XhoI)
EPT1 reintegration construct; 5' NCR + EPT1 ORF (KpnI-XhoI) + 3'
NCR (SacII-SacI)
BTA1 overexpression construct; PENO1-BTA1 (NotI-SacI)

pSFS2A
pSFS2A
pBT51
pBT1
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PEM1 expression vector was also created. To create this vector JCO165 and JCO166
were used to amplify an EcoRI-flanked SAT1-PMET3 fragment from pYLC229 (Chen et al.,
2008), which was subsequently cloned into the EcoRI site of a pBluescript SK+ plasmid
to yield two isogenic clones: pYLC314 and pYLC315. The 5’ NCR of PEM1 was amplified
from genomic C. albicans DNA with JCO199 and JCO200 as a KpnI-ApaI fragment and
cloned into pYLC315 (KpnI-ApaI) upstream of the SAT1 marked PMET3 promoter yielding
pYLC410. To complete the construct, the PEM1 ORF was amplified along with the 3’ NCR
with JCO215 and JCO216 and this SacII-SacI fragment was cloned into pYLC410
downstream of the PMET3 promoter (SacII-SacI) to yield the PEM1 conditional expression
vector pYLC414.
The SAT1 flipper vector pSFS2A was used to create a PEM2 knockout vector,
pYLC388

(Reuss

et

al.,

2004).

A

592

bp

5’

NCR

to

PEM2

(OPI3/C3_06570C_A/orf19.7446) was amplified using JCO192 and JCO193 and cloned
in the KpnI and ApaI sites of pSFS2A. A 587 bp NCR 3’ to the PEM2 ORF was amplified
using JCO194 and JCO195 and cloned into the SacII and SacI sites, resulting in
pYLC388.
pYLC388 was used to create a reintegration construct for PEM2. The 5’ NCR was
released from pYLC388 by restriction with ApaI and KpnI. A 1297 bp fragment including
the PEM2 ORF (OPI3/C3_06570C_A/orf19.7446) and approximately 500 bp of NCR 5’
to the ORF was amplified with BTO67 and JCO192. This fragment was subcloned into
pYLC388 at the ApaI-KpnI sites to create pBT33.
The PEM1 reintegration construct was created using pSFS2A (Reuss et al., 2004).
pSFS2A was linearized using ApaI and XhoI. A 3451 bp fragment including approximately
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500 bp of the 5’ NCR of PEM1, the PEM1 ORF (CHO2/CR_02540W_A/orf19.169), and
approximately 300 bp of the 3’ NCR of PEM1 was amplified using BTO52 and BTO53 to
introduce ApaI-XhoI sites, and subsequently was cloned into the linearized vector to
create pBT47. pBT47 was linearized using NotI and SacI. A 622 bp NCR 3’ to the PEM1
ORF (-356 to -978) was amplified using BTO54 and BTO55 to introduce NotI-SacI sites,
and subsequently cloned into the linearized pBT47 vector to create the PEM1
reintegration vector, pBT49.
For the construction of an overexpression vector, pYLC314 was used. The PMET3
promoter was removed from pYLC314 by restriction with PstI, which flanks both sides of
the insert. The constitutively active PENO1 promoter, +928 to +1 5’ of the ENO1 ORF
(C1_08500C_A/orf19.395), was amplified from wild type C. albicans genomic DNA using
the primers BTO30 and BTO31 to introduce BamHI and NotI sites, and was cloned into
the BamHI and NotI sites of pYLC314 to create pBT1.
To overexpress EPT1, a 1,509 bp fragment including the EPT1 ORF
(C7_02690C_A/orf19.3695) and approximately 300 bp of NCR 3’ to the ORF was
amplified from C. albicans genomic DNA using BTO35 and BTO36, and was cloned into
the NotI and SacI sites of pBT1 to create the EPT1 overexpression vector, pBT11.
To create an EPT1 knockout vector, the 5’ and 3’ NCRs of the EPT1 ORF
(C7_02690C_A/orf19.3695) were cloned into pSFS2A plasmid flanking the SAT1 flipper
construct (Reuss et al., 2004). First, a 471 bp fragment of the 5’ NCR of the EPT1 ORF
was amplified from C. albicans genomic DNA using BTO44 and BTO45 and subsequently
cloned into the KpnI and XhoI sites of pSFS2A. In addition, a 494 bp fragment of the 3’
NCR of EPT1 was amplified with BTO46 and BTO47 and cloned into the NotI and SacI
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sites to create pBT16.
To create an EPT1 reintegration construct a 2312 bp fragment including the EPT1
ORF, 903 bp 5’ NCR of the EPT1 ORF, and 200 bp of the 3’ NCR was amplified from
genomic C. albicans DNA using TRO1044 and TRO1045. This PCR product was cloned
into pSFS2A at the KpnI and XhoI sites to create pBT51. A 596 bp fragment of the 3’ NCR
(+202 to +798) was amplified from genomic DNA using TRO1046 and TRO1047 and
cloned into the SacI and SacII sites of pBT51 to create the finalized EPT1 reintegration
construct, pBT53.
To create a BTA1 (C1_11490C_A/orf19.1171) overexpression construct, a 2570
bp fragment including the BTA1 ORF and approximately 300 bp of the 3’ NCR was
amplified with BTO28 and BTO29 and was subsequently cloned into the NotI and SacI
sites of pBT1 to create pBT5.

Candida albicans strain construction
Plasmids were cut at the indicated restriction site(s) and linearized fragments were
purified using the QIAquick PCR Purification Kit (QIAGEN, 28106) for single restriction
digests, or the QIAquick Gel Extraction Kit (QIAGEN, 28704) if restriction digests resulted
in multiple fragments. All Candida albicans transformations were performed via
electroporation as described previously (Hasim et al., 2014) and plates containing 200
µg/mL nourseothricin (GoldBio, N-500-1) were used for selection of C. albicans
transformants (Table 2.1). Following transformation, mutations were confirmed via PCR
using the indicated primers (Appendix B).
To create the pem2∆/∆ strain, pYLC388 was linearized (KpnI, SacI) and
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transformed into wild type C. albicans (SC5314). The SAT1 marker was removed by FLPmediated recombination from YLC393 using the SAT1 flipper method to create YLC400
(PEM2/pem2Δ) (Reuss et al., 2004). Linearized pYLC388 was again used to transform
YLC400, which resulted in the pem2Δ/Δ-SAT1 strain (YLC405). The SAT1 marker was
removed by recombination from YLC405 to create YLC406 (pem2Δ/Δ).
YLC406 was transformed with a linearized pYLC390 fragment (KpnI, SacI) to
create the PEM1/pem1Δ-SAT1 pem2Δ/Δ mutant BTY38. The SAT1 marker was removed
by recombination to create BTY66 (PEM1/pem1Δ pem2Δ/Δ). BTY66 was again
transformed with linearized pYLC390 (KpnI, SacI) to create a pem1Δ/Δ-SAT1 pem2Δ/Δ
mutant (BTY72), and the SAT1 marker was removed by recombination to create BTY77
(pem1∆/∆ pem2∆/∆). To overexpress BTA1 in the pem1∆/∆ pem2∆/∆ background, pBT5
was linearized with MscI and transformed into BTY77 to create a pem1∆/∆ pem2∆/∆
PENO1::PENO1-BTA1 strain, BTY81.
To reintegrate PEM1 and PEM2 into the homozygous double mutant, pBT33 was
linearized (KpnI, SacI) and transformed into BTY77 to create a pem1∆/∆
pem2∆/pem2∆::PEM2-SAT1 strain, BTY138. The SAT1 marker was removed by
recombination from BTY138, resulting in BTY147 (pem1∆/∆ pem2∆/pem2∆::PEM2SAT1). BTY147 was transformed with linearized pBT49 (ApaI, SacI) to create BTY167
(pem1∆/∆::PEM1 pem2∆/pem2∆::PEM2-SAT1). The SAT1 marker was removed by
recombination from BTY167 to create the pem1∆/∆::PEM1 pem2∆/pem2∆::PEM2 mutant
(BTY169).
To create a repressible PEM1 mutant, SC5314 was transformed with linearized
pYLC390 (KpnI-SacI) to yield a PEM1/pem1Δ-SAT1 strain (YLC394). The SAT1 marker
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was remove by recombination from YLC394 to yield a PEM1/pem1Δ strain (YLC401).
YLC401 was then transformed with the PEM1 conditional expression vector pYLC414
(KpnI) to yield a pem1Δ/pem1Δ::PMET3-PEM1-SAT1 strain (YLC417).
To overexpress EPT1, SC5314 was transformed using linearized pBT11 (MscI) to
create BTY88 (PENO1::PENO1-EPT1). To knock out EPT1, pBT16 was linearized (KpnI,
SacI) and transformed into SC5314 resulting in an EPT1/ept1∆-SAT1 strain (BTY97). The
SAT1 marker was removed by recombination from BTY97, resulting in BTY101
(EPT1/ept1∆). BTY101 was transformed with linearized pBT16 again to create the
ept1Δ/Δ-SAT1 strain, BTY104. The SAT1 marker was removed by recombination from
BTY104 to create BTY108 (ept1Δ/Δ), so that a reintegrant strain could be produced. Two
distinct types of reintegrant were produced: one in which the EPT1 gene was
constitutively expressed, and another in which one allele of EPT1 was reintegrated into
the EPT1 locus under its native promoter. For the first reintegrant, the overexpression
cassette pBT11 was linearized (MscI) and transformed into BTY108, resulting in the
ept1Δ/Δ PENO1::PENO1-EPT1 strain (BTY130). To reintegrate the gene under its native
promoter and at the EPT1 locus, pBT53 was linearized using KpnI and SacI and
subsequently transformed into BTY108 to yield BTY192 (ept1Δ/Δ::EPT1-SAT1). The
SAT1 marker was then removed by recombination to yield BTY200 (ept1Δ/Δ::EPT1).

Growth curves
To determine choline auxotrophy, strains were cultured overnight in liquid YNB medium
(0.67% yeast nitrogen base containing ammonium sulfate (BD Difco, 291940), 2%
dextrose), and then diluted to OD600nm = 0.1 in triplicate in fresh YNB (Styles, 2002).
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Growth was measured at OD600nm every two hours for 12 hours or at other time points as
indicated. To rescue choline auxotrophy YNB medium was supplemented with choline
chloride (Fisher Scientific, O1972-250), glycerophosphocholine (Sigma-Aldrich, G529110MG), or lysophosphatidylcholine (Avanti Polar Lipids INC., 845875P).

Lipid extraction and TLC
C. albicans strains were cultured overnight in 5mL YNB medium supplemented with 0.25
µM L-methionine/L-cysteine (represses PEM1 in pYLC417), and then diluted to an
OD600nm = 0.4 in 25 mL of YNB with 0.25 µM L-methionine/L-cysteine or YNB
supplemented with 1 mM choline chloride and 0.25 µM L-methionine/L-cysteine. Cultures
were maintained at 30°C for 12 hours at 225 RPM and then transferred to 50 mL conical
tubes and pelleted at 3000 RPM for 10 minutes. Pellets were lyophilized and weighed to
normalize for the amount of cells present. Following lyophilization, pellets were washed
with 25 mL water and resuspended in 3 mL ethanol:water (4:1). Suspensions were heated
in boiling water for 15 minutes and pelleted at 3,000 RPM for 10 minutes. The supernatant
was transferred to new tubes and back extractions were completed twice using 1 mL of
ethanol:water (4:1) following the above procedure. Lipids were dried under nitrogen gas
and resuspended in chloroform:methanol (2:1). TLC plates were washed once with
chloroform:methanol (2:1) and dried at 100°C for 15 minutes. Lipid extracts were spot
inoculated

on

TLC

plates

(Millipore,

HX377581)

and

chloroform:ethanol:water:triethylamine (35:30:7:35) was used as a solvent system for
separation (Chen et al., 2010). Phospholipids were visualized under UV following
treatment with primuline (Fisher Scientific, 8064-60-6).
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Mouse models
Outbred male ICR mice at 5 to 6 weeks of age were obtained from Envigo for use in this
study. C. albicans strains were cultured overnight in 50 mL YPD at 30°C and 225 RPM.
After approximately 16 hours they were transferred to 50 mL Falcon tubes and centrifuged
at 3,500 RPM for 5 minutes. The pellets were subsequently washed twice with 25 mL of
water. Cells were counted via hemocytometer and diluted to 5x106 cells/mL unless
otherwise noted. Mice were injected via the lateral tail vein with 0.1 mL of the C. albicans
suspension. C. albicans suspensions were plated on YPD and incubated overnight at
30°C to determine cell viability. Following infection, mice were monitored for signs of
illness for 21 days and were sacrificed after succumbing to infection.
For experiments in which fungal burden was measured, mice were sacrificed 5
days post infection and kidneys were harvested. Kidneys were placed in 1 mL water within
pre-weighed whirl-pack bags and homogenized. Serial dilutions (10-1, 10-2, and 10-3) were
prepared in water, and 1 mL of each dilution was added to 1.1% Noble agar pours (3.5
mL) at 55°C and poured onto YPD plates in duplicate for each dilution set. Plates were
incubated at 30°C overnight and colony forming unit (CFUs) were counted after 24 hours.

Ethics statement
All mouse model experiments in this study were performed under an animal protocol
(0016-0714) that was approved by the University of Tennessee Institutional Animal Care
and Use Committee (IACUC) and followed the ethical guidelines set forth by the National
Institute of Health (NIH) for the ethical treatment of animals.
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In vitro cytotoxicity assays
The FaDu oral epithelial cell line was used in this study (Martinez-Lopez et al., 2006).
Cells were routinely cultured in EBSS medium (Fisher Scientific, SH30024.01) with 10%
fetal bovine serum (Fisher Scientific, BP1600-100) and 1% penicillin/streptomycin
(Invitrogen, 15140-122) at 37°C and 5% CO2. Prior to the cell killing assay, 5x105 cells/mL
of FaDu cells were plated in a 24 well plate. For each C. albicans strain, 1 mL of FaDu
cells was plated in triplicate. C. albicans strains were cultured overnight in 5 mL YPD, and
then washed twice with sterile water. Cells were resuspended in 10 mL H2O and counted
via hemocytometer. Solutions containing 2.5x106 cells/mL of each strain (MOI=5) were
made in EBSS supplemented with 2% Human Serum (MP Biomedicals, ICN2930149)
and 1% penicillin/streptomycin.
Wells containing FaDu cells were aspirated and 1 mL of C. albicans cell
suspensions were added to FaDu cells for co-incubation. In addition, the following control
wells were included in triplicate: C. albicans alone, FaDu cells alone, medium alone, FaDu
cells with lysis solution, and lysis solution with medium. Plates were centrifuged at 250xg
for 5 minutes and incubated for 4 hours at 37°C at 5% CO2. Following incubation, plates
were spun at 250xg for 5 minutes, and 50 µL of each supernatant was assayed for LDH
release using the CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, G1780)
using the manufacturer’s protocol. Cytotoxicity was expressed as a relative percentage
of average wild type cytotoxicity and three biological replicates were performed (each with
technical replicates in triplicate).
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PC synthesis assay
This procedure was done as previously described for a phosphatidylserine synthase
assay with some changes (Bae-Lee and Carman, 1984; Cassilly et al., 2017). The optimal
PC synthesis assay mixture contained 50 mM Tris-HCl pH 7.5, 0.1% Triton X-100, 0.5
mM MnCl2 and 0.1 mM DAG (Avanti Polar Lipids INC.) added as a suspension in 1%
Triton X-100 and 0.5 mg protein in a total volume of 0.1 mL. The assay was performed
by monitoring the incorporation of 0.5 mM cytidine diphosphocholine (Sigma-Aldrich)
spiked with 10% by volume

[14C]-methyl

cytidine diphosphocholine (∼0.2 μCi) into the

chloroform-soluble product at 37°C for a predetermined amount of time. The reaction was
terminated by the addition of 1 mL chloroform:methanol (2:1). Following this the reaction
was extracted as previously described. Samples were fully dried in scintillation vials, 2.5
mL scintillation fluid was added to each vial, and they were measured with a liquid
scintillation counter (Tri-Carb 2900TR).

In vivo PE synthesis assay
Cultures were grown to logarithmic phase at 30°C in YNB in media supplemented with
100 μM choline chloride and 0.2 μCi/mL of [14C]ethanolamine. Phospholipids were isolated
as described in Surlow et al. (Surlow et al., 2014). Lipid extracts representing equivalent
amounts of optical density units (ODUs) were spotted onto silica gel TLC plates and plates
were developed in chloroform:ethanol:water:triethylamine (30:35:7:35). A Typhoon 8600
phosphorimager was used for visualization and quantitation of PC and PE regions of
intensity (ROI).
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Statistical analyses and BLAST parameters
All statistical analyses were carried out using GraphPad Prism (version 7.04). For
mouse survival curves the log-rank (Mantel-Cox) test was performed and for all other
analyses unpaired t-tests between the indicated strains were used to determine statistical
significance. For all analyses, p<0.05 was used as a cutoff to determine statistical
significance. To align protein sequences from S. cerevisiae to C. albicans, Basic Local
Alignment Search Tool Protein-Protein (BLASTP) was used (NCBI, CGD). Sequences
were obtained for S. cerevisiae S288C from the Saccharomyces Genome Database
(SGD) and BLASTP was performed via the Candida Genome Database (CGD). The
default settings were used to query assembly 22 of C. albicans SC5314 for hits. These
settings included allowgaps = yes, gapext = 1, gapopen = 11, matrix = BLOSUM62.
Results
Disruption of PEM1 and PEM2 causes choline auxotrophy in C. albicans
To determine if CDP-DAG mediated PC biosynthesis is required for virulence in C.
albicans, methylation of PE to PC was disrupted by constructing a pem1∆/∆ pem2∆/∆
knockout mutant using the SAT1 flipper method (Reuss et al., 2004). The pem1∆/∆
pem2∆/∆ mutant is expected to be a choline auxotroph because it can only make PC from
imported choline via the Kennedy pathway (Figure 2.1). Therefore, growth of the pem1∆/∆
pem2∆/∆ mutant was observed for 48 hours in minimal media (YNB) with or without 100
µM choline supplementation (Figure 2.2, A). Little growth occurred in minimal medium
lacking choline, indicating that the pem1∆/∆ pem2∆/∆ mutant cannot synthesize PC
efficiently due to disruption of the CDP-DAG pathway. Residual growth of the pem1∆/∆
pem2∆/∆ may be due to the ability to store PC or choline within the cell. Addition of 100
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Figure 2.2. The pem1∆/∆ pem1∆/∆ mutant is a choline auxotroph.
(A) Wild type, pem1Δ/Δ pem2Δ/Δ, and pem1Δ/Δ::PEM1 pem2Δ/Δ::PEM2 strains were grown overnight in minimal
media, diluted to an OD600nm = 0.1, and then cultured for 48 hours in minimal media, with or without 100 μM choline
(CHO). Wild type and pem1Δ/Δ pem2Δ/Δ were also cultured for 48 hours in minimal media, with or without varying
concentrations of (B) choline (CHO), (C) glycerophosphocholine (GPC), or (D) lysophosphatidylcholine (LPC). These
assays were performed with three biological replicates.
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µM choline or reintegration of the methyltransferase genes (pem1∆/∆::PEM1
pem2∆/∆::PEM2 strain) restored growth to wild-type levels, which indicates that
exogenous choline can be used to synthesize PC via the Kennedy pathway. In fact,
choline levels as low as 10 µM also restored growth to nearly wild-type levels (Figure 2.2,
B). Choline is found at ~11 µM in rodent serum (Klein et al., 1993).
To further investigate the ability of C. albicans to acquire choline from other
exogenous sources we tested several choline-containing compounds that are commonly
found in human and rodent tissues/serum, including lysophosphatidylcholine (LPC) and
glycerophosphocholine (GPC), (Croset et al., 2000; Ilcol et al., 2005) to determine if they
could also restore growth. LPC is as high as 450 µM in rat serum (Suarez-Garcia et al.,
2017) and GPC is as high as 4.5 µM, but GPC can be over 1 mM in homogenized brain
tissue and approximately 270 µM/g protein in homogenized kidney tissue (Bauernschmitt
and Kinne, 1993; Klein et al., 1993). The growth of the pem1∆/∆ pem2∆/∆ mutant was
restored to the wild type level in minimal media when supplemented with either 100 µM
GPC or LPC and was restored to nearly wild-type levels even at 10 µM (Figure 2.2, C-D).
To confirm that the pem1∆/∆ pem2∆/∆ mutant’s lack of growth in choline-free
media correlates with loss of PC synthesis, total lipids were extracted from cells growing
in minimal medium lacking a source of choline and analyzed by thin layer chromatography
(TLC) (Figure 2.3). While wild type C. albicans was able to produce PC regardless of
supplementation, the pem1∆/∆ pem2∆/∆ mutant failed to produce PC unless
supplemented with choline. Single mutants for both PEM1 and PEM2 were also tested
for PC synthesis. For PEM1, a pem1∆/PEM1::PMET3-PEM1 conditional knockout was
used, and for PEM2 a pem2∆/∆ conventional knockout was made. Both were cultured
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Figure 2.3. Choline auxotrophy correlates to a loss of PC.
Wild-type, pem1∆/∆ pem2∆/∆, pem2∆/∆, and pem1∆/PEM1::PMET3-PEM1 mutants
were cultured in the presence of 0.25 µM L-methionine in minimal media (YNB) with
(“+C”) or without (“-C”) 1 mM choline and total lipids were extracted. Phospholipids
were separated with thin layer chromatography (TLC) and visualized using primulin.
The pem1∆/∆ pem2∆/∆ mutant only produces PC when supplemented with choline.
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with or without 1 mM choline (Figure 2.3). In addition, the YNB media included YNB 0.25
µM cysteine/methionine to shut off expression of PEM1 in the pem1∆/PEM1::PMET3-PEM1
strain. The pem1∆/PEM1::PMET3-PEM1 strain was fully capable of PC production even in
the absence of choline when methionine/cysteine were present, but the pem2∆/∆ mutant
failed to produce PC unless supplemented with choline and there was an increase in the
intermediate product monomethylethanolamine. This resembles S. cerevisiae, in which
PEM2 has overlapping substrate specificity and can methylate PE (Preitschopf et al.,
1993; Henry et al., 2012). This also indicates that Pem1 cannot efficiently methylate the
intermediate products monomethylethanolamine or dimethylethanolamine to PC on its
own. To further investigate this phenomenon, growth curves were performed for the
pem1∆/PEM1::PMET3-PEM1 and pem2∆/∆ strains in minimal medium containing 0.25 µM
cysteine/methionine. It was found that loss of PEM1 confers a slight growth defect,
whereas loss of PEM2 results in a severe growth defect, however, this defect is not as
severe as that observed for the pem1∆/∆ pem2∆/∆ mutant (data not shown).
In some fungi, such as Neurospora crassa, there is an alternative for PC called
diacylglyceryl-N,N,N-trimethylhomoserine (DGTS) that can act as a functional analog to
PC, but lacks phosphate, and is typically expressed under conditions of phosphate
starvation (Riekhof et al., 2014). Candida albicans contains a putative BTA1 ORF
(C1_11490_A/orf19.8764), however the function of this gene has not been demonstrated
experimentally. Given that the pem1∆/∆ pem2∆/∆ mutant is auxotrophic for PC, we
hypothesized that overexpression of BTA1 would restore growth for this strain in the
absence of choline. A pem1Δ/Δ pem2Δ/Δ PENO1-BTA1 strain was created and cultured in
minimal media (YNB) lacking choline, and it was evident that overexpression of BTA1
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restored growth (Figure 2.4). Thus, C. albicans contains a functional copy of BTA1, and
overexpression of this DGTS synthase is able to compensate for the loss of PC in this
organism. The fact that C. albicans pem1∆/∆ pem2∆/∆ fails to grow in the absence of
choline indicates that C. albicans is not expressing BTA1 as a means to compensate for
loss of PE methylation.

PE from the CDP-DAG pathway accumulates in the pem1∆/∆ pem2∆/∆ mutant
If PE methylation to PC is blocked, it is expected that PE will accumulate in the cell and
PC from this pathway will decrease. To test this,

[14C]ethanolamine

radiolabeling assays

of whole cells were performed using the pem1∆/∆ pem2∆/∆ mutant. This experiment
measures the accumulation of PE that is derived from the Kennedy pathway. There was
an approximate 1.44-fold increase in radiolabeled PE in pem1∆/∆ pem2∆/∆ mutants as
compared to the wild type (***p<0.001) (Figure 2.5) and little or no PC was detected.
Thus, blockage of PE methylation results in the expected depletion of labeled PC and a
buildup of labeled PE. When the methyltransferases are reintegrated into the mutant,
statistically significant decreases in PE radiolabel accumulation and concurrent increases
in PC radiolabel accumulation are measured relative to the mutant ( *p<0.05). These data
do not measure the total PE and PC in the cells, as the phospholipid pools produced by
the CDP-DAG pathway for PE or the Kennedy pathway for PC are unlabeled (Figures
2.1, 2.5), but the data do reveal that blockage of the CDP-DAG pathway at this point
increases PE and decreases PC specifically generated from imported ethanolamine.

55

Figure 2.4. BTA1 overexpression rescues choline auxotrophy.
Constitutive expression of the DGTS synthase, Bta1, suppresses growth defects
caused by a loss of de novo PC synthesis in wild type C. albicans cultured in minimal
media (YNB).
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Figure 2.5. Radiolabeling of pem1Δ/Δ pem2Δ/Δ.
Strains were cultured in the presence of [14C]ethanolamine and incorporation of the
radiolabel into PE and PC was quantified using thin-layer chromatography (TLC) of
extracted lipids (***p<0.001, *p<0.05; unpaired t-test compared to wild-type). This assay
was performed with biological replicates in triplicate
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Blockage of PC synthesis by the PE methyltransferase mutant pem1∆/∆ pem2∆/∆
results in hypervirulence
Choline, GPC, and LPC can fully support growth of pem1∆/∆ pem2∆/∆ mutants in vitro
(Figure 2.2). These compounds are all found in the host, and therefore can be used to
make PC by pathways that are alternatives to the CDP-DAG pathway, such as the
Kennedy pathway (Figure 2.1). However, it was still possible that loss of PEM1 and PEM2
would affect virulence, so the mutants were tested in a mouse model of systemic infection.
Outbred ICR mice were infected with 3x105 cells each of either wild type (n=35), pem1∆/∆
pem2∆/∆ (n=25), or pem1∆/∆::PEM1 pem2∆/∆::PEM2 (n=10) via the tail vein. The
pem1∆/∆ pem2∆/∆ strain is fully virulent (Figure 2.6), indicating that PC biosynthesis by
the CDP-DAG pathway is not required for full virulence, as the Kennedy pathway can
synthesize enough PC in vivo to support virulence using choline obtained from the host.
Moreover, mice infected with the pem1∆/∆ pem2∆/∆ mutant succumb to infection more
rapidly than those infected with wild type (**p<0.01) (Figure 2.6). This was unexpected,
and we hypothesized that the pem1∆/∆ pem2∆/∆ mutant might be more virulent because
the blockage of PC biosynthesis by the CDP-DAG pathway leads to increased PE, as
seen in vitro (Figure 2.5). This could be because a block of the CDP-DAG pathway
upregulates an alternative PE synthesis pathway, such as the Kennedy pathway.
Alternatively, there may just be a buildup of PE as it cannot be methylated. In either case,
this may have a downstream effect on virulence. If so, then overexpression of the
Kennedy pathway (overexpression of PE synthesis enzymes by an alternative means),
should increase virulence in a similar manner.
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Figure 2.6. The pem1∆/∆ pem2∆/∆ mutant is hypervirulent.
Mice were infected via the lateral tail vein with 3x105 wild type (WT), pem1Δ/Δ pem2Δ/Δ,
or pem1Δ/Δ::PEM1 pem2Δ/Δ::PEM2 cells. Mice infected with the pem1Δ/Δ pem2Δ/Δ
mutant succumb to infection more rapidly than those infected with wild type C. albicans
(**p<0.01 compared to wild-type; log-rank (Mantel-Cox) test). The number of mice
representing each strain is shown in parentheses beside each strain.
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In contrast to S. cerevisiae, in C. albicans one enzyme, Ept1, catalyzes the final
step for both PE and PC biosynthesis in the Kennedy Pathway.
The Kennedy pathway can use exogenous choline and ethanolamine from the
environment to form PC and PE, respectively, and it also makes PC from internal stores
of choline that have been released by phospholipase activity (Dowd et al., 2001;
Fernandez-Murray et al., 2009). The current model for the C. albicans Kennedy pathway
is inferred from that characterized in baker’s yeast (Figure 2.1). In S. cerevisiae there are
two branches of the Kennedy pathway; the CDP-ethanolamine and CDP-choline
branches (Gibellini and Smith, 2010) (Figure 2.7, A). Each branch catalyzes analogous
reactions to convert ethanolamine or choline into PE or PC, respectively. To begin
synthesis of either PE or PC, ethanolamine or choline are imported into the cell by the
ethanolamine/choline importer Hnm1 (Nikawa et al., 1986; Nikawa et al., 1990). These
precursors are then phosphorylated by either ethanolamine (Eki1) or choline (Cki1)
kinase to form phosphoethanolamine (P-Etn) or phosphocholine (P-Cho), respectively
(Gibellini and Smith, 2010). P-Etn and P-Cho are used to form the high-energy
intermediates CDP-ethanolamine and CDP-choline by the ethanolamine and choline
cytidyltransferases, Ect1 and Pct1, respectively (Gibellini and Smith, 2010). Finally,
diacylglycerol is condensed with CDP-ethanolamine by Ept1 to form PE, or CDP-choline
by Cpt1 to form PC, with the release of CMP in both cases (Gibellini and Smith, 2010).
The two S. cerevisiae enzymes that represent each step of the Kennedy pathway
(one from each branch, Figure 2.7, A) share high sequence identity. For example, when
searching the C. albicans protein database in the Candida Genome Database (CGD) with
the Basic Local Alignment Search Tool (BLAST) using the S. cerevisiae Eki1 sequence
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Figure 2.7. C. albicans dual-purpose ethanolamine/choline phosphotransferase.
(A) Model for the S. cerevisiae Kennedy pathway and (B) proposed model for C.
albicans Kennedy pathway. Abbreviations: Etn, ethanolamine; Cho, choline; P-Etn,
phosphoethanolamine;
P-Cho,
phosphocholine;
CDP-Etn,
cytidinediphosphoethanolamine; CDP-Cho, cytidinediphosphocholine.
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as a query, hits are given for both the C. albicans Eki1 (C7_01320W/orf19.6912) and Cki1
(C3_05300C/orf19.6966) sequences (e-values of 6e-7 and 8e-87, respectively). The
same is true for S. cerevisiae Cki1. Thus, this holds true for the enzymes in the first two
steps of the Kennedy pathway. However, we recovered only one protein sequence when
we used BLAST to search CGD with the S. cerevisiae Ept1 or Cpt1 protein sequences.
For either S. cerevisiae protein, a single C. albicans protein is revealed that is designated
as Ept1 (C7_02690C/orf19.3695; e-value of 3e-114 for Ept1 and 7e-111 for Cpt1). We
hypothesized that C. albicans differs from S. cerevisiae in that it uses a single
phosphotransferase (C. albicans Ept1) to catalyze the addition of both CDP-ethanolamine
and CDP-choline to DAG to make PE and PC, respectively (Figure 2.7, B). If so, blocking
this step of the pathway would impede Kennedy pathway mediated synthesis of both PE
and PC. Alternatively, overexpressing it may increase synthesis of both PE and PC as
well.
In order to determine if Ept1 alone catalyzes the final step of both branches of the
Kennedy pathway in C. albicans, an ept1∆/∆ knockout strain was generated using the
SAT1 flipper method (Reuss et al., 2004). In addition, EPT1 was cloned into an
overexpression vector under the control of the strong, constitutive ENO1 promoter in
order to create a PENO1-EPT1 overexpression plasmid. This PENO1-EPT1 plasmid was
integrated into wild-type C. albicans. In addition, reintegrants were made for ept1∆/∆ in
which one allele of EPT1 was expressed at its native locus and under control of its native
promoter or the PENO1-EPT1 plasmid was used to reintegrate the gene.
To determine if these alterations in EPT1 affected PC synthesis from its precursors
CDP-choline and diacylglycerol (DAG), as predicted, a CDP-cholinephosphotransferase
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assay was performed on membranes isolated from each strain. Membranes were isolated
from the strains and incubated with

[14C]CDP-choline

and DAG, and the level of

[14C]PC

synthesized was measured. Disruption of EPT1 resulted in a total loss of PC synthesis,
while overexpression of EPT1 in wild-type or ept1∆/∆ resulted in twice the level of [14C]PC
as found in wild-type (Figure 2.8, A, **p<0.01). Thus, Ept1 is solely responsible for
catalyzing PC synthesis from CDP-choline and DAG.
Due to difficulty in obtaining radiolabeled

[14C]CDP-ethanolamine,

the role for C.

albicans Ept1 in PE synthesis was tested by measuring synthesis of
[14C]ethanolamine

[14C]PE

from

in whole cells. Each strain was cultured in minimal (YNB) media

supplemented with

[14C]ethanolamine,

and lipids were extracted (Surlow et al., 2014),

separated by TLC, and quantified to measure incorporation of the radiolabel into PE
(Figure 2.8, B, *p<0.05). Confirming our hypothesis, the ept1Δ/Δ strain does not
incorporate a detectable amount of radiolabel into PE. In contrast, the PENO1-EPT1 strain
incorporates increased radiolabel into PE. Finally, the ept1∆/∆ mutant transformed with
PENO1-EPT1 or EPT1 on its native promoter has a restored ability to incorporate the
radiolabels into both phospholipids (Figure 2.8, A-B). Thus, EPT1 solely catalyzes the
final step of both the CDP-choline and CDP-ethanolamine branches of the Kennedy
pathway in C. albicans (Figure 2.7, B).

Overexpression of EPT1 results in hypervirulence in the mouse systemic infection
model
Given that overexpression of EPT1 increases PE/PC synthesis by the Kennedy pathway,
we wanted to determine if this would also cause hypervirulence as observed for
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Figure 2.8. Synthesis of both PC and PE via the Kennedy pathway requires EPT1.
(A) Membranes were isolated from all strains and used in an in vitro PC synthesis assay,
where [14C]CDP-choline incorporation into PC was measured. Enzyme activity was
measured as counts per minute per milligram of protein, and is expressed as a
percentage of wild-type (**p<0.01; unpaired t-test compared to wild-type, WT). (B) Each
strain was cultured in the presence of [14C]ethanolamine and incorporation of the
radiolabel into PE was quantified by phosphorimager from thin-layer chromatography
(*p<0.05; compared to wild-type, WT by the unpaired t-test). Each of these assays was
performed with three biological replicates.
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pem1∆/∆ pem2∆/∆, which also accumulates PE (Figure 2.5). Therefore, wild-type and
PENO1-EPT1 strains were tested in the mouse model of systemic candidiasis. Mice
infected with PENO1-EPT1 C. albicans succumbed to infection more rapidly than those
infected with wild type (**p<0.01) (Figure 2.9, A). Thus, the PENO1-EPT1 and pem1∆/∆
pem2∆/∆ mutants both accumulate PE and exhibit hypervirulence. We wanted to
determine if this hypervirulence would correlate with increases in kidney fungal burden.
Outbred ICR mice (Envigo) were infected with 5x105 cells of the wild-type and PENO1EPT1 strains (n=10 for each strain). Five days post infection, the mice were necropsied,
and kidneys were harvested to determine fungal burden. Mice infected with the PENO1EPT1 overexpression strain exhibited an average increase in fungal burden of 38.1%
when compared to mice infected with wild type C. albicans, however this difference was
not statistically significant (Figure 2.9, B, *p=0.1885).

Disruption of EPT1 results in a decrease in kidney fungal burden in mice
As EPT1 is necessary for PE and PC synthesis through the Kennedy pathway, and its
overexpression increases virulence, we tested an ept1∆/∆ mutant in this model to
determine if it exhibits decreased virulence. For survival curves in the systemic infection
model there was not a significant decrease in virulence for the ept1∆/∆ strain compared
to wild type (Figure 2.9, A). However, it should be noted that mice infected with the
ept1∆/∆ strain began to succumb to infection at 11 days post infection, which is slightly
delayed compared to those infected with the wild-type (which begin to succumb to
infection at 7 days post infection), which may indicate a modest, although not statistically
significant, decrease in virulence. Although there was not a statistically significant
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Figure 2.9. Overexpression of EPT1 causes hypervirulence.
(A) Mice infected with PENO1-EPT1 overexpression strain (n=14) succumb to infection more rapidly than the wild type (WT,
n=15) (**p<.01; compared to WT, log-rank (Mantel-Cox) test). Mice infected with either one of two isogenic ept1∆/∆ mutants
do not differ significantly from those infected with wild type C. albicans (n=10 each). The n values for wild-type and PENO1EPT1 were derived from three separate experiments, and those for ept1∆/∆ were derived from two separate experiments.
(B) Mice infected with ept1∆/∆ have a decreased kidney fungal burden five days post infection compared to those infected
with the wild type (*p<0.05; unpaired t-test, n=15 mice per strain). Mice infected with the ept1∆/∆ PENO1-EPT1 reintegrant
resemble those infected with the wild type. Experiments were performed three times using five mice per strain and kidney
homogenates were plated with two technical replicates for reproducibility. (C) Expression level of C. albicans EPT1 affects
cytotoxicity in co-culture with human epithelial cells in vitro. The PENO1-EPT1 overexpression strain has increased
cytotoxicity (*p<0.05; unpaired t-test) compared to wild type, whereas ept1∆/∆ has decreased cytotoxicity (**p<0.01). The
ept1∆/∆ PENO1-EPT1 reintegrant resembles wild type for cytotoxicity. Biological replicates were performed in triplicate and
technical replicates were also performed in triplicate (n=9 total replicates per strain).
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difference in survival curves, mice infected with the ept1∆/∆ mutant had a significant
average decrease in kidney fungal burden of 44.97% as compared to the wild type
(*p<0.05) (Figure 2.9, B). This decrease in fungal burden may correlate with the slight
delay seen in survival curves for mice infected with the ept1∆/∆ strain. Conversely, mice
infected with the reintegrant ept1∆/ept1∆::PENO1-EPT1 strain did not exhibit any significant
differences in fungal burden compared to mice infected with wild type C. albicans.

EPT1 expression affects cytotoxicity of C. albicans against epithelial cells
The mechanism by which EPT1 impacts virulence is unclear, as there are no clear
impacts on growth rate in growth curves (data not shown). Thus, we examined another
virulence factor, which is the ability of C. albicans to damage epithelial cells. This can be
assessed by measuring the release of the cytoplasmic enzyme lactase dehydrogenase
(LDH) from host cells. In order to measure cytotoxicity of each mutant compared to wildtype, 2.5x106 C. albicans cells were co-cultured with human oral epithelial cells (FaDu
cell line). A CytoTox 96® cytotoxicity assay kit (Promega) was used to quantify the release
of LDH after four hours. There was a statistically significant decrease in cytotoxicity of the
ept1∆/∆ mutant as compared to the wild type (**p<0.01) (Figure 2.9, C). Conversely, the
PENO1-EPT1 overexpression mutant has increased cytotoxicity compared to the wild type
(*p<0.05) (Figure 2.9, C). The ept1∆/∆ PENO1-EPT1 reintegrant does have a modest
increase in cytotoxicity versus the wild type, but it is not statistically significant (Figure
2.9, C).
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Discussion
In a previous communication we demonstrated that the synthesis of phospholipids via the
CDP-DAG pathway is absolutely required for Candida albicans to be able to cause
disease in the mouse model of systemic infection (Chen et al., 2010). The phospholipids
produced in this pathway specifically are PS, PE, and PC (Figure 2.1). Blocking synthesis
of PS or PE by disrupting the PS synthase (cho1Δ/Δ mutant) or both PS decarboxylases
(psd1Δ/Δ psd2Δ/Δ mutant) results in avirulence (Chen et al., 2010). Although the full
mechanism is not clear (Davis et al., 2018), PS and PE synthesis by the CDP-DAG
pathway clearly play a crucial role in virulence. However, at the outset of this study the
role of PE’s downstream product, PC, was less clear. In addition, no prior studies have
directly evaluated the role of the Kennedy pathway with regard to virulence in C. albicans.

Increased PE in two different pathways correlates with hypervirulence
To determine if PC was important for the ability to cause disease, we blocked CDP-DAG
mediated PC biosynthesis by the pem1∆/∆ pem2∆/∆ mutation. Systemic infections carried
out in mice revealed that this mutation did not block virulence, but instead mice infected
with the pem1∆/∆ pem2∆/∆ mutant succumb to infection more rapidly than those infected
with wild-type (Figure 2.6).
The pem1∆/∆ pem2∆/∆ mutation causes a loss of PC synthesis by methylation of
PE, but simultaneously leads to a build-up of PE (Figure 2.5). Synthesis of PE has been
shown to be required for virulence (Chen et al., 2010; Davis et al., 2018), which suggests
the possibility that increased PE might lead to greater virulence. Therefore, we increased
PE synthesis through the Kennedy pathway by overexpressing EPT1 (Figures 2.7, 2.8),
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and this led to hypervirulence as well (Figure 2.9, A). This suggests that increased PE
synthesis causes hypervirulence, however it should be noted that overexpression of
EPT1 also causes increased PC synthesis.
We favor increased synthesis of PE rather than PC as an explanation of
hypervirulence since PE generated by Ept1 builds up, but PC goes down in the
hypervirulent pem1∆/∆ pem2∆/∆ mutant (Figure 2.5). Thus, the common phospholipid to
increase in both pem1∆/∆ pem2∆/∆ and PENO1-EPT1 (Figures 2.5 and 2.8) is PE.
Furthermore, PE synthesized from either the CDP-DAG or Kennedy pathways can
support virulence (Chen et al., 2010; Davis et al., 2018). Thus, taken altogether, these
data suggest PE is the primary phospholipid influencing virulence.
However, the mechanism by which elevated PE causes virulence is not clear at
this point. We do note that increased EPT1 correlates with increased damage of epithelial
cells, and although modest, this assay is measuring only short term (4 hours) damage,
so increased damage over time (~10 days) may accumulate leading to more rapid
terminal infection. However, the full mechanism by which increased virulence is mediated
is unknown.

EPT1 is required for full virulence during systemic infections
Overexpression of EPT1 leads to hypervirulence, but we also wanted to determine
whether the Kennedy pathway is required for full virulence in C. albicans, as this pathway
is present in a variety of eukaryotic pathogens and is required for virulence in some
(Gibellini et al., 2009). Furthermore, it has been demonstrated that blocking the ability of
C. albicans to import glycerophosphocholine (GPC), an intermediate metabolite that may
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be shunted into the Kennedy pathway, attenuates virulence in the mouse model of
systemic infection (Bishop et al., 2013). Until now, no virulence studies have been
performed on the Kennedy pathway in C. albicans, and so it has also remained unknown
whether this pathway is redundant in C. albicans, or if it is specifically required for growth
in the host.
We found that disruption of EPT1 caused a modest decrease in kidney fungal
burden (Figure 2.9, B), but not a significant increase in mouse survival (Figure 2.9, A).
This modest decrease in fungal burden might help explain the modest increase in the
time in which mice begin to succumb to infection in the ept1∆/∆ mutant (11 days)
compared to wild-type (7 days) (Figure 2.9, A), however, the overall difference in curves
was not statistically significant, so the modest decrease in fungal burden does not appear
to have a large impact on overall virulence. The decrease in kidney fungal burden also
correlated with a modest decrease in damage to epithelial cells (Figure 2.9, C). Thus, it
is possible that the ept1∆/∆ mutant is unable to damage host cells as well as wild-type C.
albicans, and this could help explain the loss of fungal burden. Also, it is not entirely clear
whether the effect is related to PE or PC, as Ept1 synthesizes both in C. albicans.

C. albicans Ept1 synthesizes both PE and PC in the Kennedy pathway
Prior to this study the model for the Kennedy pathway in C. albicans was based entirely
on that elucidated for S. cerevisiae. However, we found that while all the enzymes
involved in the first two steps of either PE or PC biosynthesis had homologs in C. albicans,
only one enzyme for the last step of synthesis was found in C. albicans: Ept1. Given the
results of the homology search and the fact that there is some overlap in substrate
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specificity between EPT1 and PCT1 in S. cerevisiae (Gibellini et al., 2009), we
hypothesized that this enzyme was responsible for both PE and PC biosynthesis in C.
albicans. This was tested using

[14C]

radiolabeling. Our findings are that the knockout

cannot incorporate radiolabeled precursors into either PE or PC, and that when the gene
is overexpressed an increased amount of the radiolabeled precursors are incorporated
into PE and PC. This indicates that Ept1 is the only enzyme that catalyzes this reaction
in C. albicans, and we can therefore block the Kennedy pathway by knocking out EPT1
and overexpress the pathway by overexpressing EPT1. We do not yet fully understand
how the Kennedy pathway influences virulence, but the ability to modulate virulence in
either direction using EPT1 expression levels indicates that this is an important pathway
for controlling the pathogenicity of this fungus.
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Appendix B
Genetic modifications
Short oligonucleotides (primers) were used for the creation of plasmids in E. coli,
and to knock out, overexpress, or reintegrate genes in C. albicans (Table B.1). In addition,
primers were used to verify the integration or absence of genes from specific loci in the
C. albicans genome, as well as within plasmid constructs in E. coli, and to sequence
genes upon integration to identify any potential mutations (Table B.1).
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Table B.1. Primers used in chapter two.
Primer
JCO95
JCO96
JCO165
JCO166
JCO192
JCO193
JCO194
JCO195
JCO196
JCO197
JCO198
JCO199
JCO200
JCO201
JCO203
JCO215
JCO216
JCO217

Description/Function
PMAL2 reverse primer to confirm presence/absence of SAT1 flipper vectors
URA3 terminator forward primer to confirm presence/absence of SAT1
flipper vectors
EcoRI linked forward primer to amplify the SAT1 marker for conditional
PEM1 knockout
EcoRI linked reverse primer to amplify 5' NCR of PMET3 for conditional
PEM1 knockout
KpnI linked forward primer to amplify 5’ NCR of PEM2
ApaI linked reverse primer to amplify 5’ NCR of PEM2
SacII linked forward primer to amplify 3’ NCR of PEM2
SacI linked reverse primer to amplify 3’ NCR of PEM2
PEM2 3’ NCR reverse primer to confirm PEM2 knockout
KpnI linked forward primer to amplify 5’ NCR of PEM1
ApaI linked reverse primer to amplify 5’ NCR of PEM1
SacII linked forward primer to amplify 3’ NCR of PEM1
SacI linked reverse primer to amplify 3’ NCR of PEM1
PEM1 3’ NCR reverse primer to confirm PEM1 knockout
PEM2 ORF reverse primer to confirm PEM2 knockout
SacII linked forward primer to amplify PEM1 ORF for conditional knockout
SacI linked reverse primer to amplify PEM1 ORF for conditional knockout
Forward primer to amplify 5' NCR of PEM1 to confirm conditional knockout

Sequence
5'-GATTATTAGTTAAACCACTGC-3'
5'-TGAAGGGGGAGATTTTCACT-3'
5AAAGAATTCCGTCAAAACTAGAGAATAATAAAG3’
5’-AAAGAATTCGTTTTCTGGGGAGGGTATTT-3’
5’-AAAGGTACCCAGTTTCCATACCAGTCTCA-3’
5’-AAAGGGCCCGACAGGAGTAATGAATGTAT-3’
5’-AAACCGCGGTCTTGTGGTATTGATTCGGGG-3’
5’-AAAGAGCTCACCCGTTTTTTTTTTCATTGC-3’
5'-TTGTCCACTTCTTCATCAGCA-3'
5’-AAAGGTACCTTTCATTGATCTTTATTGAAA-3’
5’-AAAGGGCCCTGTTCAAAAAAAAAAAAAA-3’
5’-AAACCGCGGGGAGTTTTGTATTAATTTT-3’
5’-AAAGAGCTCATTGAACATAAATTGAGTT-3’
5'-ATTTGGTCCACGTCCAATCA-3'
5'-GGTTCTTCAAACAATAATGCG-3'
5'-AAACCGCGGATGACTTTCACAATCAATAAT-3'
5'-AAAGAGCTCTTATACATCTTTTTTATCAGT-3'
5'-TCCCCCTTTTTCCTCTAAAAG-3'
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Table B.1. (Continued)
Primer
JCO220
BTO24
BTO25
BTO26
BTO27

Description/Function
Reverse primer to amplify SAT1 ORF to confirm conditional knockout
PEM1 5' NCR forward primer to confirm PEM1 knockout
PEM1 5' NCR forward primer to confirm PEM1 knockout
PEM1 3' NCR reverse primer to confirm PEM1 knockout
PEM1 ORF reverse primer to confirm PEM1 knockout

BTO28
BTO29
BTO30

NotI linked forward primer to amplify BTA1 ORF
SacI linked forward primer to amplify BTA1 ORF
BamHI linked forward primer to amplify 5' NCR of ENO1

BTO31

NotI linked reverse primer to amplify 5' NCR of ENO1

BTO33
BTO34

PENO1 colony PCR forward to confirm overexpression inserts
BTA1 colony PCR reverse

BTO35

NotI linked forward primer to amplify EPT1 ORF

BTO36

SacI linked reverse primer to amplify EPT1 ORF

BTO37

NotI linked forward primer to amplify PCT1 ORF

BTO38
BTO42
BTO43
BTO44
BTO45

SacI linked reverse primer to amplify PCT1 ORF
PCT1 ORF reverse primer to confirm PCT1 overexpression
EPT1 ORF reverse primer to confirm EPT1 overexpression
KpnI linked forward primer to amplify 5' NCR of EPT1
XhoI linked reverse primer to amplify 5' NCR of EPT1

Sequence
5'-CTTTATTATTCTCTAGTTTTGACG-3'
5'-CACGAGTACCCTTTGATTG-3'
5'-GATAGACAATCATTCTTATACAGT-3'
5'-GTAGTGGACAAGTTAGACTTACA-3'
5'-GTATTGAATTCCACTGGCATGGA-3'
5'AAAAGCGGCCGCGAATGTCAGAATTCATAGTTG3'
5'-AAAAGAGCTCCACATAAAGAGGGGATATTC-3'
5’-AAAAGGATCCAGGTCTGTCATATTTCTATC-3’
5’AAAAGCGGCCGCGTTGTAATATTCCTGAATTATC3’
5'-GACTAACGATTTCTATAAGG-3'
5'-GAAACAAATCAACTATGAATT C-3'
5’-AAAAGCGGCCGCATGGGACTTTTCATTCCAAC3’
5’-AAAAGAGCTCCAAGATGTTTTAGCTCCTG-3’
5’AAAAGCGGCCGCAATATGGCTAGACTTACTAG-3’
5’-AAAAGAGCTCCAATTAAATCCTGTGACATTG-3’
5'-CTCTTTCTAGTAAGTCTAGC-3'
5'-GTTAGTTGGAATGAAAAGTC-3'
5-AAAAGGTACCCTTTTGTTAGGAGCTGTAG-3’
5’-AAAACTCGAGGTGTTCTTGGTGTTGATTC-3’
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Table B.1. (Continued)
Primer

Description/Function

BTO46

NotI linked forward primer to amplify 3' NCR of EPT1

BTO47
BTO52
BTO53

SacI linked reverse primer to amplify 3' NCR of EPT1
ApaI linked forward primer to amplify PEM1 ORF for reintegration
XhoI linked reverse primer to amplify PEM1 ORF for reintegration

BTO54

NotI linked forward primer to amplify 3' NCR of PEM1 for reintegration

BTO55
BTO56
BTO57
BTO58
BTO59

SacI linked reverse primer to amplify 3’ NCR of PEM1 for reintegration
EPT1 5' NCR forward primer to confirm EPT1 knockout
EPT1 ORF reverse primer to confirm EPT1 knockout
EPT1 3' NCR reverse primer to confirm EPT1 knockout
EPT1 ORF forward primer to confirm EPT1 knockout

BTO67

ApaI linked reverse primer to amplify PEM2 ORF for reintegration

BTO87
BTO88

PEM2 ORF reverse primer to confirm PEM2 reintegration
PEM2 5' NCR forward primer to confirm PEM2 reintegration

BTO89

NotI linked forward primer to amplify ECT1 ORF

BTO90

SacI linked reverse primer to amplify ECT1 ORF

BTO91

NotI linked forward primer to amplify PSD2 ORF

BTO92
BTO95
BTO96

SacI linked reverse primer to amplify PSD2 ORF
ECT1 ORF reverse primer to confirm ECT1 overexpression
PSD2 ORF reverse primer to confirm PSD2 overexpression

Sequence
5’-AAAAGCGGCCGCGATACGTTTTGTTTGGTTAC3’
5’-AAAAGAGCTCCACCAGAACAAAGAGAATC-3’
5’-AAAAGGGCCCCTGTTGAATACAATCTCTTG-3’
5’-AAAACTCGAGCTGACTGAAGATGGAATTG-3’
5’-AAAAGCGGCCGCGTAAGTCTAACTTGTCCAC3’
5’-AAAAGAGCTCCAATGAGTGATAGAAGACG-3’
5'-GTGATGATGATGGTTCTTTC-3'
5'-GAGTTTCATTTAAATAAGGATC-3'
5'-CACATTATCGATGAAGCTAG-3'
5'-GCTTATCGAGGATTATATCC-3'
5’-AAAAGGGCCCCCCCGAATCAATACCACAAGA3’
5'-CTTGAGCAATTGATGACATG-3'
5'-GCAATGACATTTGATAGCTG-3'
5’-AAAAGCGGCCGCATGTACGAAAGGCCAGAAG3’
5’-AAAAGAGCTCCTAGAACTAACAAATGGACTG-3’
5’AAAAGCGGCCGCATGAGATCTTCTGGCTATTTAA3’
5’-AAAAGAGCTCCATAATCCATATTCACGAATG-3’
5'-CTTCTGGCCTTTCGTACAT-3'
5'-TTAAATAGCCAGAAGATCTC-3'
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Table B.1. (Continued)
Primer

Description/Function

BTO105
BTO106

EPT1 3' NCR reverse primer to confirm EPT1 reintegration
EPT1 5' NCR forward primer to confirm EPT1 reintegration

TRO1044

KpnI linked forward primer to amplify EPT1 for reintegration

TRO1045

XhoI linked reverse primer to amplify EPT1 for reintegration

TRO1046

SacII linked forward primer to amplify 3' NCR of EPT1 for reintegration

TRO1047

SacI linked reverse primer to amplify 3' NCR of EPT1 for reintegration

Sequence
5'-GATCAAGAAATTGCTCTTAGAG-3'
5'-CTGGATTTATATTCAGAATCAT-3'
5’-AAAAGGTACCCCCCCCTCTGAACAAAAATTG3’
5’-AAAACTCGAGCCAAAAGCAAAGTAAAAGCAA3’
5’-AAAACCGCGGTGGATTGGATTGGATTGGATC3’
5’AAAAGAGCTCTCAACTTTTCCTCCAACTACAAA-3’
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Publication Note
A version of this chapter has been submitted for peer review and publication. If accepted
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E. Sparer, and Todd B. Reynolds. Overexpression of Candida albicans EPT1 Alters Cell
Wall Composition and Hyphal Length.
The author contributions are as follows: RT and TBR designed and created
plasmids and C. albicans strains. RT performed RNA extractions and sequencing.
Bioinformatic analysis was performed by RT and EG. AW performed chitin and β(1,3)glucan staining and subsequent flow cytometry. JJ and RT performed staining and flow
cytometry of macrophages. RT performed all other assays and wrote the manuscript. TBR
directed the project and edited the manuscript.
Abstract
Candida albicans is a leading cause of systemic bloodstream infections in
immunocompromised patients and phospholipid biosynthesis is an important requirement
for this organism to grow and cause disease. We have previously demonstrated that the
psd1Δ/Δ

psd2Δ/Δ

mutant,

which

cannot

synthesize

the

phospholipid

phosphatidylethanolamine (PE) by the CDP-DAG pathway, is avirulent in the mouse
model of systemic candidiasis and has decreased cytotoxicity against oral epithelial cells
in vitro. Similarly, an ept1Δ/Δ mutant, which cannot produce PE by the Kennedy pathway,
exhibits decreased kidney fungal burden in systemically infected mice and has decreased
epithelial cell cytotoxicity in vitro. Conversely, overexpression of EPT1 results in a
hypervirulent phenotype both in vivo and in vitro. Thus, mutations that increase PE
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synthesis increase virulence, and mutations that decrease PE synthesis decrease
virulence. However, the mechanism by which virulence is regulated by these PE
regulatory enzymes is only partially understood. In the present study RNA sequencing
was performed to elucidate this mechanism by identifying transcriptional dysregulation
that occurs in strains with either deficient or excessive PE biosynthesis. It was found that
decreased PE synthesis by either loss of EPT1 or PSD1 and PSD2 leads to downregulation of genes involved in the TCA cycle, glycolysis, amino acid biosynthesis, and
fatty acid oxidation, which implicates impacts on mitochondrial function. Loss of PSD1
and PSD2, but not EPT1, causes significant increases in transcription of glycosylation
machinery genes, which may reflect the substantial cell wall defects in this mutant. These
accumulated defects could contribute to the defects in virulence experienced by mutants
with deficient PE synthesis. In contrast to mutants with decreased PE synthesis, there
were no transcriptional differences between the EPT1 overexpression strain and the wildtype besides an increase in EPT1, indicating that the hypervirulent phenotype is a
consequence of post-transcriptional changes. Upon further analysis it was found that
overexpression of EPT1 causes increased chitin content, decreased β(1,3)-glucan
exposure, and increased hyphal length. These phenotypes may explain the previously
observed hypervirulence in the EPT1 overexpressor and appear to be a result of posttranscriptional regulation.
Introduction
The opportunistic human fungal pathogen Candida albicans causes oral and vaginal
mucosal infections as well as dangerous systemic infections. Both mucosal and systemic
candidiasis are common in immunocompromised individuals, and it remains problematic
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that there are only three major classes of drugs that can be used to treat systemic
infections (Cowen et al., 2015). Drugs within these classes target some component of the
cell membrane or cell wall (Cowen et al., 2015). However, there are currently no antifungal
drugs for the treatment of systemic candidiasis that target phospholipid biosynthetic
pathways. These pathways are not entirely conserved amongst mammals and fungi and
are required for growth and pathogenesis of C. albicans (Chen et al., 2008; Chen et al.,
2010). Therefore, these are good areas in which to identify novel drug targets. Since
many phospholipid biosynthetic processes in C. albicans have been inferred from the
model yeast Saccharomyces cerevisiae, it is imperative to gain a better understanding of
phospholipid biosynthetic processes and to evaluate their impact on virulence in C.
albicans.
The major phospholipids of C. albicans are phosphatidylglycerol (PG), cardiolipin
(CL), phosphatidylinositol (PI), phosphatidylethanolamine (PE), phosphatidylserine (PS),
and phosphatidylcholine (PC) (Singh et al., 2010; Cassilly et al., 2017). The de novo route
for the synthesis of PS, PE, and PC is the cytidine-diphosphate diacylglycerol (CDP-DAG)
pathway (Carman and Han, 2011). In this pathway, PS is synthesized by the Cho1
enzyme from serine and CDP-DAG (Atkinson et al., 1980; Letts et al., 1983). PS is then
decarboxylated by Psd1 and Psd2 to form PE, which can then be methylated by Pem1
and Pem2 to form PC (Kodaki and Yamashita, 1987; Clancey et al., 1993; Trotter and
Voelker, 1995). We have previously reported that PE synthesis by the CDP-DAG pathway
is a requirement for virulence in the mouse systemic model of infection as a psd1Δ/Δ
psd2Δ/Δ mutant has a heavy attenuation of virulence and the cho1Δ/Δ mutant is
completely avirulent (Chen et al., 2010).
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In addition to the CDP-DAG pathway, C. albicans can synthesize PE and PC by
an alternative route known as the Kennedy pathway (Gibellini and Smith, 2010). We have
recently reported that the ethanolamine/choline phosphotransferase gene EPT1 is
required for the synthesis of both PE and PC by the Kennedy pathway, which is different
from the model organism S. cerevisiae in which there is one phosphotransferase enzyme
for the synthesis of each lipid (Gibellini and Smith, 2010; Tams et al., 2019). Furthermore,
a modest decrease in fungal burden is observed in the kidneys of ept1Δ/Δ infected mice,
and ept1∆/∆ exhibits decreased cytotoxicity against oral epithelial cells in vitro compared
to wild-type cells (Tams et al., 2019). Interestingly, we found that when synthesis of PE
is increased by overexpressing the EPT1 gene, the fungus becomes hypervirulent in the
mouse systemic model of infection and has increased cytotoxicity against oral epithelial
cells (Tams et al., 2019). Another mutant which cannot methylate PE to PC, pem1Δ/Δ
pem2Δ/Δ, has increased PE, and this strain is also hypervirulent in the mouse systemic
infection model (Tams et al., 2019). Thus, the synthesis level of PE in the cell correlates
with virulence and may act as a dimmer switch for virulence. However, the mechanism
by which the level of Ept1/PE regulates virulence remains unknown.
To elucidate this mechanism, a transcriptomic analysis of the wild-type, psd1Δ/Δ
psd2Δ/Δ, ept1Δ/Δ, and EPT1 overexpression strains was performed. Since we have
previously determined that these strains have a gradient of cytotoxicity against epithelial
cells, and that increased damage correlated to increased PE, we hypothesized that there
would be a gradient of gene expression for impacted genes (Tams et al., 2019). For
example, there may be a gene that is overexpressed in the EPT1 overexpressor that has
decreased expression in the wild-type and even lower expression in PE deficient mutants
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(or vice versa). Therefore, strains were cultured under similar conditions in which
cytotoxicity defects were observed (i.e. hyphal growth in tissue culture), and
transcriptional profiling was used to elucidate how PE levels impact virulence.
In addition to this approach, and because it has been demonstrated that changes
in phospholipid biosynthesis can impact cell wall structure (Davis et al., 2014), our
alternative hypothesis was that there were changes in cell wall structure, which could lead
to changes in host-pathogen interactions. Therefore, we examined two components of
the cell wall that have been shown to have immunomodulatory functions. Of these
components, β(1,3)-glucan is an extensively studied cell wall carbohydrate polymer that
impacts immune recognition in the host. For example, it has been demonstrated that
immune recognition of β(1,3)-glucan is a key factor in the ability of tissue resident
macrophages, which are primary mediators of immunosurveillance, to recognize and
clear fungal infections (Davis et al., 2014; Xu and Shinohara, 2017). C. albicans strains
with significant exposure or “unmasking” of β(1,3)-glucan are less virulent than those that
mask these residues, and mice deficient in the Dectin-1 receptor, which is a C-type
signaling lectin involved in recognition of β(1,3)-glucan, are more susceptible to C.
albicans infections (Herre et al., 2004; Taylor et al., 2007; Chen et al., 2010; Davis et al.,
2014). A loss of phosphatidylserine biosynthesis increases exposure of β(1,3)-glucan,
and thus it is possible that overexpression of phospholipid biosynthesis may also impact
exposure of β(1,3)-glucan (Davis et al., 2014).
Another cell wall component that can modulate host-pathogen interactions is chitin,
which is a β(1,4)-linked N-acetylglucosamine polymer common in fungal cell walls and
numerous invertebrate organisms (Lenardon et al., 2010). Purified fungal chitin can
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modulate the immune system by inducing inflammatory tumor necrosis factor alpha (TNFα) mediated response, or alternatively anti-inflammatory interleukin 10 (IL-10) mediated
response in macrophages in a particle size-dependent manner (Da Silva et al., 2009).
Further, fungal chitin can drive decreased production of reactive nitrogen species in
macrophages (Wagener et al., 2017). Therefore, in hypervirulent strains it is possible that
there are changes to the cell wall that allow the fungus to modulate the immune system
in order to better evade immunosurveillance. Since β(1,3)-glucan masking is important
for immune evasion and because chitin can modulate the host immune response, the
second goal of this study was to identify differences in these components between the
wild-type and hypervirulent EPT1 overexpression strain.
Materials and Methods
Culture conditions and growth media
Candida albicans strains from the SC5314 background were routinely cultured in YPD
(1% yeast extract, 2% dextrose, 2% peptone) in a shaking incubator at 225 RPM and
30°C (Gillum et al., 1984) (Table 1). The RAW 264.7 macrophage cell line was routinely
cultured in Dulbecco’s Modified Eagle Medium with L-Glutamine (DMEM) (Gibco,
11965118) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, 16000044) and
1% penicillin/streptomycin at 37°C and 5% CO2 (Raschke et al., 1978). Escherichia coli
strains (DH5-α; NEB, C2987I) were cultured in LB broth (1% tryptone, 1% NaCl, 0.5%
yeast extract) in a rotating incubator at 37°C.
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Table 3.1. C. albicans strains used in chapter three.
Strain
SC5314
YLC339
YLC375

Parent Strain
Clinical isolate
YLC335
YLC373

Genotype
Prototrophic Wild Type
cho1Δ/Δ
psd1Δ/Δ psd2Δ/Δ

Source
Gillum et al.
Chen et al.
Chen et al.

BTY88
BTY104

SC5314
BTY101

PENO1::PENO1-EPT1-NAT1
ept1Δ/Δ-SAT1

Tams et al.
Tams et al.

BTY204
pBT11 (E. coli)

YLC339
pBT1 (E. coli)

cho1Δ/Δ PENO1::PENO1-EPT1-NAT1
EPT1 Overexpression Vector

This Study
Tams et al.
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Strain construction
Candida albicans strains (Table 1) were created with the use of the SAT1 flipper method
(Reuss et al., 2004). To overexpress EPT1 in the cho1Δ/Δ background, a cho1Δ/Δ PENO1EPT1 strain was constructed. The EPT1 overexpression construct, pBT11, was linearized
(MscI) and transformed into YLC339 (cho1∆/∆) via electroporation as described
previously (Hasim et al., 2014; Tams et al., 2019). Transformants were selected with the
use of YPD supplemented with 200 μg/mL nourseothricin (Gold Bio, N-500-1), and
successful transformants were confirmed using PCR with the primers BTO33 (5’GACTAACGATTTCTATAAGG-3’) and BTO43 (5’-GTTAGTTGGAATGAAAAG TC-3’).

RNA Isolation, purification, and sequencing
The wild-type, EPT1 overexpressor, ept1Δ/Δ, and psd1Δ/Δ psd2Δ/Δ strains were cultured
for approximately 16 hours in 5 mL YPD shaking at 225 RPM and 30°C. Following
incubation, each strain was washed twice with 35 mL sterile ddH2O and resuspended in
5 mL ddH2O. Each strain was diluted, in duplicate, to OD600nm = 0.5 in 25 mL of Earl’s
balanced salt solution (EBSS) (GE Life Sciences, SH30024.01) supplemented with 1%
penicillin/streptomycin (Gibco, 15140122) and 2% human serum (MP Biomedicals,
92930149) that was pre-warmed to 37°C in T125 tissue culture flasks. Flasks were
incubated at 37°C and 5% CO2 for 4 hours, as was performed in prior cytotoxicity assays
(Tams et al., 2019). Following incubation, hyphae were removed with a sterile rubber cell
scraper and transferred to 50 mL conical tubes. Samples were washed twice with sterile
PBS and were resuspended in 750 µL acid-phenol (pH = 4.5), vortexed, and transferred
to 2 mL screw cap tubes that contained 750 µL TES buffer (10 mM Tris pH 7.5, 10 mM
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EDTA pH 8.0, 0.5% SDS) and 0.5 grams Zirconia beads. Each tube was filled completely
with TES so that no air remained and was placed on ice for 2 minutes. Samples were
homogenized in a bead beater for one minute and allowed to rest on ice for 2 minutes.
Four total cycles of homogenization were performed, and samples were subsequently
incubated at 65°C for 30 minutes with vigorous vortexing at 10-minute intervals. After
incubation, samples were centrifuged for 5 minutes at 13,000 RPM at room temperature
and the aqueous layer was transferred to a fresh tube containing 700 µL acidphenol/chloroform, vortexed, and centrifuged at 13,000 RPM for 5 minutes. This process
was repeated using 600 µL phenol/chloroform (pH=6.7) until the interface was clear. The
supernatant was transferred to a fresh tube and nucleic acids were precipitated with
DEPC treated 3M NaOAc and 100% ethanol. Samples were stored at -80°C for
approximately 16 hours, thawed, and the RNA pellet was centrifuged, washed with 70%
ice-cold ethanol, air dried, resuspended in 50 µl RNase Free H2O, and quantified using a
spectrophotometer. Following quantification, DNase treatment was performed with a
Turbo DNase-Free kit (Ambion, AM1907) according to the manufacturer’s protocol.
To determine final RNA concentration and quality, samples were analyzed with the
2100 series bioanalyzer (Agilent Technologies, CA, USA) at the University of Tennessee
Genomics Core. Following quality control analysis, a cDNA library was prepared with the
Nextera XT library kit (Illumina Inc., CA, USA) by following the manufacturer’s protocol,
and the library was validated via bioanalyzer (Agilent Technologies, CA, USA). The cDNA
library was pooled and sequenced in-house using an Illumina MiSeq V2 flow cell (Illumina
Inc, CA, USA).
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Transcriptomic analysis
The C. albicans reference genome (version A22-s07-m01-r71) and corresponding
annotations were downloaded from the Candida Genome Database (Skrzypek et al.,
2017). Samples were analyzed using the University of Tennessee Advanced Computing
Facility (ACF) resources. The quality of each sample was analyzed using FastQC (version
0.11.5) and trimming was performed using Trimmomatic (version 0.36). Read quality was
again confirmed following trimming with FastQC (version 0.11.5). The reference genome
and corresponding annotations were converted to a haploid reference and annotation set
by removing the B allele for each gene using in-house scripts. This was also repeated the
A allele. Read mapping and annotation was performed with STAR (version 2.5.3a) (Dobin
et al., 2013). Mapped read counts were obtained with htseq (version 0.10.0) (Anders et
al., 2015) and DEseq2 (version 1.18.1) (Anders and Huber, 2010) was used within the RStudio Environment (R version 3.4.3) to perform differential expression analysis. In-house
Python scripts were used to generate a list of genes that were co-upregulated and codownregulated in both the ept1Δ/Δ and psd1Δ/Δ psd2Δ/Δ strains as compared to the
wild-type. Specifically, this list included genes that had greater or less than a 0.6 log2-fold
(~1.5-fold) change in both mutants compared to wild-type. The genes in this list also meet
the requirement of having a Benjamini-Hochberg adjusted p-value of <0.05. GraphPad
Prism (version 7.04) was used to generate heat maps, and the Candida Genome
Database (CGD) GOslim mapper feature was used to determine functional groupings of
differentially expressed genes (Skrzypek et al., 2017). In addition, the Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathway analysis tool was used to determine which
pathways had multiple genes that were differentially expressed (Kanehisa and Goto,
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2000). To validate RNA sequencing data, transcripts per kilobase million (TPM) was
calculated using CLC Genomics Workbench (version 10.1.1) and the proportion of
transcripts mapping to housekeeping genes for each sample set was determined. Briefly,
Illumina reads were imported into CLC and trimmed with limit = 0.01, maximum number
of ambiguities = 2 and automatic read-through adapter trimming = yes. Reads were
mapped with mismatch cost = 2, insertion cost = 3, deletion cost = 3, length fraction =
0.8, and similarity fraction = 0.8.

β(1,3)-glucan and chitin detection assays
Chitin staining and surface β(1,3)-glucan exposure of cells at either stationary or log
phase of growth was quantified with the use of flow cytometry. To stain cells at stationary
phase, 5 mL cultures of C. albicans in YPD were grown shaking for approximately 16
hours at 30°C and 225 RPM, and then diluted to OD600nm = 0.5 for β(1,3)-glucan staining,
or OD600nm = 1.5 for chitin staining. To stain log-phase cells, stationary cultures were
diluted to OD600nm = 0.1 in 5 mL YPD and incubated for 3.5 hours at 30°C and 225 RPM.
Staining of β(1,3)-glucan was performed as described previously with three biological
replicates for each strain (Chen et al., 2019).
Chitin staining was achieved using calcofluor white (PolySciences Inc., 4359).
Stationary phase cultures were diluted to OD600nm = 1.5, washed three times with 500
μL PBS, and resuspended in 500 µL of 0.01 mg/mL calcofluor white. Cells were then
rocked in the dark for 5 minutes at room temperature, washed 3 times with 500 μL water,
and resuspended in 500 µL FACS buffer for flow cytometry analysis. All samples were
analyzed with an LSRII flow cytometer (Becton Dickinson Biosciences) and data for each
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sample was collected for 100,000 gated events. This experiment was performed with
three biological replicates. Data was analyzed with FlowJo (version 10.11) and statistical
significance was determined by performing an unpaired t-test with GraphPad Prism
(version 7.04).
Surface exposed β(1,3)-glucan was further assessed when cells were put under
physical or chemical stress. Heat was used to induce physical stress. Stationary phase
C. albicans was diluted to an OD600nm = 0.5 in 1 mL of PBS and incubated at 90°C for
20 minutes (Wheeler and Fink, 2006). After incubation, tubes were removed and β(1,3)glucan staining was performed as described above. Alternatively, chemical stress was
induced by the addition of sub-minimum inhibitory concentrations (MIC) of caspofungin
(Merck, NJ, USA). Stationary cultures of C. albicans were diluted to OD600nm = 0.5 in 5
mL of YPD containing either 15.6 ng/mL (1/8th M.I.C.), 31.3 ng/mL (1/4th M.I.C.), or 46.9
ng/mL (3/8th M.I.C.) caspofungin. Cultures were incubated at 30°C and 225 RPM for 30
minutes and 1 mL of each sample was removed for analysis of either β(1,3)-glucan
exposure or chitin as previously described. Chitin analysis after caspofungin treatment
was performed in biological and technical triplicate. β(1,3)-glucan analysis after
caspofungin treatment was performed with a minimum of two biological replicates per
strain and per condition, each in technical triplicate.

Yeast growth and hyphal length measurements
For yeast form cells, each strain was cultured to stationary phase for approximately 16
hours in YPD shaking at 225 RPM and 30°C and then diluted to OD600nm = 0.1 in fresh
YPD in triplicate. Cells were again cultured by shaking at 225 RPM and 30°C, and
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OD600nm was measured every two hours for 12 hours.
For hyphal length measurements, stationary phase cells were washed twice with
30 mL sterile PBS. Following washes, cells were resuspended in 5 mL PBS. Cultures
were diluted to OD600nm = 1.0 in 1 mL of RPMI + 20% human serum that was pre-warmed
to 37°C. Serial dilutions were performed and 100 μL of each culture was plated in triplicate
in a 96 well plate at a final OD600nm of 1.0x10-4. Cells were then incubated for 3 hours at
37°C to induce the formation of hyphae. Following incubation, six images per well were
obtained on an inverted microscope. For each experiment the length of 200 hyphae, from
the base of the cell to the hyphal tip, was measured for each strain using ImageJ software
(version 1.52a) and was expressed as percent average wild-type hyphal length. This
experiment was performed three times (n=600/strain total) (Schindelin et al., 2015).
Results
Loss of PE synthesis causes global changes to the C. albicans transcriptome
The EPT1 overexpression strain has increased cytotoxicity against oral epithelial cells
that correlates with increased PE synthesis by the Kennedy pathway (Tams et al., 2019).
Conversely, loss of PE synthesis by either the CDP-DAG pathway or the Kennedy
pathway results in decreased cytotoxicity (Davis et al., 2018; Tams et al., 2019). To
determine the mechanism by which PE level impacts virulence, a transcriptional profile of
these strains was obtained after growth under the same conditions in which differences
in cytotoxicity were previously observed. Each strain was cultured in duplicate in tissue
culture flasks (37ºC, 5% CO2, EBSS + 2% Human Serum, 1% pen/strep) for four hours
and RNA was extracted and sequenced with an Illumina MiSeq. RNA integrity number
(RIN) values ranged from 8.6-9.8 and nearly 38.5 million 150 bp paired-end reads were
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obtained for the sample set after sequencing. FastQC was used to remove index or
adapter contamination from reads, and to remove leading and trailing reads with PHRED
scores <30. Sequence quality was determined both before and after trimming. The diploid
reference genome and annotations (version A22-s07-m01-r71) were obtained from the
Candida Genome Database (CGD) (Skrzypek et al., 2017) and were converted to haploid
versions using in-house scripts that removed the B chromosomes and corresponding
annotations. This was performed to circumvent issues with proper mapping, as most
reads were thrown out or assigned poor mapping quality scores when a diploid reference
was used. STAR was used to map reads, and approximately 90% of reads mapped
uniquely to the genome for all samples (Anders and Huber, 2010). Mapped reads were
counted using htseq and differential expression analysis was performed using DEseq2.
To ensure that there was no bias caused by removal of the B alleles, this analysis was
also performed by mapping to reference genomes in which the A alleles had been
removed, and it was found that the difference between the two mapping scenarios was
negligible. Transcripts per kilobase million (TPM) was obtained using CLC Genomics
Workbench.
A principal component plot (PCA) was created using R Studio to determine
similarity of samples and replicates (Figure 3.1, A). Between all replicates, there was tight
clustering, indicating little technical and biological variability. The wild-type and EPT1
overexpressor strains also clustered tightly, indicating similar gene expression profiles.
More significant differences were observed for the mutants deficient for PE production,
with the psd1Δ/Δ psd2Δ/Δ strain displaying the greatest variance from wild-type (Figure
3.1, A). To verify that gene expression estimates derived from this dataset are valid, the

95

Figure 3.1. PCA analysis and housekeeping gene expression profiles.
(A) Principal component plot for transcriptomic analysis reveals that replicates have little variation. The EPT1 strain
is similar to wild-type, and the PE deficient strains have the greatest differences versus wild-type. (B) TPM for
housekeeping genes are similar among all strains. (C-D) Log transformed TPM for housekeeping genes (TEF1, ACT1,
TUB1, EFG1, and PMA1) is plotted versus wild-type for (C) ept1Δ/Δ, (D) EPT1 overexpressor, and (E) psd1Δ/Δ
psd2Δ/Δ; The color for each gene corresponds to the figure legend in panel B.
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proportion of reads mapping to five common housekeeping genes (TEF1, ACT1, TUB1,
EFG1, and PMA1) were obtained, and the average TPM of replicates for each sample
set was plotted as was performed by Martin et al. (Figure 3.1, B) (Martin et al., 2017).
Housekeeping gene expression was similar among all sample sets, even for PMA1 which
had expression as low as ~ 102 TPM (Figure 3.1, B). To further demonstrate that
expression of housekeeping genes was similar for each sample set as compared to the
wild type, the average TPM of each sample set was log transformed and plotted against
the corresponding wild type values (Figures 3.1, C-E). Linear regression analysis was
performed, and the R-squared values were >0.97 for each sample set, indicating a strong
correlation.
For this analysis, genes that had greater than a log2 fold-change of 0.6
(approximately 1.5-fold) compared to wild-type were considered differentially expressed,
and the cut-off for statistical significance used a Benjamini-Hochberg adjusted *p < 0.05.
There were vast changes to the transcriptome of the psd1Δ/Δ psd2Δ/Δ mutant, and to a
lesser extent the ept1Δ/Δ mutant (Figure 3.2, B-C). In total, there were 618 statistically
significant up-regulated genes and 599 down-regulated genes in the psd1Δ/Δ psd2Δ/Δ
mutant as compared to the wild type. For the ept1Δ/Δ knockout, there were 21 statistically
significant up-regulated genes and 48 down-regulated genes when compared to wildtype. To determine how loss of PE by either pathway affected gene expression, genes
that were co-upregulated or co-downregulated in both mutants were compiled. There
were 6 genes that were co-upregulated in both the ept1Δ/Δ and psd1Δ/Δ psd2Δ/Δ
mutants, and 35 genes co-downregulated in both mutants compared to wild-type (Figure
3.3, A). The set of co-regulated genes was used as an input for Kyoto Encyclopedia of
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Figure 3.2. Differential expression analysis.
MA plots were used to visualize log fold-change of (A) EPT1 overexpressor, (B) ept1Δ/Δ and (C) psd1Δ/Δ psd2Δ/Δ
mutants versus wild-type. Gold points represent genes that have Benjamini-Hochberg adjusted p-values <0.05 and
black points are those with p-values >0.05. Genes above the red line have positive expression compared to wild type,
and those that are below the line have negative expression values. The only statistically significant differentially
expressed gene in the EPT1 overexpressor strain is EPT1 (log2 fold-change = 2.74, *p<0.05). For the ept1Δ/Δ strain,
there are 69 statistically significant differentially expressed genes (greater or less than log2-fold change of 0.6), and for
the psd1Δ/Δ psd2Δ/Δ mutant there are 1,217 statistically significant differentially expressed genes.
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Figure 3.3. Heat map of co-expressed genes.
(A) Heat map of genes that have >0.6 log2-fold change versus wild-type with a Benjamini-Hochberg adjusted p-value of
<0.05 in both the psd1Δ/Δ psd2Δ/Δ and ept1Δ/Δ mutants. Genes that are co-down-regulated are blue and genes that are
co-up-regulated are yellow. (B) Pathways that are impacted by the loss of PE were determined using KEGG pathway
analysis. Pathways with more than one gene differentially expressed in both the psd1Δ/Δ psd2 Δ/Δ and ept1Δ/Δ mutants
are displayed for each mutant.
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Genes and Genomes (KEGG) pathway analysis to determine which pathways had
multiple genes that were differentially expressed when PE was depleted by either the
CDP-DAG or Kennedy pathway. A bar chart identifying pathways containing more than
one gene with differential expression was compiled (Figure 3.3, B). Each mutant was
individually examined for differential expression of genes involved in these specific
pathways using KEGG (Figure 3.3, B).
Overall, eleven pathways emerged that had more than two genes with differential
expression present for both mutants. When the psd1Δ/Δ psd2Δ/Δ mutant is examined
alone the number of genes differentially expressed within these pathways greatly
increases (Figure 3.3, B). There were multiple commonalities between these pathways.
First, 2-oxocarboxylic acid metabolism and pyruvate metabolism are tied to the citric acid
(TCA) cycle. Second, the synthesis of valine, leucine, and isoleucine are potential end
products from the TCA cycle. Thirdly, the peroxisome is involved in the β-oxidation of fatty
acids to form acetyl-CoA for the TCA cycle. There are also changes to fatty acid
degradation and metabolism, which is not unexpected as we have disrupted major
phospholipid biosynthetic routes.
In addition to the eleven identified pathways with genes that are differentially
expressed in both mutants, there were several pathways identified in the psd1Δ/Δ
psd2Δ/Δ mutant that had genes with differential expression and for which the ept1Δ/Δ
mutant had fewer than two genes differentially expressed. These included genes directly
involved in the TCA cycle, protein processing at the ER, glycolysis, oxidative
phosphorylation, tRNA biosynthesis, and N and O glycan biosynthesis. Overall, it was
found that the genes involved in amino acid biosynthesis, the TCA cycle, the peroxisome,
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oxidative respiration, and glycolysis were down-regulated (Figure 3.4). Several of these
functions are again part of the core carbon metabolism in the cell, and down-regulation
of the TCA cycle and oxidative phosphorylation may indicate that there are mitochondrial
defects in the psd1Δ/Δ psd2Δ/Δ mutant. In fact, this aligns with previous research that
demonstrated mitochondrial defects in the psd1Δ/Δ psd2Δ/Δ mutant via increased growth
in the presence of paraquat and hypersensitivity to farnesol (Chen et al., 2010; Hasim et
al., 2018).
Pathways that involve genes that were up-regulated in the psd1Δ/Δ psd2Δ/Δ
mutant included N and O glycan biosynthesis, tRNA synthesis, and protein processing at
the endoplasmic reticulum (ER) (Figure 3.4). Glycosylation of cell wall proteins occurs
within the ER and Golgi, and this function is important for proper folding and export of
glycoproteins (Orlean, 2012). The increased expression of genes involved in these
processes may be in response to cell wall stress incurred by a loss of PE. The psd1Δ/Δ
psd2Δ/Δ mutant is known to have cell wall stability issues which can be suppressed by
addition of an osmotic stabilizer to growth medium (Chen et al., 2010).

Overexpression of EPT1 does not impact the transcriptome, but does reduce
β(1,3)-glucan exposure
Surprisingly, it was found that in the PE overexpressor (PENO1-EPT1), there was only one
gene with statistically significant differential expression compared to the wild-type. This
gene was EPT1 (log2-fold change = 2.74, *p< 0.05), which is constitutively expressed in
this strain (Figure 3.2, A; Table 1). While we have previously used radiolabeling assays
to confirm that the EPT1 overexpressor has increased Ept1 activity, this data further
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Figure 3.4. Differentially expressed pathways in psd1Δ/Δ psd2Δ/Δ.
Several pathways have multiple differentially expressed genes in both the psd1Δ/Δ
psd2Δ/Δ and ept1Δ/Δ mutants. These pathways, along with other significantly
different genes/pathways were further investigated for the psd1Δ/Δ psd2Δ/Δ mutant.
Down-regulated pathways included those involved in glycolysis, oxidative
phosphorylation, the TCA cycle, peroxisomal functions, and amino acid biosynthesis.
Several pathways were found to be modestly up-regulated in the psd1Δ/Δ psd2Δ/Δ
mutant, including N- and O- glycan biosynthesis, tRNA synthesis, and protein
processing at the ER. Yellow values are up-regulated and blue values are downregulated. All genes shown have greater or less than a log2-fold change of 0.6 and
Benjamini-Hochberg adjusted *p<0.05.
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validates that the overexpression construct functions as expected (Tams et al., 2019).
However, since there are no other differentially expressed genes, we hypothesized that
the hypervirulent phenotype is due to post-transcriptional changes in the cell that either
alter the virulence properties of the fungus or host immune recognition.
Alterations that affect virulence often do so by affecting the cell wall. The cell wall
is the interface whereby C. albicans interacts with the host, and because the cell must be
able to mask immunogenic components of the wall to effectively avoid the host immune
response, we investigated cell wall components in the EPT1 overexpressor that influence
host-pathogen interactions.
The fungal cell wall is largely composed of chitin, β(1,3)glucan, β(1,6)glucan, and
mannosylated cell wall glycoproteins (mannan) (Gow et al., 2017). The mannan of the
cell wall allows the fungus to hide or mask β(1,3)-glucan during infection, which is an
important function as β(1,3)-glucan is an immunogenic polysaccharide that interacts with,
among other receptors, host Dectin-1 on resident macrophages to initiate a
proinflammatory response (Gow et al., 2007; Gow et al., 2017). We have previously found
that there is an increase in exposure of β(1,3)-glucan in the cho1Δ/Δ mutant due to a loss
of CDP-DAG generated PS (Davis et al., 2018). We hypothesized that a loss of Kennedy
pathway mediated PE biosynthesis would result in increased β(1,3)-glucan exposure and
that overexpression of EPT1, which overproduces PE, could have an impact on cell wall
architecture and perhaps mask β(1,3)-glucan (Tams et al., 2019).
Immunofluorescent staining and flow cytometry were performed to determine the
amount of exposure for wild-type, EPT1 overexpressor, and ept1Δ/Δ strains. In addition,
cho1Δ/Δ was used as a positive control for β(1,3)-glucan exposure based on our previous
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observations (Davis et al., 2018). A cho1Δ/Δ PENO1-EPT1 strain was also constructed to
determine if overexpression of the Kennedy pathway in the cho1Δ/Δ background would
decrease β-1,3 glucan exposure in this mutant. Each strain was cultured in YPD and
stained with a mouse anti-β(1,3)-glucan primary antibody and a phycoerythrin conjugated
goat anti-mouse IgG secondary antibody. Samples were then measured by flow
cytometry. In stationary phase cells, no difference was observed for β(1,3)-glucan
exposure (Figure 3.5, A). However, in log phase cells there is a modest but statistically
significant decrease in β(1,3)-glucan exposure in the EPT1 overexpressor compared to
wild-type (*p<0.05) (Figure 3.5, B). The cho1Δ/Δ strain, as expected, had increased
β(1,3)-glucan exposure when compared to the wild-type (Figure 3.5, B; ***p<0.0001).
Overexpression of EPT1 in the cho1Δ/Δ background resulted in a statistically significant
decrease in β(1,3)-glucan exposure compared to the parental cho1Δ/Δ strain (Figure 3.5,
B; ααp<0.01). These data suggest that overexpression of EPT1, which causes an increase
in Kennedy pathway mediated PE synthesis, can cause decreased β(1,3)-glucan
exposure, even in highly exposed cells. Therefore, we chose to further investigate this
phenomenon.
Within the host during infection, Candida cells exhibit β(1,3)-glucan exposure over
time (Hopke et al., 2016) or in response to treatment with drugs like caspofungin (Wheeler
and Fink, 2006). Because EPT1 overexpression could cause decreased β(1,3)-glucan
exposure in cho1∆/∆ and wild-type cells, we wanted to test the impact of EPT1
overexpression on β(1,3)-glucan exposure in response to stresses that induce
unmasking. Two cell wall stressors that cause unmasking were applied to stationary
phase cells: (1) a sub-minimum inhibitory concentration (MIC) of caspofungin and (2) heat
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Figure 3.5. Overexpression of EPT1 reduces β(1,3)-glucan exposure.
(A) There is a statistically significant increase in β(1,3)-glucan exposure for the cho1Δ/Δ for stationary phase cells, and
this exposure is decreased upon overexpression of EPT1. There was no statistically significant difference when EPT1 is
overexpressed in the wild-type background (***p<0.0001 vs. wild-type, unpaired t-test). (B) There is a decrease in mean
fluorescent intensity (MFI) of β(1,3)-glucan exposure when EPT1 is overexpressed in the cho1Δ/Δ background, and a
modest decrease in MFI of the EPT1 overexpressor as compared to wild-type in log phase cells (***p<0.0001 vs. WT,
*p<0.05 vs. WT, ααp<0.01 vs. cho1Δ/Δ; n = 3, unpaired t-test). (B) This difference is also observed for stationary phase
cells overexpressing EPT1 that have been heat shocked at 90˚C for 20 minutes (***p<0.0001 vs. WT, *p<0.05 vs. WT,
αp<0.05 vs. cho1Δ/Δ; n = 3, unpaired t-test).
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shock at 90ºC. The cells were subsequently analyzed for β(1,3)-glucan exposure with
flow cytometry. A decrease in β(1,3)-glucan exposure was observed for stationary phase
cells overexpressing EPT1 in either the wild-type or cho1Δ/Δ backgrounds in response to
heat shock (Figure 3.5, C). Treatment of stationary phase cells with a sublethal
concentration of caspofungin (47 ng/mL) induced β(1,3)-glucan exposure for both the
wild-type and EPT1 overexpressor as compared to their respective untreated controls
(Figure 3.6, A; ***p<0.0001). However, overexpression of EPT1 diminished caspofungin
induced β(1,3)-glucan exposure at 15.6 ng/mL (1/8th MIC), 31.3 ng/mL (1/4th MIC), and
47 ng/mL (3/8th MIC) caspofungin (Figure 3.6, B; *p<0.05, **p<0.01, ***p<0.0001). These
data suggest that overexpression of EPT1 confers a general resistance to β(1,3)-glucan
exposure in response to cell wall stress, and this protection could potentially aid in evasion
from immunosurveillance during stresses encountered in vivo.

Overexpression of EPT1 increases cell wall chitin
Chitin levels correlate with changes in β(1,3)-glucan exposure as well as alterations in
virulence; thus, it was important to determine if overexpression of EPT1 altered chitin
level (Marakalala et al., 2013; Hasim et al., 2017; Wagener et al., 2017). Purified fungal
chitin less than 40 μM in size can cause increased production of IL-10 in vivo, which
drives an anti-inflammatory response (Da Silva et al., 2009). Alternatively, purified chitin
can cause a pro-inflammatory TNF-α response in vivo if particle size is between 40-70
μM (Da Silva et al., 2009). Therefore, chitin levels in the wild-type, EPT1 overexpressor,
cho1Δ/Δ, and cho1Δ/Δ EPT1 overexpressor strains were assessed by staining with
calcofluor white (CFW) and measuring by flow cytometry (Figures 3.7, A-B). The cho1Δ/Δ
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Figure 3.6. Caspofungin induced β(1,3)-glucan unmasking.
(A) Treatment with caspofungin (46.875 ng/mL) induces β(1,3)-glucan unmasking in
both the wild-type (3.39-fold) and EPT1 overexpression (3.00-fold) strains compared
to untreated controls (n = 3, ***p<0.0001; unpaired t-test). (B) The wild-type and EPT1
overexpressor were incubated with the indicated sublethal dose of caspofungin and
immunofluorescent staining of β(1,3)-glucan was analyzed with flow cytometry.
Overexpression of EPT1 provides protection from caspofungin induced β-1,3-glucan
unmasking (n = 6-9/strain, ***p<0.0001, **p<0.01; unpaired t-test).
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Figure 3.7. Overexpression of EPT1 increases total chitin.
(A) Flow cytometry data of calcofluor white stained cells normalized to the wild-type mean fluorescent intensity (MFI) (n
= 9/strain, ***p<0.0001, *p<0.05 unpaired; t-test). (B) A representative histogram for flow cytometry of calcofluor white
stained cells (n = 100,000 events/strain). An average increase of 1.65-fold MFI was observed for the EPT1
overexpressor compared to wild-type, and overexpression of EPT1 in the cho1Δ/Δ background resulted in a 1.88-fold
increase compared to cho1Δ/Δ, or a 3.96-fold increase compared to wild-type (***p<0.0001, unpaired t-test). (C) Cells
were treated with 46.875 ng/mL caspofungin for 30 minutes and flow cytometry was performed to determine chitin
content. There is a 1.83-fold increase in MFI for wild-type cells exposed to caspofungin, but the EPT1 overexpression
strain already exhibits increased chitin and does not increase further upon treatment (n = 6/strain, ***p<0.0001, NS =
not significant; unpaired t-test).

109

strain was used as a positive control as we have previously demonstrated an increase in
chitin for this strain (Hasim et al., 2017). In the EPT1 overexpression strain, a 1.65-fold
increase in chitin staining was observed when compared to the wild-type strain (Figure
3.7, A; ***p<0.0001). The cho1Δ/Δ mutant has a more intense increase in chitin staining
of 2.11-fold change as compared to wild-type (Figure 3.7, A). This effect is compounded
when the EPT1 gene is overexpressed in the cho1Δ/Δ background to a 1.88-fold increase
over cho1Δ/Δ (***p<0.0001, Figure 3.7, A) or 3.96-fold increase over wild-type. Treatment
with echinocandins such as caspofungin causes an increase in chitin content (Walker et
al., 2008). Therefore, wild-type and EPT1 overexpressor were stressed for 30 minutes
with 47 ng/mL caspofungin and then stained with CFW and measured with flow cytometry.
Interestingly, there was a statistically significant increase in chitin staining for the wildtype in the presence of caspofungin of 1.83-fold, but not the EPT1 overexpressor, which
already has an increase in chitin (***p<0.0001, Figure 3.7, C). However, when we tested
the EPT1 overexpressor for changes in TNF-α release from macrophages, we observed
no significant differences from wild-type (data not shown).

Overexpression of EPT1 increases hyphal length
In addition to defensive virulence factors like β(1,3)-glucan exposure, Candida has a
variety of offensive virulence factors. The most well studied of these is hyphal growth.
Hyphal formation is a major virulence factor in C. albicans that allows for escape from
macrophages, damage to mammalian cells, and aids in biofilm formation (Angiolella et
al., 2008; Carlisle et al., 2009; Mayer et al., 2013; Duvenage et al., 2019). There have
been several instances in which hypervirulence in C. albicans was associated with an
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increased ability to form hyphae. One such study explored the phenotype of a PIR32
deletion strain and found that not only was this strain hyper-filamentous and hypervirulent,
but that it also had an increase in chitin content (Bahnan et al., 2012). Since we observed
hypervirulence and an increase in chitin content in the EPT1 overexpressor, we
hypothesized that this strain may also have an increased ability to form filaments. When
induced to form hyphae in RPMI with 20% human serum at 37°C, differences were seen
in hyphal length after 3 hours. A 9.5% increase in length was observed on average for
the EPT1 overexpressor strain compared to wild-type (Figure 3.8, A; p<0.0001). The
cho1Δ/Δ mutant had a 32.1% decrease in hyphae length compared to wild-type, but
overexpression of EPT1 in the cho1Δ/Δ background resulted in a 16% increase compared
to the cho1Δ/Δ mutant (*p<0.0001). These data indicate that overexpression of EPT1
does increase filamentation. However, in yeast form cells there was no difference in
growth curves between either the EPT1 overexpressor, the ept1Δ/Δ mutant, or the wildtype strains (Figure 3.8, B). Growth was also tested via spot dilutions on YPD plates and
there were no differences in growth rate at 30ºC (data not shown). Therefore, the increase
in filamentation seems to be hyphal specific.
Discussion
The amount of PE synthesized in the cell has a direct impact on C. albicans virulence.
Cells that cannot produce PE by either of the two major pathways are less virulent in the
mouse model of systemic candidiasis and less cytotoxic against epithelial cells in vitro
(Chen et al., 2010; Davis et al., 2018; Tams et al., 2019). Synthesis of PE via the CDPDAG pathway is more important for virulence than is Kennedy pathway mediated PE
synthesis, as loss of PE synthesis by the CDP-DAG pathway results in a greater virulence
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Figure 3.8. Overexpression of EPT1 results in increased hyphal length.
(A) Stationary cultures were diluted to O.D.600nm = 1.0x10-4 in RPMI + 20% human
serum and were incubated for 3 hours at 37°C in technical triplicate. Following
incubation, six images per well were obtained on an inverted microscope at 200x
total magnification. The length of hyphae was obtained using ImageJ software, and
was expressed as percent average wild-type hyphae length. This experiment was
performed three times (n=600 hyphae/strain, ***p<0.0001 vs. WT, αααp<0.0001 vs.
cho1Δ/Δ, unpaired t-test). (B) Stationary cultures were diluted to O.D.600nm = 0.1 in
YPD and incubated at 225 RPM and 30°C. Growth was measured by obtaining the
O.D.600nm at two-hour time points for 12 hours. Strains were cultured in triplicate.
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defect in the mouse model and a larger decrease in cytotoxicity than seen in ept1Δ/Δ
mutants (Davis et al., 2018; Tams et al., 2019). Conversely, overexpression of EPT1
results in increased PE synthesis and hypervirulence (Tams et al., 2019). To determine
why increased PE would lead to increased virulence, a transcriptomic approach has been
taken. However, we have found that there are no transcriptional differences in the EPT1
overexpressor as compared to the wild-type under similar conditions in which we see
differing levels of cytotoxicity in vitro (Figure 3.2, A). Therefore, the changes in cytotoxicity
must be due to post-transcriptional changes within the cell.
In contrast, loss of PE greatly impacts the transcriptomic profile of the cell (Figure
3.2, B-C). This impact is greater for the psd1Δ/Δ psd2Δ/Δ mutant, which is expected given
its known growth defects, cell wall issues, and strongly attenuated virulence in the mouse
model (Chen et al., 2010). Interestingly, we have found that the psd1Δ/Δ psd2Δ/Δ mutant
has decreased expression of genes in several pathways involved in energy production
and core carbon metabolism of the cell; specifically, the TCA cycle, glycolysis, and
oxidative respiration (Figure 3.4). PE is an important component of the mitochondrial
membrane as disruption of PE synthesis decreases inner membrane potential (Bottinger
et al., 2012), which explains our findings of decreased expression of cellular respiration
genes. The psd1Δ/Δ psd2Δ/Δ mutant also has increased expression of genes involved in
protein processing and glycosylation (Figure 3.4). These are important for secretion of
properly manufactured glycoproteins on the cell surface, and we believe that the
increased regulation of these genes is a compensatory mechanism for cell wall stress
(Orlean, 2012). We have previously found that this mutant has a growth defect that can
be restored when an osmotic stabilizer such as sorbitol is added to the growth medium
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(Chen et al., 2010). However, the main goal of transcriptomic analysis was to determine
why overexpression of EPT1 increased virulence, and we found no differences in the
transcriptional profile for this mutant, which indicates that there must be posttranscriptional changes in the cell that occur with increased PE that cause virulence to
increase. Therefore, we tested an alternative hypothesis that the cell wall architecture is
altered, which could have an immunomodulatory effect or aid in evasion of
immunosurveillance.
The two primary changes observed in the cell wall of the EPT1 overexpressor were
decreased β(1,3)-glucan exposure when exposed to cell wall stressors, and an increase
in chitin (Figures 3.5, C; 3.6, B; 3.7, A). β(1,3)-glucan exposure causes a Dectin-1
mediated TNF-α response in macrophages and it has been shown that neutrophils can
cause unmasking of cells in vitro (Taylor et al., 2007; Davis et al., 2014). To cause
unmasking of cells in vitro, our cells were stressed with a sub-MIC dose of caspofungin
or heat shock (Figures 3.5, C; 3.6, B). We have determined that cells overexpressing
EPT1 have protection from β(1,3)-glucan exposure when in log phase or alternatively in
stationary phase when stressed with caspofungin or heat stress (Figures 3.5, C; 3.6, B).
If the EPT1 overexpressor can more effectively resist β(1,3)-glucan exposure in vivo, then
immune evasion could partially explain the hypervirulent phenotype. It has been
demonstrated that small particles of purified fungal chitin can increase production of IL10 in vivo, and that large chitin particles can induce a TNF-α response (Da Silva et al.,
2009). While there was a 1.65-fold increase of chitin for the EPT1 overexpressor as
compared to the wild-type (Figure 3.7, A), we were not able to elucidate any differences
in TNF-α response from RAW 264.7 macrophages (data not shown). Most of the chitin
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synthesis in C. albicans is performed by Chitin Synthase 3 (CHS3), which is
transcriptionally controlled based on cell cycle (Lenardon et al., 2007). However,
localization of CHS3 to the site of polarized growth is the major regulatory mechanism,
and this is controlled by post-transcriptional events (Lenardon et al., 2007). Therefore, it
is reasonable that there are no transcriptional changes of chitin synthase genes even
though there is an increase in chitin content in the EPT1 overexpression mutant.
Besides changes in cell wall architecture that may contribute to immune evasion
as a defensive mechanism, we have demonstrated that overexpression of EPT1 also
causes increased filamentation (Figure 3.8, A). The ability to form hyphae is a major
virulence determinant in C. albicans, as they are used to escape the phagosome, lyse
epithelial and endothelial cells, and help to form biofilms (Mayer et al., 2013; Westman et
al., 2018). To our knowledge there have been at least four other instances in which
hypervirulence in C. albicans correlated with increased hyphae length or production, and
in one case this correlated with an increased level of chitin (Angiolella et al., 2008; Carlisle
et al., 2009; Bahnan et al., 2012; Duvenage et al., 2019). It is currently unclear as to why
the EPT1 overexpressing cells form longer hyphae at an early timepoint, but one possible
explanation is that increased phospholipid synthesis in the cell increases availability for
this structural component of cell membrane synthesis. However, yeast form cells
overexpressing EPT1 do not replicate at an increased rate, so this may be a hyphal
specific difference (Figure 3.8, B).
Since hyphae are a major virulence factor of C. albicans that contribute to the
ability to lyse mammalian cells and contribute to tissue invasion, this is one possible
explanation for hypervirulence of the EPT1 overexpression strain (Mayer et al., 2013). It
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is important for C. albicans to switch between yeast and hyphae forms, as locking it in
either form results in avirulence, and this is presumably due to an inability to disseminate
for hyphae locked cells, or an inability to damage tissue for yeast locked cells (Saville et
al., 2003). However, it has been shown that driving cells into hyphal formation (by
overexpression of the UME6 transcription factor, for example) increases virulence in the
mouse model (Carlisle et al., 2009). Since hyphae are a major determinant in the ability
to form deep-seated infections, it is possible that increased hyphal development in the
EPT1 overexpressor, in conjunction with changes in cell wall architecture that could
impact immune evasion, may contribute to the previously observed increase in
cytotoxicity and virulence (Tams et al., 2019). Given that the increase in chitin observed
for the EPT1 overexpressor does not cause a clear change in TNF-α release from
macrophages, the increase in hyphal growth is the most likely explanation for the
increased virulence.

Author contributions
RT and TBR designed and created plasmids and C. albicans strains. RT performed RNA
extractions and sequencing. Bioinformatic analysis was performed by RT and EG. AW
performed chitin and β(1,3)-glucan staining and subsequent flow cytometry. JJ assisted
with flow cytometry. RT performed all other assays and wrote the manuscript. TBR
directed the project. TBR and TS edited the manuscript.

116

Funding
This work was funded by the National Institutes of Health grants NIH 1R21AI130895
(TBR), NIH 1R01AL105690 (TBR), and NIH R01DK079984 (TS). The funders had no role
in the design or execution of the project or the decision to publish.

Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial
or financial relationships that could be construed as a potential conflict of interest.

Acknowledgements
We thank Veronica Brown and the UT Genomics Core for assistance in cDNA library
preparation and sequencing, and Dr. Lauren Krausfeldt for her comments and
suggestions regarding transcriptomic analysis. We also thank Steven Wilhelm, Robbie
Martin, Tian Chen and Kyle Bonifer for helpful discussions and other contributions.

117

References
Anders, S., and Huber, W. (2010). Differential expression analysis for sequence count
data. Genome Biol 11(10), R106. doi: 10.1186/gb-2010-11-10-r106.
Anders, S., Pyl, P.T., and Huber, W. (2015). HTSeq--a Python framework to work with
high-throughput sequencing data. Bioinformatics 31(2), 166-169. doi:
10.1093/bioinformatics/btu638.
Angiolella, L., Stringaro, A.R., De Bernardis, F., Posteraro, B., Bonito, M., Toccacieli, L.,
et al. (2008). Increase of virulence and its phenotypic traits in drug-resistant strains
of Candida albicans. Antimicrob Agents Chemother 52(3), 927-936. doi:
10.1128/AAC.01223-07.
Atkinson, K.D., Jensen, B., Kolat, A.I., Storm, E.M., Henry, S.A., and Fogel, S. (1980).
Yeast mutants auxotrophic for choline or ethanolamine. J Bacteriol 141(2), 558564.
Bahnan, W., Koussa, J., Younes, S., Abi Rizk, M., Khalil, B., El Sitt, S., et al. (2012).
Deletion of the Candida albicans PIR32 results in increased virulence, stress
response, and upregulation of cell wall chitin deposition. Mycopathologia 174(2),
107-119. doi: 10.1007/s11046-012-9533-z.
Bottinger, L., Horvath, S.E., Kleinschroth, T., Hunte, C., Daum, G., Pfanner, N., et al.
(2012). Phosphatidylethanolamine and cardiolipin differentially affect the stability
of mitochondrial respiratory chain supercomplexes. J Mol Biol 423(5), 677-686.
doi: 10.1016/j.jmb.2012.09.001.
Carlisle, P.L., Banerjee, M., Lazzell, A., Monteagudo, C., Lopez-Ribot, J.L., and Kadosh,
D. (2009). Expression levels of a filament-specific transcriptional regulator are
sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad
Sci U S A 106(2), 599-604. doi: 10.1073/pnas.0804061106.
Carman, G.M., and Han, G.S. (2011). Regulation of phospholipid synthesis in the yeast
Saccharomyces cerevisiae. Annu Rev Biochem 80, 859-883. doi:
10.1146/annurev-biochem-060409-092229.
Cassilly, C.D., Farmer, A.T., Montedonico, A.E., Smith, T.K., Campagna, S.R., and
Reynolds, T.B. (2017). Role of phosphatidylserine synthase in shaping the
phospholipidome of Candida albicans. FEMS Yeast Res 17(2), (2): fox007. doi:
10.1093/femsyr/fox007.
Chen, T., Jackson, J.W., Tams, R.N., Davis, S.E., Sparer, T.E., and Reynolds, T.B.
(2019). Exposure of Candida albicans beta (1,3)-glucan is promoted by activation
of
the
Cek1
pathway.
PLoS
Genet
15(1),
e1007892.
doi:
10.1371/journal.pgen.1007892.
Chen, Y.L., Kauffman, S., and Reynolds, T.B. (2008). Candida albicans uses multiple
mechanisms to acquire the essential metabolite inositol during infection. Infect
Immun 76(6), 2793-2801. doi: 10.1128/IAI.01514-07.
Chen, Y.L., Montedonico, A.E., Kauffman, S., Dunlap, J.R., Menn, F.M., and Reynolds,
T.B. (2010). Phosphatidylserine synthase and phosphatidylserine decarboxylase
are essential for cell wall integrity and virulence in Candida albicans. Mol Microbiol
75(5), 1112-1132. doi: 10.1111/j.1365-2958.2009.07018.x.
Clancey, C.J., Chang, S.C., and Dowhan, W. (1993). Cloning of a gene (PSD1) encoding
phosphatidylserine decarboxylase from Saccharomyces cerevisiae by
118

complementation of an Escherichia coli mutant. J Biol Chem 268(33), 2458024590.
Cowen, L.E., Sanglard, D., Howard, S.J., Rogers, P.D., and Perlin, D.S. (2015).
Mechanisms of Antifungal Drug Resistance. Cold Spring Harb Perspect Med 5(7),
a019752. doi: 10.1101/cshperspect.a019752.
Da Silva, C.A., Chalouni, C., Williams, A., Hartl, D., Lee, C.G., and Elias, J.A. (2009).
Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J
Immunol 182(6), 3573-3582. doi: 10.4049/jimmunol.0802113.
Davis, S.E., Hopke, A., Minkin, S.C., Jr., Montedonico, A.E., Wheeler, R.T., and
Reynolds, T.B. (2014). Masking of beta(1-3)-glucan in the cell wall of Candida
albicans from detection by innate immune cells depends on phosphatidylserine.
Infect Immun 82(10), 4405-4413. doi: 10.1128/IAI.01612-14.
Davis, S.E., Tams, R.N., Solis, N., Wagner, A.S., Chen, T., Jackson, J.W., et al. (2018).
Candida albicans cannot acquire sufficient ethanolamine from the host to support
virulence in the absence of de novo phosphatidylethanolamine synthesis. Infect
Immun 86(8), e00815-00817. doi: 10.1128/IAI.00815-17.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., et al. (2013).
STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1), 15-21. doi:
10.1093/bioinformatics/bts635.
Duvenage, L., Walker, L.A., Bojarczuk, A., Johnston, S.A., MacCallum, D.M., Munro,
C.A., et al. (2019). Inhibition of Classical and Alternative Modes of Respiration in
Candida albicans Leads to Cell Wall Remodeling and Increased Macrophage
Recognition. MBio 10(1), e02535-02518. doi: 10.1128/mBio.02535-18.
Gibellini, F., and Smith, T.K. (2010). The Kennedy pathway--De novo synthesis of
phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62(6), 414-428.
doi: 10.1002/iub.337.
Gillum, A.M., Tsay, E.Y., and Kirsch, D.R. (1984). Isolation of the Candida albicans gene
for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae
ura3 and E. coli pyrF mutations. Mol Gen Genet 198(2), 179-182.
Gow, N.A., Netea, M.G., Munro, C.A., Ferwerda, G., Bates, S., Mora-Montes, H.M., et al.
(2007). Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect
Dis 196(10), 1565-1571. doi: 10.1086/523110.
Gow, N.A.R., Latge, J.P., and Munro, C.A. (2017). The Fungal Cell Wall: Structure,
Biosynthesis, and Function. Microbiol Spectr 5(3), (3):FUNK-0035-2016. doi:
10.1128/microbiolspec.FUNK-0035-2016.
Hasim, S., Allison, D.P., Retterer, S.T., Hopke, A., Wheeler, R.T., Doktycz, M.J., et al.
(2017). beta-(1,3)-Glucan Unmasking in Some Candida albicans Mutants
Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell
Wall Elasticity. Infect Immun 85(1), e00601-00616. doi: 10.1128/IAI.00601-16.
Hasim, S., Hussin, N.A., Alomar, F., Bidasee, K.R., Nickerson, K.W., and Wilson, M.A.
(2014). A glutathione-independent glyoxalase of the DJ-1 superfamily plays an
important role in managing metabolically generated methylglyoxal in Candida
albicans. J Biol Chem 289(3), 1662-1674. doi: 10.1074/jbc.M113.505784.
Hasim, S., Vaughn, E.N., Donohoe, D., Gordon, D.M., Pfiffner, S., and Reynolds, T.B.
(2018). Influence of phosphatidylserine and phosphatidylethanolamine on farnesol
tolerance in Candida albicans. Yeast 35(4), 343-351. doi: 10.1002/yea.3297.
119

Herre, J., Marshall, A.S., Caron, E., Edwards, A.D., Williams, D.L., Schweighoffer, E., et
al. (2004). Dectin-1 uses novel mechanisms for yeast phagocytosis in
macrophages. Blood 104(13), 4038-4045. doi: 10.1182/blood-2004-03-1140.
Hopke, A., Nicke, N., Hidu, E.E., Degani, G., Popolo, L., and Wheeler, R.T. (2016).
Neutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall
Remodeling and Altered Immune Recognition. PLoS Pathog 12(5), e1005644. doi:
10.1371/journal.ppat.1005644.
Kanehisa, M., and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes.
Nucleic Acids Res 28(1), 27-30.
Kodaki, T., and Yamashita, S. (1987). Yeast phosphatidylethanolamine methylation
pathway. Cloning and characterization of two distinct methyltransferase genes. J
Biol Chem 262(32), 15428-15435.
Lenardon, M.D., Munro, C.A., and Gow, N.A. (2010). Chitin synthesis and fungal
pathogenesis.
Curr
Opin
Microbiol
13(4),
416-423.
doi:
10.1016/j.mib.2010.05.002.
Lenardon, M.D., Whitton, R.K., Munro, C.A., Marshall, D., and Gow, N.A. (2007).
Individual chitin synthase enzymes synthesize microfibrils of differing structure at
specific locations in the Candida albicans cell wall. Mol Microbiol 66(5), 1164-1173.
doi: 10.1111/j.1365-2958.2007.05990.x.
Letts, V.A., Klig, L.S., Bae-Lee, M., Carman, G.M., and Henry, S.A. (1983). Isolation of
the yeast structural gene for the membrane-associated enzyme
phosphatidylserine synthase. Proc Natl Acad Sci U S A 80(23), 7279-7283.
Marakalala, M.J., Vautier, S., Potrykus, J., Walker, L.A., Shepardson, K.M., Hopke, A., et
al. (2013). Differential adaptation of Candida albicans in vivo modulates immune
recognition
by
dectin-1.
PLoS
Pathog
9(4),
e1003315.
doi:
10.1371/journal.ppat.1003315.
Martin, R.M., Dearth, S.P., LeCleir, G.R., Campagna, S.R., Fozo, E.M., Zinser, E.R., et
al. (2017). Microcystin-LR does not induce alterations to transcriptomic or
metabolomic profiles of a model heterotrophic bacterium. PLoS One 12(12),
e0189608. doi: 10.1371/journal.pone.0189608.
Mayer, F.L., Wilson, D., and Hube, B. (2013). Candida albicans pathogenicity
mechanisms. Virulence 4(2), 119-128. doi: 10.4161/viru.22913.
Orlean, P. (2012). Architecture and biosynthesis of the Saccharomyces cerevisiae cell
wall. Genetics 192(3), 775-818. doi: 10.1534/genetics.112.144485.
Raschke, W.C., Baird, S., Ralph, P., and Nakoinz, I. (1978). Functional macrophage cell
lines transformed by Abelson leukemia virus. Cell 15(1), 261-267.
Reuss, O., Vik, A., Kolter, R., and Morschhauser, J. (2004). The SAT1 flipper, an
optimized tool for gene disruption in Candida albicans. Gene 341, 119-127. doi:
10.1016/j.gene.2004.06.021.
Saville, S.P., Lazzell, A.L., Monteagudo, C., and Lopez-Ribot, J.L. (2003). Engineered
control of cell morphology in vivo reveals distinct roles for yeast and filamentous
forms of Candida albicans during infection. Eukaryot Cell 2(5), 1053-1060.
Schindelin, J., Rueden, C.T., Hiner, M.C., and Eliceiri, K.W. (2015). The ImageJ
ecosystem: An open platform for biomedical image analysis. Mol Reprod Dev 82(78), 518-529. doi: 10.1002/mrd.22489.

120

Singh, A., Prasad, T., Kapoor, K., Mandal, A., Roth, M., Welti, R., et al. (2010).
Phospholipidome of Candida: each species of Candida has distinctive
phospholipid
molecular
species.
OMICS
14(6),
665-677.
doi:
10.1089/omi.2010.0041.
Skrzypek, M.S., Binkley, J., Binkley, G., Miyasato, S.R., Simison, M., and Sherlock, G.
(2017). The Candida Genome Database (CGD): incorporation of Assembly 22,
systematic identifiers and visualization of high throughput sequencing data.
Nucleic Acids Res 45(D1), D592-D596. doi: 10.1093/nar/gkw924.
Tams, R.N., Cassilly, C.D., Anaokar, S., Brewer, W.T., Dinsmore, J.T., Chen, Y.-L., et al.
(2019). Overproduction of Phospholipids by the Kennedy Pathway Leads to
Hypervirulence in Candida albicans. Frontiers in Microbiology 10, 86. doi:
10.3389/fmicb.2019.00086.
Taylor, P.R., Tsoni, S.V., Willment, J.A., Dennehy, K.M., Rosas, M., Findon, H., et al.
(2007). Dectin-1 is required for beta-glucan recognition and control of fungal
infection. Nat Immunol 8(1), 31-38. doi: 10.1038/ni1408.
Trotter, P.J., and Voelker, D.R. (1995). Identification of a non-mitochondrial
phosphatidylserine decarboxylase activity (PSD2) in the yeast Saccharomyces
cerevisiae. J Biol Chem 270(11), 6062-6070. doi: 10.1074/jbc.270.11.6062.
Wagener, J., MacCallum, D.M., Brown, G.D., and Gow, N.A. (2017). Candida albicans
Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on
Macrophage Antimicrobial Functions. MBio 8(1), e01820-01816. doi:
10.1128/mBio.01820-16.
Walker, L.A., Munro, C.A., de Bruijn, I., Lenardon, M.D., McKinnon, A., and Gow, N.A.
(2008). Stimulation of chitin synthesis rescues Candida albicans from
echinocandins. PLoS Pathog 4(4), e1000040. doi: 10.1371/journal.ppat.1000040.
Westman, J., Moran, G., Mogavero, S., Hube, B., and Grinstein, S. (2018). Candida
albicans Hyphal Expansion Causes Phagosomal Membrane Damage and Luminal
Alkalinization. MBio 9(5), e01226-01218. doi: 10.1128/mBio.01226-18.
Wheeler, R.T., and Fink, G.R. (2006). A drug-sensitive genetic network masks fungi from
the immune system. PLoS Pathog 2(4), e35. doi: 10.1371/journal.ppat.0020035.
Xu, S., and Shinohara, M.L. (2017). Tissue-Resident Macrophages in Fungal Infections.
Front Immunol 8, 1798. doi: 10.3389/fimmu.2017.01798.

121

: Candida albicans Cannot Acquire Sufficient Ethanolamine
from the Host to Support Virulence in the Absence of De Novo
Phosphatidylethanolamine Synthesis

122

Publication Note
A version of this chapter has been previously published by Sarah E. Davis, Robert N.
Tams, Norma V. Solis, Andrew S. Wagner, Tian Chen, Joseph W. Jackson, Sahar Hasim,
Anthony E. Montedonico, Justin Dinsmore, Timothy E. Sparer, Scott G. Filler, and Todd
B. Reynolds:
Davis, S.E., Tams, R.N., Solis, N., Wagner, A.S., Chen, T., Jackson, J.W., et al.
2018. Candida albicans cannot acquire sufficient ethanolamine from the host to support
virulence in the absence of de novo phosphatidylethanolamine synthesis. Infection and
Immunity. 86(8).
It should be noted that this article has two primary authors, Sarah E. Davis, and
Robert N. Tams. The author contributions are as follows: SED initially wrote the
manuscript, which was edited by NVS, SH, AM, RNT, SGF and TBR. Several resubmissions were made, which required extensive revisions. These revisions were
performed primarily by RNT, and by ASW, TC, and JWJ.
SED, SH, and RNT performed mouse intravenous models. SH created and utilized
the AtSDC construct. SED and RNT performed mouse oral model studies, and
cytotoxicity assays. RNT and SED performed growth curves. SED and TC performed
immunofluorescence studies. ASW and JWJ performed flow cytometry (data not
included). RNT performed lipid extractions, TLC, and papaumide-A kill assays. SED,
TBR, and RNT created and edited figures. Further editing of the manuscript was
performed by RNT and TBR, as well as other authors, and the project was directed by
TBR. TBR, SGF, and SED provided funding for these experiments.

123

Abstract
Candida albicans mutants for phosphatidylserine (PS) synthase (cho1∆/∆) and PS
decarboxylase (psd1∆/∆ psd2∆/∆) are compromised for virulence in mouse models of
systemic infection and oropharyngeal Candidiasis (OPC). Both of these enzymes are
necessary to synthesize phosphatidylethanolamine (PE) by the de novo pathway, but
these mutants are still capable of growth in culture media as they can import ethanolamine
from media to synthesize PE through the Kennedy pathway. Given that the host has
ethanolamine in its serum, the exact mechanism by which virulence is lost in these
mutants is not clear. There are two competing hypotheses to explain their loss of
virulence. 1) PE from the Kennedy pathway cannot substitute for de novo synthesized
PE. 2) The mutants cannot acquire sufficient ethanolamine from the host to support
adequate PE synthesis. These hypotheses can be simultaneously tested if ethanolamine
availability is increased for Candida while it is inside the host. We accomplish this by
transcomplementation of C. albicans with the Arabidopsis thaliana serine decarboxylase
gene (AtSDC), which converts cytoplasmic serine to ethanolamine. Expression
of AtSDC in either mutant restores PE synthesis even in the absence of exogenous
ethanolamine. AtSDC also restores virulence to cho1∆/∆ and psd1∆/∆ psd2∆/∆ in
systemic and OPC infections. Thus, in the absence of de novo PE synthesis, C.
albicans cannot acquire sufficient ethanolamine from the host to support virulence. In
addition, expression of AtSDC restores PS synthesis in the cho1∆/∆ mutant, which may
be due to causing PS decarboxylase to run backwards and convert PE to PS.
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Introduction
Candida spp. are human commensal fungi that colonize the gastrointestinal tract, as well
as vaginal and oral mucosa. They reside as oral flora in approximately 30-60% of healthy
individuals and usually do not cause disease (Pankhurst, 2009). However, in
immunocompromised patients Candida spp. are able to cause a common oral infection
known as oropharyngeal Candidiasis (OPC) or thrush (Pankhurst, 2009; Thompson et
al., 2010). OPC is one of the first indicators of suppression of adaptive immunity and is
seen in up to 95% of acquired immune deficiency syndrome (AIDS) patients at some time
during their infection (Rabeneck et al., 1993). Other risk factors for OPC include use of
steroid inhalers or dentures, and it is becoming a common infection in recipients of solid
organ transplants (Lynch, 1994; Hancock et al., 2003; Soysa et al., 2008; DongariBagtzoglou et al., 2009). These infections are detrimental to the comfort of patients,
causing difficulty in chewing and swallowing, and in severe cases will result in reduced
food intake and weight loss (Pankhurst, 2009). It is important to note that these oral
infections can be refractory to medications and exhibit drug resistance, making treatment
challenging (Revankar et al., 1998; Thompson et al., 2010). Out of all Candida species,
C. albicans is the species most commonly isolated from oral lesions (Vazquez and Sobel,
2002).
C. albicans and related species are also capable of causing more serious systemic
infections, when it enters the bloodstream and deep organs, and these infections have a
mortality rate of ~30% (Eggimann et al., 2003; Bustamante, 2005; Morrell et al., 2005).
Systemic infections tend to occur in neutropenic patients and are associated with
intravascular catheters. Previously, we discovered that mutations that block the de novo
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pathway

for

synthesizing

the

phospholipids

phosphatidylserine

(PS)

and/or

phosphatidylethanolamine (PE) compromise the virulence of C. albicans in a mouse
model of systemic candidiasis and could potentially serve as good drug targets (Chen et
al., 2010). The cho1∆/∆ mutation disrupts PS synthase, the first step of the de novo
pathway (Figure 4.1, enzymes shown in green), which generates PS from
cytidyldiphosphate-diacylglycerol (CDP-DAG) and serine (Atkinson et al., 1980;
Yamashita and Nikawa, 1997). A second pair of mutations (psd1∆/∆ psd2∆/∆) blocks the
second step of the pathway, whereby a pool of PS is decarboxylated to PE by Psd1p or
Psd2p (Clancey et al., 1993; Trotter and Voelker, 1995; Birner et al., 2001). The cho1∆/∆
mutant has a complete loss of PS and cannot make PE by this pathway, whereas the
psd1∆/∆ psd2∆/∆ mutant cannot synthesize PE from PS, and therefore accumulates PS
(Chen et al., 2010; Cassilly et al., 2017). In both mutants, PE can be synthesized via an
alternative pathway called the Kennedy pathway (Figure 4.1, enzymes shown in blue),
where diacylglycerol (DAG) and ethanolamine are used to make PE (Henry et al., 2012)
(Figure 4.1). Thus, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are ethanolamine
auxotrophs (Chen et al., 2010).
The cho1∆/∆ mutant is avirulent and psd1∆/∆ psd2∆/∆ is highly attenuated in a
mouse model for systemic Candidiasis (Chen et al., 2010). The cho1∆/∆ mutant exhibits
more severe cell wall defects than the psd1∆/∆ psd2∆/∆ mutant, and this is manifested in
increased exposure of cell wall β(1-3)-glucan (unmasking) to the immune system, as well
as an altered cell wall structure as seen by transmission electron microscopy (TEM) and
increased chitin levels (Wheeler et al., 2008; Chen et al., 2010; Davis et al., 2014). The
avirulence of the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants is somewhat surprising given
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Figure 4.1. Pathways for synthesizing aminophospholipids in C. albicans.
Enzymes are named after their confirmed or predicted homologs in S. cerevisiae. The
Kennedy pathway enzymes are shown in blue, and the de novo pathway proteins are
shown in green. Arabidopsis thaliana Serine Decarboxylase (AtSDC) is shown in red.
Ser: serine, Eth: ethanolamine, Cho: choline, Eth-P: phosphoethanolamine, Cho-P:
phosphocholine,
Etn-CDP:
cytidyldiphosphate-ethanolamine,
Cho-CDP:
cytidyldiphosphate-choline, PS: phosphatidylserine, PE: phosphatidylethanolamine,
PC: phosphatidylcholine, CDP-DAG: cytidyldiphosphate-diacylglycerol, DAG:
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that both mutants can grow in the presence of exogenous ethanolamine, and host serum
contains ~30 µM ethanolamine (Houweling et al., 1992). Therefore, in this communication
we specifically address the molecular mechanism by which these mutants are
compromised for virulence in vivo using both systemic and OPC infection models.
Results
To determine if cho1∆/∆ and psd1∆/∆ psd2∆/∆ have defects in oral infections by C.
albicans, we compared these mutants to wild-type and reintegrant strains in the mouse
OPC model. It was discovered that there was a decrease in pathogenicity for both
cho1∆/∆ and psd1∆/∆ psd2∆/∆ in OPC infections (Figure 4.2, A-B). The cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants both showed decreased colonization of the tongues of mice
based on recovered colony forming units (CFUs).
In addition to the mouse OPC model, a tissue culture model has been used to
study the damage of oral epithelial cells (FaDu) by C. albicans. This can be measured
based on the release of lactate dehydrogenase (LDH), a cytoplasmic enzyme, as a proxy
for FaDu cell damage (Sun et al., 2010). When C. albicans strains are co-incubated with
FaDu cells, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants show reduced damage of the
epithelial cells (Figure 4.2, C).

Loss of de novo PE synthesis compromises virulence because mutants cannot
acquire sufficient ethanolamine in the host
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ phospholipid biosynthesis mutants show decreased
virulence in three models of virulence: murine systemic infection (Chen et al.,
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Figure 4.2. The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are attenuated for
virulence during in vivo and in vitro models of OPC.
Mice were inoculated orally with A. wild-type (WT), cho1∆/∆ (cho1) and
cho1∆/∆::CHO1 (cho1R) reintegrant strains or B. WT, psd1∆/∆ psd2∆/∆ (psd1,2), or
psd1∆/∆ psd2∆∆::PSD1 (psd1,2R) reintegrant strains. After five days their tongues
were harvested, and the cfus/gram of tissue were measured. *p-value<0.0002,
compared to WT. C. The strains were co-incubated with FaDu cells, and the level of
lactate dehydrogenase (LDH) released into the media was measured as a proxy for
FaDu cell damage. **p-value 0.0007, *** p-value 0.0005, all compared to wild-type.
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2010), murine OPC (Figure 4.2, A-B), and FaDu epithelial damage (Figure 4.2, C). The
main feature shared by both mutants is the inability to synthesize PE from PS. However,
it is not clear why loss of PE synthesis through the de novo pathway compromises
virulence given the existence of a functional Kennedy pathway. One hypothesis is that
PE synthesized by Psd1 or Psd2 is fundamentally different in composition or localization
than PE synthesized through the Kennedy pathway, and therefore Kennedy pathway PE
cannot compensate for de novo pathway PE. A competing hypothesis is that PE from
either pathway is sufficient, but C. albicans cannot acquire enough ethanolamine from the
host to satisfy its PE requirement via the Kennedy pathway.
The way to test these competing hypotheses is to increase PE synthesis through
the Kennedy pathway while C. albicans is in the host during an infection. This requires
that we provide sufficient ethanolamine intracellularly to C. albicans, as it is possible that
the amount of ethanolamine in the host is not sufficient to support growth or virulence of
these mutants. The level of ethanolamine in mouse serum is estimated to be ~30µM
(Houweling et al., 1992). However, we found that the level of ethanolamine required to
support growth of these Candida mutants in culture media at 37˚C is greater than 100µM
(Figure 4.3). Therefore, the mutants may not be able to import sufficient ethanolamine
from the host to support virulence.
In order to provide ethanolamine intracellularly, a codon optimized serine
decarboxylase enzyme derived from Arabidopsis thaliana (AtSDC) was expressed in our
C. albicans strains (Rontein et al., 2001). Serine decarboxylase activity is found in plants,
but not in mammals or fungi. AtSDC decarboxylates serine to ethanolamine within the

130

Figure 4.3. 1mM ethanolamine is required to support growth of the cho1∆/∆
and psd1∆/∆ psd2∆/∆ mutants in minimal medium.
A. The cho1∆/∆ and B. psd1∆/∆ psd2∆/∆ strains were grown overnight in YPD,
and then diluted to an OD600 of 0.1 and grown in minimal media + various levels
of ethanolamine (Eth) at 37˚C with shaking, and their growth was measured for
up to 48 hours. Growth is compared to wild-type (WT) with 0µM ethanolamine.
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cytoplasm, and the ethanolamine can be used by the Kennedy pathway to synthesize PE
(Figure 4.1). If the loss of virulence in both mutants is due to an inability to acquire
sufficient ethanolamine from the host, then addition of AtSDC should restore
ethanolamine prototrophy and virulence in mouse models of Candidiasis. If, alternatively,
PE must be made by the de novo pathway to support virulence because Kennedy
pathway derived PE is insufficient, then AtSDC will not rescue the virulence defect for
either mutant.
The ability of AtSDC to support PE synthesis by the Kennedy pathway was tested
in two ways. First, it was found to restore ethanolamine prototrophy in the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ strains by supporting growth in minimal media lacking ethanolamine
(Figure 4.4, A-C). In fact, when grown in media lacking ethanolamine, mutants expressing
AtSDC grew at rates similar to wild-type and exhibited better growth than the same mutant
strain supplemented with ethanolamine (Figure 4.4, A-C). Second, thin layer
chromatography (TLC) confirmed that PE levels were restored in the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants growing in the absence of ethanolamine when AtSDC is
expressed (Figure 4.4, D).
We then examined if addition of AtSDC would restore virulence for the cho1∆/∆
and psd1∆/∆ psd2∆/∆ mutants in a mouse model of systemic infection (Figure 4.5, A-B).
Indeed, the addition of this enzyme fully restored virulence to both the cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants in the systemic infection model. The differences seen in the
survival curves were reflected in fungal burden measurements (Figure 4.5, C). It is
interesting to note that although both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants had
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Figure 4.4. Expression of AtSDC restores ethanolamine prototrophy in cho1∆/∆ and
psd1∆/∆ psd2∆/∆ mutants.
A, B, & C Mutant and wild-type (WT) strains ± AtSDC were grown in minimal media ±
ethanolamine (Eth) at 37˚C and a growth curve was plotted. D Phospholipids were
isolated from each strain grown in minimal media lacking ethanolamine, and then
separated by TLC. Lipid spots were visualized with primuline stain under ultraviolet light.
Strains included cho1∆/∆ (cho1), psd1∆/∆ (psd1), and psd1∆/∆ psd2∆/∆ (psd1 psd2), all
± AtSDC.
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Figure 4.5. Expression of AtSDC restores virulence in cho1∆/∆ and
psd1∆/∆ psd2∆/∆ in a mouse model of systemic candidiasis. A & B
Mice were infected by tail-vein with 5x105 cells from each strain and survival was
graphed over time. The number of mice per strain are shown beside the strain name
in parenthesis. The cho1∆/∆ and psd1∆/∆ psd2∆/∆ survival curves were significantly
different than wild-type (*P value = 0.0004). C. Mice were infected with 5x105 cells by
tail-vein and after five days, they were euthanized, and kidneys were removed, and
colony forming units (cfus)/gram of kidney were measured by plating. * pvalue<0.0001, compared to WT (wild-type), and ** p-value=0.0031 compared to
cho1∆/∆. Mutant strains: cho1 (cho1∆/∆), psd1 (psd1∆/∆), psd1,2 (psd1∆/∆ psd2∆∆),
SDC (AtSDC).
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much lower fungal burden than wild-type, the cho1∆/∆ mutant exhibited a significantly
lower fungal burden than psd1∆/∆ psd2∆/∆ (Figure 4.5, C).
We further determined if the AtSDC expressing mutants would be restored for
virulence in the OPC model. Indeed, when these strains were tested in this model, they
revealed that the mutants expressing AtSDC had virulence levels similar to wild-type
(Figure 4.6, A). In the previous experiments shown in Figure 4.2, cho1∆/∆ and psd1∆/∆
psd2∆/∆ were tested separately, and with outbred (ICR) and inbred (Balb/c) mice,
respectively. However, when compared in the same experiment with outbred mice (CD1), the psd1∆/∆ psd2∆/∆ mutant appears to be more virulent than the cho1∆/∆ mutant.
Finally, we determined if the addition of AtSDC would restore the ability of the mutants to
damage epithelial cells. This was found to be the case for both mutants (Figure 4.6, B).
In both cases, the mutants with AtSDC caused as much damage as wild-type.

Expression of the AtSDC restores β(1,3)-glucan unmasking in cho1∆/∆ by restoring
PS synthesis
Previous work from Davis et al (Davis et al., 2014) revealed that cho1∆/∆, but not psd1∆/∆
psd2∆∆, exhibits increased exposure of β(1,3)-glucan (unmasking). This data showed
that PS, but not PE, regulates unmasking. Therefore, complete restoration of virulence in
cho1∆/∆ by AtSDC was unexpected as AtSDC synthesizes ethanolamine specifically.
Therefore, we measured whether β(1,3)-glucan unmasking in the cho1∆/∆ mutant would
be affected by PE synthesis through the Kennedy pathway due to expression of AtSDC.
The addition of AtSDC led to full restoration of β(1,3)-glucan unmasking in the cho1∆/∆
mutant similar to wild-type (Figure 4.7). Thus, production of PE from the Kennedy
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Figure 4.6. Expression of AtSDC restores virulence to cho1∆/∆ or
psd1∆/∆ psd2∆/∆ for in vivo and in vitro models of OPC.
A. An OPC infection model was performed with mice and after five days, they were
sacrificed, tongues were removed, and CFUs/gram tongue were measured. * Pvalue<0.01, compared to wild-type (WT). ** P-value<0.01, compared to cho1∆/∆AtSDC. ***P-value<.01, compared to psd1∆/∆ psd2∆∆. **** P-value<0.01, compared
to psd1∆/∆ psd2∆∆-AtSDC. B. The wild-type (WT), cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants were compared to their respective AtSDC transformants, for their abilities to
damage FaDu cells based on release of lactate dehydrogenase (LDH). ¥ pvalue=0.0157, å p-value=0.0163, both compared to WT, ¥¥ p-value=0.0071
compared to cho1∆/∆, åå p-value=0.0201 compared to psd1∆/∆ psd2∆∆. Strains:
cho1 (cho1∆/∆), psd1 (psd1∆/∆), psd1,2 (psd1∆/∆ psd2∆∆), SDC (AtSDC)
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Figure 4.7. Expression of AtSDC suppresses cho1∆/∆ β(1,3)-glucan unmasking in
cho1∆/∆.
A Cells were stained with anti-β(1,3)-glucan primary and phycoerythrin-conjugated
secondary antibodies, and 100,000 cells were measured by flow cytometry for each
replicate sample. Experiments were performed with three replicates per strain. B Cells
were stained with anti-β(1,3)-glucan primary and Cy3-conjugated secondary antibodies
and viewed by immunofluorescent microscopy. *P-value<0.0001, **P-value=0.0067.
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pathway can bypass the cho1∆/∆ mutation regarding β(1,3)-glucan exposure.
This left the possibility that PE production by AtSDC was allowing the regeneration
of PS. There is no other PS synthase in C. albicans. However, if sufficient product is
present, an enzyme can be made to run backward, and the cho1∆/∆ mutant possess the
two PS decarboxylase enzymes Psd1 and Psd2. Thus, we hypothesized that PS
synthesis is restored in the cho1∆/∆ mutant when AtSDC is expressed. Therefore, we ran
thin-layer chromatography to determine if the cho1∆/∆ AtSDC mutant synthesizes PS,
and we found that it did (Figure 4.8, A). Furthermore, strains that contain PS are
susceptible to the PS-binding toxin papuamide A (PapA) at 10 and 5µg/ml PapA, while
the cho1∆/∆ mutant (lacking PS) is resistant, as reported previously (Cassilly et al., 2016).
In contrast to cho1∆/∆, the cho1∆/∆ AtSDC strain is susceptible, indicating that it contains
PS (Figure 4.8, B). This would explain why AtSDC restores β(1,3)-glucan masking to the
cho1∆/∆ mutant.
Discussion
The data presented in this communication address the main question of whether the
cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants’ losses in virulence are due to a shared loss of
PE synthesis from one specific pathway (de novo) or if it was due to an overall loss of PE
synthesis. Based on the results with AtSDC strains (Figures 4.5 and 4.6), PE synthesized
by the Kennedy pathway can compensate for loss of de novo synthesized PE. However,
the Kennedy pathway does not compensate for loss of virulence in the cho1∆/∆ or
psd1∆/∆ psd2∆/∆ mutants lacking AtSDC, and this is likely because the mutants are
unable to import sufficient ethanolamine to support virulence in the host. In culture, these
mutants require >100µM (Figure 4.3), and serum ethanolamine is estimated to be 30µM
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Figure 4.8. Expression of AtSDC in the cho1∆/∆ mutant leads to PS production.
A Strains were grown overnight in YPD and phospholipids were extracted and run
on TLC to determine if PS was being synthesized. Lipid spots were compared to
purified standards, which are marked on the TLC. The PS spot is marked with a black
arrow in the cho1∆/∆ and cho1∆/∆ AtSDC lanes. B Cells were grown overnight in
YPD, diluted to 105/ml in fresh YPD, and 100µl were added to wells containing YPD
+ PapA or the methanol/water solvent control at the concentrations shown and then
incubated overnight without shaking at 30˚C.
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(Houweling et al., 1992). In addition, even with 1 mM ethanolamine, neither the cho1∆/∆
nor psd1∆/∆ psd2∆/∆ mutants recover wild-type levels of growth, but they do so with
AtSDC (Figures 4.3, 4.4), thus one possible explanation is that C. albicans is unable to
transport ethanolamine into the cell at an efficiency that allows it to restore virulence.
The inability of ethanolamine auxotrophs like cho1∆/∆ and psd1∆/∆ psd2∆/∆ to
cause disease is interesting given that auxotrophic mutants in Candida spp. are only
sometimes associated with avirulence. For instance, an auxotroph for inositol (ino1∆/∆),
a metabolite used to synthesize the phospholipid phosphatidylinositol is not compromised
for virulence (Chen et al., 2008). In addition, auxotrophs for the amino acids lysine,
histidine, leucine, or arginine are fully virulent (Noble and Johnson, 2005; Gabriel et al.,
2014). In addition, the related fungal pathogen Candida glabrata, is a natural niacin
auxotroph (Domergue et al., 2005) and C. albicans is a biotin auxotroph (Odds, 1988;
Ahmad Hussin et al., 2016), yet they are both virulent. In contrast, mutants that are
auxotrophs for the nucleotides uridine or adenine are avirulent (Lay et al., 1998; Donovan
et al., 2001), as is a mutant for fatty acid synthesis (fas2∆/∆) (Zhao et al., 1997). Thus, it
is not a forgone conclusion that auxotrophic mutants are going to be comprised for
virulence, but this is clearly the case with the ethanolamine auxotrophs in this study.
This study also has an unusual innovation in that we tested for auxotrophy in vivo
during infection, which is rarely done because of technical difficulties. Often auxotrophs
are assumed to be avirulent due to insufficient nutrient acquisition in the host based on
correlations with in vitro phenotypes on plates or in culture media. Thus, auxotrophies
often cannot be easily tested in vivo during infection. However, in this study, with the
AtSDC gene we were able to demonstrate that provision of ethanolamine from a source
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other than the host restored virulence in vivo. This confirms that ethanolamine auxotrophy
is indeed a major contributor to the loss of virulence in the cho1∆/∆ and psd1∆/∆ mutants.
One potential related explanation for the virulence loss of cho1∆/∆ and
psd1∆/∆ psd2∆/∆ besides auxotrophy is that they grow more slowly compared to wildtype even with ethanolamine supplementation (Figure 4.4). In contrast, expression of
AtSDC restores both mutants to wild-type growth. However, as reported in Chen et al.
(Chen et al., 2010) the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants’ growth in media
supplemented with ethanolamine was similar to that of the single mutant psd1∆/∆ which
is fully virulent in the tail-vein infection model. Thus, there is not necessarily a strong
correlation between in vitro growth in culture and virulence, an observation that was also
made by Noble, et al in their study of the virulence of ~700 homozygous Candida albicans
mutants (Noble et al., 2010).
Finally, it was noted, based on fungal burden levels, that the psd1∆/∆ psd2∆/∆
mutant had a modest, but significantly, higher fungal burden in both the systemic model
of infection and the OPC model. These differences in fungal burdens do correlate with
the cho1∆/∆ mutant’s β(1-3)-glucan unmasking compared to that of psd1∆/∆ psd2∆/∆
(Davis et al., 2014), however there may be other explanations as these mutants are both
pleiotropic.
The role of Kennedy pathway PE in β-glucan exposure
Regarding unmasking, another observation made in this study is that supplying sufficient
PE via the AtSDC can restore masking in the cho1∆/∆ mutant. Although, initially we
thought it might be acting to restore unmasking in the absence of PS, we have found that
AtSDC can cause PS synthesis in the absence of PS synthase gene. The most likely
143

explanation is that the excess PE synthesized by the Kennedy Pathway in the cho1∆/∆
strain expressing AtSDC causes the Psd1 and/or Psd2 PS decarboxylase enzymes to
run in reverse and restores PS and therefore β(1,3)-glucan masking. This is a surprising
result and is the first time, to our knowledge, that this has been suggested in vivo for a
PS decarboxylase enzyme.
Materials and Methods
Strains and media
The C. albicans strains used in this study are in Table 4.1. The media used for growth
and maintenance of the strains was YPD (yeast extract, peptone, dextrose) broth and
plates (Styles, 2002). For growth curves, we used minimal media (yeast nitrogen base,
dextrose) ± ethanolamine (Styles, 2002). The AtSDC strains were generated as follows:
First, the AtSDC gene was codon optimized by site-directed mutagenesis to change its
single CTG codon at amino acid position 447 to TTG in the yeast expression vector
pVT103-U (Rontein et al., 2001), and was then PCR amplified with SDO17 (5’AAAACCATGGATGGTTGGATCTTTGGAATCTGA-3’)

and

SDO18

(5’-

AAAAAGATCTCTAGACCATGCTCCTACCTAGA-3’) which introduced NcoI and BglII
sites that were used to replace the dTomato ORF found between these sites in the PENO1dTomato-NATr plasmid (Brothers et al., 2013), creating the plasmid PENO1-AtSDC. This
plasmid was linearized with EcoRV, and then transformed by electroporation as
previously described (Chen et al., 2010), and selected on YPD plates containing 200
µg/ml nourseothricin.
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Table 4.1. C. albicans strains used in chapter four.
Strain

Parent Strain

Genotype

Source

SC5314

Clinical Isolate

Prototrophic wild type

Gillum et al., 1984

YLC337

SC5314

cho1∆/∆

Chen et al., 2010

YLC344

YLC337

cho1∆/∆::CHO1-SAT1

Chen et al., 2010

YLC280

SC5314

psd1∆/∆

Chen et al., 2010

YLC294

YLC280

psd1∆/∆::PSD1-SAT1

Chen et al., 2010

YLC375

SC5314

psd2∆/∆ psd1∆/∆

SED029

YLC375

psd1∆/∆ psd2∆∆::PSD1-SAT1

Chen et al., 2010
This study

SED030

SC5314

PENO1-AtSDC-SAT1

This study

SED031

YLC337

cho1∆/∆ PENO1-AtSDC-SAT1

This study

SED032

YLC280

psd1∆/∆ PENO1-AtSDC-SAT1

This study

SED033

YLC375

psd1∆/∆ psd2∆/∆ PENO1-AtSDC-SAT1

This study
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Papuamide A toxicity assay
The PapA assay was performed as described in (Cassilly et al., 2016).

LDH release assay from FaDu cells during C. albicans infection in tissue culture
For measurement of LDH, cytotoxicity assays were performed using the protocol and
materials found in the CytoTox 96® Non-Radioactive Cytotoxicity Assay Kit (Promega,
G1780). Briefly, 5x105 FaDu cells/mL were plated in EBSS media with 10% FBS in a 24
well plate with a total volume of 1 mL/well. C. albicans strains were grown overnight in 5
mL YPD. The following day C. albicans cultures were washed with water and
resuspended in EBSS with 2% human serum. Media was aspirated from FaDu cells, and
1mL/well C. albicans was added at a multiplicity of infection of 5 and centrifuged at 200xg
for 5 minutes. Wells containing FaDu or C. albicans cells were included as controls and
all samples were tested in triplicate by incubating for 4 hours at 37°C and 5% CO2.
Following incubation, the plate was again centrifuged at 200xg for 5 minutes and 50μL of
each supernatant was transferred to a 96 well plate. An equal volume of reconstituted
substrate mix was added to each well and incubated for 30 minutes protected from light.
50μL of stop solution was added to each well and absorbance was measured at 490nm.
Percent cytotoxicity was calculated as described in the manufacturer’s protocol by
comparing samples to epithelial cells treated with lysis solution (Sun et al., 2010).

Hot ethanol extraction of total phospholipids and thin layer chromatography (TLC)
Sample extraction and TLC for Figure 4.8 was performed as previously described (Chen
et al., 2010) using plates from GE Healthcare that can separate PS very well, but are no
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longer available for sale, and are therefore a limited resource. Due to this limitation, for
the TLC shown in Figure 4.4, which focused on PE, the following exceptions were made
to conserve the GE plates. Before running with samples, TLC silica gel plates (Fisher cat#
M1057290001) were prepared by baking them in a drying oven at 100˚C for 15 minutes.
After baking, these plates were run with 50mM EDTA. Plates were then run with a
chloroform: methanol (1:1) migration solvent to remove EDTA, dried, and baked in the
oven again for 15 minutes. The samples were then loaded and run as described (13).
Lipids were visualized on the dried plate by spraying with Primuline dye (5mg of Primuline,
cat# 206865, Sigma) in 100ml of acetone, and illuminating with UV light.

Microscopy and flow cytometry
For flow cytometry, cell staining was performed with an anti-β-(1,3)-glucan primary
antibody (Biosupplies Australia), and a goat anti-mouse-phycoerythrin (PE) secondary
antibody (Jackson ImmunoResearch). Three biological replicates for all strains were used
in each experiment, and all were analyzed on the same day. In brief, 5ml cultures of C.
albicans strains were grown shaking overnight at 30°C and diluted the following morning
to an OD600 of 0.5 in 1ml of 1x PBS. Cells were subsequently washed twice with PBS and
blocked for 1 hour in PBS plus 3% BSA. Following blocking, cells were rocked at 4°C for
90 minutes in a 1:800 dilution of anti-β-(1,3)-glucan primary antibody in PBS plus 3%
BSA. Cells were then washed four times with PBS and rocked once more at 4°C for 20
minutes in a 1:300 dilution of goat anti-mouse-PE secondary antibody in PBS plus 3%
BSA. Cells were washed 4 additional times with PBS and finally resuspended in 500ul of
FACS buffer for flow cytometry analysis. Samples were run on a FACSCalibur LSRII flow
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cytometer (Becton Dickinson) and data for each sample was collected for 100,000 gated
events. Data was analyzed with the use of FlowJo 10.11 (FlowJo LLC, OR, USA) and all
statistics were run using a Student t test.
For immunofluorescence, this procedure was done as described in (Davis et al.,
2014). C. albicans cells were grown overnight in YPD medium at 30°C. An anti-β(1-3)glucan antibody (Biosupplies Australia Pty Ltd., Australia) at a 1:800 dilution was used as
the primary antibody, and a goat anti-mouse antibody conjugated to Cy3 (Jackson
ImmunoResearch Inc., USA) at 1:300 dilution was used as secondary antibody. For
imaging, Candida cells were resuspended in 100 μL of PBS and visualized with LEICA
DM5500B epi-fluorescent microscope with Hamamatsu Orca-ER CCD digital camera.
The pictures were taken through Leica Application Suite AF (Advanced Fluorescence)
software.

Oropharyngeal candidiasis model
This experiment was performed as previously described (Kamai et al., 2001; Solis and
Filler, 2012). Briefly, eight mice per strain of C. albicans were immunosuppressed with
cortisone acetate, which administered subcutaneously at 225 mg/kg on days -1, 1 and 3
relative to infection. To induce infection, the mice were anesthetized with ketamine and
xylazine, after which a calcium alginate swab saturated with 106 C. albicans cells was
placed sublingually for 75 min. After recovery from anesthesia, the mice were provided
with food and water ad libitum. They were sacrificed after 5 days of infection, and then
their tongues were harvested and divided lengthwise. One half was weighed,
homogenized and quantitatively cultured.
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Mouse systemic infection model
To prepare strains for injection, 1.0 OD600 of cells from overnight test tube cultures were
washed 5 times with 1 mL ddH2O, resuspended, and counted by hemocytometer. These
washed cultures were then diluted to 5*106 cells/ml and 100 µl of cell suspension was
injected into ICR (Harlan) mice for a total of 5*105 yeast/mouse. N=5 mice for each
Candida strain/experiment. For fungal burdens, cultures were prepared and injected the
same way as they were for the mouse mortality assay described above. 5 days after
injection, mice were humanely euthanized, and then both kidneys were removed. One
kidney was weighed and homogenized with a Dounce homogenizer in 5 ml ddH2O. This
homogenate was diluted 1:4 and 200 µl was plated on YPD + 1M sorbitol plates for CFU
counts.

Ethics statement
The mouse studies carried out in this report followed ethical guidelines set forth by the
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model, these experiments were carried out at the University of Tennessee under the UTAnimal Care and Use Committee (UT-ACUC) approved protocol #0016-0714. The OPC
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Institutional Animal Care and Use Committee (IACUC) of the Los Angeles Biomedical
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Summary of Findings
Prior to the initiation of these studies it was known that mutations within phospholipid
biosynthetic pathways can have a negative impact on the virulence of Candida albicans.
Mutations blocking synthesis of PS and PE via the CDP-DAG pathway result in avirulence
(cho1Δ/Δ and psd1Δ/Δ psd2Δ/Δ) and blockage of inositol biosynthesis and import
together (ino1Δ/Δ itr2Δ/Δ), which is required for phosphatidylinositol (PI) synthesis,
results in avirulence (Chen et al., 2008; Chen et al., 2010). However, it was unknown
whether CDP-DAG mediated biosynthesis of PC was required for virulence or if the
alternative route for PE and PC synthesis, known as the Kennedy pathway, could
compensate for this loss. In addition, it was completely unknown whether the Kennedy
pathway was required for the growth or virulence of this organism, or alternatively if this
pathway is redundant with the CDP-DAG pathway. Thus, this is the first study that
addressed the requirement of the Kennedy pathway for virulence in C. albicans.
While auxotrophic mutants are not always avirulent, it is not necessarily surprising
that mutations in major phospholipid biosynthetic routes can confer avirulence, as these
mutations cause the organism to have a decreased capacity for synthesis of key
components of cellular membranes. This could have detrimental effects on numerous
cellular processes including signaling, protein localization or secretion, mitochondrial
membrane potential and function, altered membrane stability/fluidity, and changes to cell
wall architecture secondary to stress incurred by the plasma membrane. Contrary to
many auxotrophic mutants for phospholipid synthesis, in this work we found that pem1Δ/Δ
pem1Δ/Δ, which cannot produce PC via the CDP-DAG pathway, is hypervirulent (Tams
et al., 2019). To our knowledge, this is the first hypervirulent fungal pathogen (HVFP) for
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which hypervirulence is caused by a phospholipid biosynthetic null mutation.
Since pem1Δ/Δ pem1Δ/Δ is hypervirulent, the Kennedy pathway must therefore
have the capacity to obtain sufficient choline from the mouse to produce PC and support
growth and pathogenesis, regardless of the fact that pem1Δ/Δ pem1Δ/Δ is a choline
auxotroph (Tams et al., 2019) (Chapter 2). This is in contrast to the psd1Δ/Δ psd2Δ/Δ
mutant, for which ethanolamine auxotrophy does result in avirulence, likely because there
is not enough ethanolamine in murine serum to support virulence for psd1Δ/Δ psd2Δ/Δ
(Chen et al., 2010; Davis et al., 2018) (Chapter 4). While we have not yet been able to
identify why the pem1Δ/Δ pem2Δ/Δ strain is hypervirulent, preliminary histology does
indicate increased tissue necrosis and neutrophil invasion in the kidney tissue of pem1Δ/Δ
pem2Δ/Δ infected mice as compared to wild-type (data not shown). Besides
hypervirulence, the only other major phenotype that we have been able to elucidate for
this mutant is a build-up of PE synthesized from the Kennedy pathway (Tams et al., 2019).
Since blocking PC synthesis via the CDP-DAG pathway resulted in hypervirulence, we
hypothesized that the cell wall was compensating for the loss of PC by increasing flux of
phospholipid synthesis through the Kennedy pathway, and that this possibly resulted in
hypervirulence. Therefore, in an attempt to re-capitulate the hypervirulent phenotype, we
overexpressed the Kennedy pathway via constitutive expression of EPT1 and found that
this mutant was also hypervirulent in the mouse model of disseminated candidiasis, and
additionally, that it has an increased cytotoxicity against oral epithelial cells in vitro (Tams
et al., 2019) (Chapter 2). Other phenotypes observed for this mutant are a buildup of PE
and PC (correlative to the increased PE observed in the hypervirulent pem1Δ/Δ pem2Δ/Δ
mutant), increased chitin content, protection from stress-induced β(1,3)-glucan
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unmasking, and increased hyphal growth. Further, it was found that none of these
phenotypes were the result of transcriptional changes, as evidenced by a transcriptional
profile analysis.
In addition to overexpression, EPT1 was knocked out to determine if the Kennedy
pathway was required for the virulence of this organism, as it is in some other species
(Tams et al., 2019) (Chapter 2). It was observed that deletion of EPT1 (ept1Δ/Δ) blocked
activity of the Kennedy pathway, and upon infection with the ept1Δ/Δ strain, there was
not a heavy attenuation of virulence in mice (Tams et al., 2019). However, it was observed
that there was a modest decrease in kidney fungal burden for infected mice, and also that
there was a decrease in cytotoxicity against oral epithelial cells in vitro (Tams et al., 2019).
Regardless, while the Kennedy pathway can compensate for a loss of CDP-DAG
mediated PC synthesis, this pathway alone is dispensable for virulence and growth so
long as PC can be produced via the de novo (CDP-DAG) route.
This brings up an interesting evolutionary question as to why the Kennedy pathway
is present if it is not necessary in wild type C. albicans. It has been demonstrated that
lipids produced by this pathway have different acyl chain substituents in S. cerevisiae, so
it is possible that PE and PC produced by this pathway enter a separate “pool” of
phospholipids produced by the CDP-DAG pathway (de Kroon et al., 2013). PE and PC
can be broken down via de-acylation and subsequent hydrolysis to create ethanolamine
or choline, respectively, which can be shunted back into the Kennedy pathway and thus
“re-modeled” when necessary, such as upon oxidative damage (Dowd et al., 2001). This
pathway is up-regulated at 37°C in S. cerevisiae, and if the same occurs for C. albicans,
up-regulation of the Kennedy pathway could act as a pre-emptive attempt to correct future
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membrane damage signaled by changes to environmental stimulus (Dowd et al., 2001).
However, there are also different energy requirements for the synthesis of phospholipids
by each pathway (ATP vs. SAM), so the cell may simply alter usage of pathways based
on metabolic needs (Henry et al., 2012).
It is evident from these data that the production of PE is important for growth and
virulence. However, given that synthesis of PE by the CDP-DAG pathway but not the
Kennedy pathway is required for virulence, a final study was undertaken to further
investigate the cellular requirements of PE in vivo. In vitro, psd1Δ/Δ psd2Δ/Δ requires ~1
mM ethanolamine to restore growth in minimal medium, which is much higher than the
estimated available amount of ethanolamine in mouse serum (~30 μM) (Houweling et al.,
1992; Davis et al., 2018). To determine if ethanolamine limitation was the cause of
avirulence of the cho1Δ/Δ and psd1Δ/Δ psd2Δ/Δ mutants, a serine decarboxylase was
introduced (atSDC), which converts intracellular serine to ethanolamine, and it was found
that this fully restored virulence for both mutants (Davis et al., 2018). Thus, the reason
the psd1Δ/Δ psd2Δ/Δ mutant is avirulent is because there is not enough ethanolamine in
mouse sera, or because the capability of C. albicans to import ethanolamine is too low.
Interestingly, AtSDC introduction also resulted in a restoration of β(1,3)-glucan
unmasking for the cho1Δ/Δ mutant, and we hypothesized that this was due to a
restoration of PE (Davis et al., 2018). However, further examination revealed that PS was
being produced in the cho1Δ/Δ atSDC mutant, presumably by reverse action of the PSD1
and PSD2 enzymes (Davis et al., 2018).
While these studies have expanded upon our knowledge of the requirements of
PE synthesis for C. albicans, and the impact that PE has on virulence, there are several
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areas that merit a continuation of study. There are numerous directions this project could
take but the primary considerations for future studies should be (1) to more fully elucidate
the mechanism for hypervirulence of the EPT1 overexpression strain with a strong
emphasis on chitin and cell wall changes, and (2) to independently evaluate the impact
of chitin on virulence and immune response.
Future Directions
Let’s talk about chitin
As we have noted, increases in cell wall chitin can be induced for C. albicans via cell wall
stress, such as that induced by mutation of cell wall proteins or treatment with caspofungin
(Wheeler and Fink, 2006; Bahnan et al., 2012). Since mutations in phospholipid
biosynthetic pathways can also cause cell wall stress, it is possible that overproduction
of phospholipids, by overexpression of EPT1, causes disequilibrium in the cell membrane
that results in a compensatory activation of chitin production. Although there are no
transcriptional differences in chitin synthase expression for the EPT1 overexpressor as
compared with wild-type, chitin synthesis is typically controlled via post-transcriptional
events, and therefore any differences in activity of this enzyme may have been missed in
our experimental approach (Lenardon et al., 2007).
Given the increase in chitin for the EPT1 overexpressor and the potential for chitin
to impact virulence, evaluation of the mechanism for increased chitin level in this strain is
one of the most important considerations for continuation of this project. Chitin synthase
3 (CHS3) is the major chitin synthase in C. albicans, and this gene should be labeled with
green fluorescent protein (GFP) in the EPT1 overexpression strain to determine if there
are any changes in localization in our hypervirulent mutants. Thus far, a plasmid has been
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created (pBT71) that includes a hygromycin resistance cassette suitable for use with the
EPT1 overexpressor strain. As an aside, it should also be noted that this plasmid can be
used as an important cloning tool for the lab when using strains for which a NAT1 cassette
has been used and there is a need for a secondary drug marker. In the case of pBT71,
HygR was inserted within the NotI site of the commercially available pBlueScript KS+
plasmid, and it has been confirmed that pBT71 confers resistance to hygromycin. A
second plasmid with a GFP label has been created (pBT75) from pBT71, and primers
BTO142 and BTO143 can be used to amplify a construct from pBT75 to tag CHS3 with
GFP. This has already been attempted, and although colony PCR positive clones have
been obtained with this construct (~75), there have been no colonies for which
fluorescence was obtained. Regardless, this should be attempted again with either this
plasmid or with another construct.
We have determined that there is an increase in hyphal length of the EPT1
overexpression strain at an early timepoint, and that this increase in length also occurs
when EPT1 is overexpressed in the cho1Δ/Δ background. It is unclear as to why
overexpression of EPT1 increases hyphal length, but it is possible that this correlates to
increased chitin production. While confocal microscopy with video could be used to
quantify the exact rate at which hyphae form for comparison to wild-type, a PENO1-EPT1
CHS3-GFP strain should be examined for differences in intensity or localization of the
protein. CHS3 typically localizes to the site of polarized growth on hyphae, and it would
be interesting to determine if this localization occurs at an earlier time point (or
differentially) in the EPT1 overexpresser than it does for the wild-type (Lenardon et al.,
2007). Alternatively, hyphae could be stained with calcofluor white, which stains total
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chitin, and the amount of chitin specifically within hyphal tips could be measured and
quantified with ImageJ software.
Another study that should be performed is to directly evaluate the impact of an
increase in chitin on virulence and immune regulation. There are several strains of wild
type C. albicans that have varying levels of chitin, and the amount of chitin for each strain
was shown to correspond to virulence, however, there were two reports with conflicting
results (Marakalala et al., 2013; Wagener et al., 2017). Given that our experiments
demonstrate an association of increased chitin with increased virulence, this should be
studied with greater detail. If possible, one should obtain the strains with low chitin levels
from the Aberdeen Fungal Group and overexpress EPT1 in these strains. It should then
be determined if overexpression of EPT1 increases chitin level of low chitin strains, and
if the increased chitin level correlates to increased virulence. Since SC5314, which was
used in this study, is at baseline already a highly virulent strain, overexpression of EPT1
in less virulent wild-type strains may induce a greater degree of hypervirulence as
compared to the respective parent strain.
Little is understood about how chitin levels in the cell wall and in its native form can
impact virulence and alter immune responses in live animals. The impact of chitin on
virulence and immune response should be measured directly by modulation of CHS3 with
a dose responsive regulatable system (such as the TetOff system). With this system, the
expression of the CHS3 gene could be regulated by the use of a gradient of doxycycline
concentration. Chitin content of cells treated with differing doxycycline concentrations
could be evaluated with flow cytometry. Once confirmed that chitin levels are altered in a
dose dependent manner, mouse experiments could be performed when doxycycline is
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added to the drinking water of mice. Multiple parameters could be monitored including
immunohistochemistry (noting not only necrosis and immune infiltration, but also again
confirming staining of chitin correlative of doxycycline dose in vivo) of biopsied kidneys,
immune infiltration via flow cytometry, and immune response (TNF-α and IL-10). This
would be extremely interesting to perform because most studies investigating the ability
of chitin to impact the immune response do so with tissue culture cells and purified chitin
particles. Alternative to a regulatable system, CHS3 could be overexpressed in the EPT1
overexpression strain, BTY88 (using the pBT71 plasmid as a starting point). If, however,
there were issues with the use of these strains in vivo, one could use them to perform in
vitro studies to examine immune response to varying chitin level in C. albicans in its native
state and in a uniform wild-type strain (SC5314), which has also not been done. If
experiments were to be performed in vitro, it would be also worthwhile to examine
capacity for reactive nitrogen species production from naïve bone marrow derived
macrophages as was performed by Wagener et al., as purified chitin has demonstrated
the potential decreased production of RNS (Wagener et al., 2017). This could be
performed with the use of an arginase detection kit as described in the same study.

Alternative cell wall components
GPI anchors are an important cell wall component required for the addition of the heavily
mannosylated proteins bound to the cell wall, and mutation that cause a disruption in GPI
anchor synthesis can result in non-viable yeast strains and issues with cell wall integrity
(Orlean, 2012). These anchors are also important for virulence as many virulence factors
including proteases and adhesins are covalently attached to the cell wall via a GPI anchor
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remnant (Kapteyn et al., 2000; Orlean and Menon, 2007). A requirement for the proper
construction of GPI anchors is the addition of phosphoethanolamine groups, which are
obtained from PE (Orlean and Menon, 2007). Based on this, we hypothesize that
increases in PE level of the cell may increase the amount of this substrate and thus more
GPI anchor may readily be formed. This could result in an abundance of GPI anchored
proteins on the cell surface and increase mannosylation, which could help in immune
evasion. Alternatively, increasing GPI anchored proteins on the cell surface could
increase the abundance of GPI anchored virulence factors, resulting in more cellular
damage. Either way, it would be interesting to determine if there are differences in GPI
anchors for the EPT1 overexpression and pem1Δ/Δ pem1Δ/Δ strains. We have tried
several methods of doing so but have not been able to effectively quantify GPI anchored
protein levels. We have attempted to use an Alexa Fluor conjugate of proaerolysin
(FLAER), a compound commonly used for mammalian GPI anchor detection in a clinical
setting, however this approach was unsuccessful. In addition, several common GPI
anchored cell wall proteins were fractionated and examined using Western blotting
techniques (GAS1, HWP1, ALS3) but we could not detect differences. Some of these
antibodies are not available commercially and were dated, so if one could obtain new
antibodies and probe the cells using immunofluorescence this may help to gain insight
into changes of GPI anchored proteins.
Another possibility for the investigation of GPI anchored cell wall components
would be to radiolabel the GPI anchor precursors, such as either [13C] ethanolamine or
[13C] inositol, to then obtain cell wall protein fractions, and attempt to quantify differences
with mass spectrometry. While this could be performed in-house, it may be worthwhile to
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collaborate with a group that specializes in cell wall structure for further evaluation. Other,
and more simple methods that could be used to identify changes in cell wall protein
mannosylation are to quantify intensity of concanavalin A stained cells (a fluorescent
compound which binds to mannose residues) with flow cytometry. These studies could
be performed for both the pem1Δ/Δ pem1Δ/Δ and EPT1 overexpression strains.
An alternative approach for the evaluation of GPI anchored proteins, which we
have also attempted previously, is to label an extremely common GPI anchored protein,
such as PGA59 or PGA62, with GFP. Fluorescence could then be quantified using flow
cytometry, or cell wall protein fractions could be quantified using Western blotting with an
α-GFP antibody as a proxy for changes in GPI anchored proteins. If this were to be
performed, several different common GPI anchored proteins should be examined to
ensure the differences are not only in the one tagged protein of interest. This experiment
would now be easier to perform since we have a second functional antibiotic marker
(HygR, pBT71), whereas there were issues with this previously.
A final cell wall experiment that should be performed with the pem1Δ/Δ pem1Δ/Δ
or EPT1 overexpressor is to examine the cell wall with TEM or atomic force microscopy
(AFM). While we have examined the cells with SEM and have not identified differences,
TEM would be a better method to identify any differences in cell wall thickness, and as
several HVFPs display both increased chitin and cell wall thickness, this would be a
pertinent experiment.
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Other unanswered questions
While the pem1Δ/Δ pem1Δ/Δ mutant cannot produce PC via the CDP-DAG pathway, it
can still obtain PC from the Kennedy pathway, whereas the EPT1 overexpressor
increases both PC and PE synthesis (Tams et al., 2019) (Chapter 2). Therefore, an
important question that should be asked regarding these mutants is whether changes to
PE or PC are causative of hypervirulence, and this should be addressed. We favor
increased PE synthesis as the reason for hypervirulence as increased PE is a
commonality to both pem1Δ/Δ pem1Δ/Δ and the EPT1 overexpressor, and because PC
synthesis via methylation is decreased in the pem1Δ/Δ pem1Δ/Δ mutant, yet it is still
hypervirulent. It would therefore be interesting to determine the exact phospholipid
composition of the pem1Δ/Δ pem1Δ/Δ, EPT1 overexpressor, and wild-type strains with
lipidomic analysis (mass spectrometry) to determine if there are any correlations between
the hypervirulent strains. An examination of these strains with mass spectrometry may
also help elucidate differences in acyl chain composition of phospholipids produced via
the Kennedy pathway as compared to those produced by the CDP-DAG pathway, which
has not been done in C. albicans¸ and this would determine if separate pools of PC/PE
are being produced by each pathway.
A final matter that has not been resolved is whether it is PS or PE that is required
for a restoration of β(1,3)-glucan unmasking in the cho1Δ/Δ strain, as there was an
unexpected occurrence in which PS was produced in the cho1Δ/Δ atSDC strain,
presumably by reverse action of the phosphatidylserine decarboxylase enzymes (Davis
et al., 2018). While it is most likely a combination of a loss of both phospholipids, one way
to definitively answer this question would be to knock out cho1Δ/Δ in the psd1Δ/Δ
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psd2Δ/Δ AtSDC triple mutant background. This transformation would be technically
challenging because of underlying cell wall issues, but there would be no way for this
quadruple mutant strain to create PS, as all enzymes with potential for its production
would be absent. Immunofluorescent imaging of β(1,3)-glucan in this strain would parse
apart whether it is really PS or PE that is responsible for restoration of β(1,3)-glucan
masking (or if it is a combination of the two).
Concluding Remarks
A major confounding problem with the study of phospholipids is that many of these
pathways are intertwined, and if one pathway is disrupted there are often compensatory
changes in expression or activity of alternate pathways to ameliorate issues with cell
function or viability. While we do have a good general outline of phospholipid biosynthetic
pathways for yeast, we do not have a full understanding of phospholipid pathways in C.
albicans because our common basis for our understanding of them is often elucidated
from S. cerevisiae and other Candida species. Another difficulty in the study of
phospholipid biosynthetic pathways is that proteins can localize to different regions of
phospholipid enrichment, and it is difficult to discern local changes to the profiles of lipids
in a given portion of a membrane. In addition, mutations in phospholipid synthesis are
often pleiotropic: proteins may not be secreted properly, transmembrane (and other)
proteins may localize improperly, and the balance of phospholipid intermediates which
often serve as second messengers can be disrupted. Beyond these difficulties, there are
“redundant” pathways that produce the same phospholipids. For instance, the Kennedy
pathway produces both PE and PC as does the CDP-DAG pathway, and one is required
for virulence while the other is not, as we have demonstrated in this dissertation. There
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are also redundancies for production of the same phospholipid within a single pathway
(Psd1 and Psd2 for example), for which the enzymes may localize to different locations
yet perform the same function, and this adds another layer of complexity to the gallimaufry
of phospholipid biosynthesis in C. albicans. Regardless, in this work we have ascertained
important insights into the function of the two most abundant phospholipids in C. albicans
with regard to virulence, and we have identified potential mechanisms by which changes
in the synthesis of PE and PC induce hypervirulence.
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